Sentence,class,file
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/54/ff/cia-10-1053.PMC4492631.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/54/ff/cia-10-1053.PMC4492631.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/c2/ijn-10-4185.PMC4492632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4185–4201International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4185OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8271 4Flow cytometry for intracellular sPION  quantification: specificity and sensitivity  in comparison with spectroscopic methods ralf P Friedrich,1 christina  Janko,1 Marina Poettler,1  Philipp Tripal,1 Jan Zaloga,1  Iwona cicha,1 stephan  Dürr,1,2 Johannes Nowak,3  stefan Odenbach,3 Ioana  slabu,4 Maik liebl,4 lutz  Trahms,4 Marcus stapf,5 Ingrid hilger,5 stefan lyer,1  christoph alexiou1 1Department of Otorhinolaryngology,  head and Neck surgery, section  of experimental Oncology  and Nanomedicine, University  hospital erlangen, 2Department  of Otorhinolaryngology, head and  Neck surgery, section of Phoniatrics  and Pediatric audiology, University  hospital erlangen, erlangen,  3T echnische Universität Dresden,  chair of Magnetofluiddynamics,  Measuring and automation T echnology,  Dresden, 4Physikalisch-Technische  Bundesanstalt Berlin, Berlin,  5Department of radiology, Division  of Diagnostic and  Interventional  radiology, experimental radiology,  University hospital Jena, Jena, germanyAbstract:  Due to their special physicochemical properties, iron nanoparticles offer new  promising possibilities for biomedical applications.",Non-OADS,/arxiv_data1/oa_pdf/12/c2/ijn-10-4185.PMC4492632.pdf
"Apart from their physicochemical properties, the internalization and/or binding of correspondence: christoph alexiou Department of Otorhinolaryngology,  head and Neck surgery, section  of experimental Oncology and  Nanomedicine, else Krüner-Fresenius- stiftung-Professorship, University hospital  erlangen, glückstrasse 10a, 91054  erlangen, germany Tel +49 913 1853 4769 Fax +49 913 1853 4828 email c.alexiou@web.d eJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Friedrich et al Running head recto: Quantification of cellular SPIONs with flow cytometry DOI: http://dx.doi.org/10.2147/IJN.S82714",Non-OADS,/arxiv_data1/oa_pdf/12/c2/ijn-10-4185.PMC4492632.pdf
Available from: http://www.sci - encedirect.com/science/article/pii/S030488531400824 5  22.,Non-OADS,/arxiv_data1/oa_pdf/12/c2/ijn-10-4185.PMC4492632.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/12/c2/ijn-10-4185.PMC4492632.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/c2/ijn-10-4185.PMC4492632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/ad/tcrm-11-1015.PMC4492633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1015–1025Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1015ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8501 9Comparative study on drug safety surveillance  between medical students of Malaysia and nigeria Correspondence: Mainul haque Faculty of Medicine, Universiti sultan  Zainal abidin, Kampus Kota, Jalan sultan  Mahmud, 20400 Kuala Terengganu,  Terengganu, Malaysia Tel +60 1092 6543 email runurono@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Abubakar et al Running head recto: Comparative study on drug safety surveillance on medical students DOI: http://dx.doi.org/10.2147/TCRM.S85019 abdullahi Rabiu abubakar salwani ismail nor iza a Rahman Mainul haque Faculty of Medicine, Universiti sultan  Zainal abidin, Kuala T erengganu,   T erengganu, MalaysiaBackground:  Internationally, there is a remarkable achievement in the areas of drug discovery,  drug design, and clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/48/ad/tcrm-11-1015.PMC4492633.pdf
Or use: http://youtu.be/m_Jryowpng wVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/48/ad/tcrm-11-1015.PMC4492633.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/48/ad/tcrm-11-1015.PMC4492633.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/ad/tcrm-11-1015.PMC4492633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/45/opth-9-1165.PMC4492634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1165–1176Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1165Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6202 1Leber hereditary optic neuropathy: current  perspectives Cherise Meyerson Greg van Stavern Collin McClelland Department of Ophthalmology  and visual Sciences, washington  University School of Medicine,   St Louis, MO, USAAbstract:  Leber hereditary optic neuropathy (LHON) is one of the most common inherited  optic neuropathies causing bilateral central vision loss.",Non-OADS,/arxiv_data1/oa_pdf/82/45/opth-9-1165.PMC4492634.pdf
"It was the first mitochondrial  disease to be recognized by Dr Albrecht von Graefe in 1858, but it was named after  Dr Theodore Leber who described 15 patients with the disease among four families.1  LHON was the first disorder recognized to be maternally inherited and the first to be  attributed to a point mutation in mitochondrial DNA (mtDNA).2,3 Vision loss from  LHON results from selective degeneration of retinal ganglion cells (RGCs), which are  highly sensitive to mitochondrial dysfunction and metabolic insult.4 The mechanisms  involved in the pathogenesis of LHON continue to be elucidated, paving the way for  research into potential therapeutic interventions.Correspondence: Collin McClelland Department of Ophthalmology and visual  Sciences, washington University School  of Medicine, Campus Box 8096, 660 S  euclid Ave, St Louis, MO 63110, USA Tel +1 314 362 3937 Fax +1 314 362 3725 email mcclellandc@vision.wustl.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Meyerson et al Running head recto: Leber hereditary optic neuropathy DOI: http://dx.doi.org/10.2147/OPTH.S62021",Non-OADS,/arxiv_data1/oa_pdf/82/45/opth-9-1165.PMC4492634.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/82/45/opth-9-1165.PMC4492634.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/45/opth-9-1165.PMC4492634.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0216138 0.,Non-OADS,/arxiv_data1/oa_pdf/82/45/opth-9-1165.PMC4492634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3313–3324Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3313Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8464 1exploration of natural product ingredients as  inhibitors of human hMg-coa reductase through  structure-based virtual screening shih-hung lin1 Kao-Jean huang1,2 ching-Feng Weng1 David shiuan1 1Department of life science and  institute of Biotechnology, national  Dong hwa University, hualien, Taiwan,   republic of china; 2Development  center of Biotechnology, Taipei,   Taiwan, republic of chinaAbstract:  Cholesterol plays an important role in living cells.",Non-OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
"Based on  the criteria of inhibition of hHMGR activity, many cholesterol-lowering drugs such as correspondence: David shiuan Department of life science and institute  of Biotechnology, national Dong hwa  University, hualien, Taiwan 974, republic  of china email shiuan@mail.ndhu.edu.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lin et al Running head recto: Inhibitors of human HMG-CoA reductase DOI: http://dx.doi.org/10.2147/DDDT.S84641",Non-OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
Molecular docking and analysis of ligand– protein interactions The 3D structure PDB 1HWK10 of hHMGR was cho - sen as the molecular target and obtained from the PDB  (http://www.rcsb.org/pd b).,OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
"The tetrameric structure contains the catalytic domains of hHMGR (subunit   A: Pro442–His861; B: Ser463–Gly860; C: Leu462–Gly860;  D: Ser463–Gly860) complexed with four atorvastatin  molecules at the interfaces of two adjacent monomers.10  After removing unnecessary ligands, we kept two adjacent  monomers of hHMGR, fixed with the force-field CHARMM  (Chemistry at HARvard Macromolecular Mechanics)  equipped in DS 3.5 ( http://accelrys.com/products/discovery- studi o) to add up the hydrogen atoms, partial charges, and  missing residues so that the structure can be used properly for  molecular docking processes.",OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
"The ligand-binding sites were  predicted by estimating the receptor cavities or the active sites  from PDB site records, using the tools of DS 3.5.11,12 The TCM database ( http://tcm.cmu.edu.tw /) was used  as the small molecule resource and screened using the  LigandFit software of DS 3.5 (Accelrys Software Inc., San  Diego, CA, USA), which provides a shape-based method  for accurately docking ligands into the protein-binding  sites.12–14 The ligand–protein (hHMGR) interactions were  further analyzed using the view interaction tools provided  by DS 4.0 visualizer (Accelrys Software Inc., San Diego,  CA, USA).",OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/34/dddt-9-3313.PMC4492635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/9e/jbm-6-211.PMC4492636.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 211–217Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S8155 1Predictors of atrial fibrillation recurrence after  cryoballoon ablation T olga aksu1 erkan Baysal2 Tümer erdem guler1 Sukriye Ebru Golcuk3 i˙smail erden1 Kazim serhan Ozcan1 1Department of cardiology, Derince  education and research hospital,   Kocaeli, 2Department of cardiology,   Diyarbakir Education and Research  Hospital, Diyarbakir, 3Department of  cardiology, Faculty of Medicine, Koc  University, Istanbul, T urkey correspondence: Tolga aksu   Department of cardiology, Derince  education and research hospital,   Ibni-sina Street, No 4,   Derince, Kocaeli  41000, Turkey   Tel +90 531 990 3278  Fax +90 262 317 8000  email aksutolga@gmail.co mObjective:  Cryoballoon ablation (CA) is a safe and efficient method for pulmonary vein  isolation in the treatment of paroxysmal atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/ea/9e/jbm-6-211.PMC4492636.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/ea/9e/jbm-6-211.PMC4492636.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/9e/jbm-6-211.PMC4492636.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/4b/vhrm-11-379.PMC4492637.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 379–385Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  379ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S8349 2Preoperative optimization of the vascular surgery  patient Henry T Zhan1 Seth T Purcell1,2 Ruth L Bush1 1Texas A&M Health Science Center  College of Medicine, Bryan,  2Baylor  Scott and white, T emple, TX, USA Correspondence: Ruth L Bush   Texas A&M Health Science Center  College of Medicine, MS  1359 8447 State  Highway  47, HPeB  3060, Bryan, TX   77807-3260, USA   Tel +1 979 436 0223  Fax +1 979 436 0092  email rbush@medicine.tamhsc.ed uAbstract:  It is well known that patients who suffer from peripheral (noncardiac) vascular  disease often have coexisting atherosclerotic diseases of the heart.",Non-OADS,/arxiv_data1/oa_pdf/63/4b/vhrm-11-379.PMC4492637.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/63/4b/vhrm-11-379.PMC4492637.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/4b/vhrm-11-379.PMC4492637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3405–3412Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3405Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8314 4Effect of vitamin C on inflammation and metabolic  markers in hypertensive and/or diabetic obese  adults: a randomized controlled trial Mohammed s ellulu1 asmah rahmat1 ismail Patimah2 huzwah Khaza’ai2 Yehia Abed3 1Department of nutrition  and Dietetics, 2Department of  Biomedical science, Faculty of Medicine  and health sciences, Universiti  Putra Malaysia, serdang, Malaysia;  3Faculty of Public Health, Al-Quds  University, gaza city, PalestineBackground:  Obesity is well associated as being an interfering factor in metabolic diseases  such as hypertension and diabetes by increasing the secretion of proinflammatory markers from  adipose tissue.",Non-OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
"It acts as an electron donor for eight human enzymes and neutralizes free radicals to  protect from damage.1 Because of its structural similarity to glucose, it can replace  glucose in many chemical reactions, and it can prevent the non-enzymatic glycosylation  of proteins.2 A possible mechanism for the beneficial effect of plasma vitamin C on  heart failure may relate to the fact that it enhances arterial dilation through its effect  on nitric-oxide release,3 as it protects tissues from oxidative stress and thus plays an  important role in preventing diseases.1 Large epidemiological studies have reported correspondence: asmah rahmat Department of nutrition and Dietetics,  Faculty of Medicine and health sciences,  Universiti Putra Malaysia, 43400 serdang,  selangor, Malaysia Tel +60 17 3972 310 email asmah@upm.edu.m y Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ellulu et al Running head recto: Effect of vitamin C on inflammation and metabolic markers DOI: http://dx.doi.org/10.2147/DDDT.S83144",Non-OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
"Available from: http://www.who.int/chp/steps/ resources/GPAQ_Analysis_Guide.pd f. Accessed May 26, 2015.",OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
Available from: http://www.who.int/nutrition/ publications /obesity/WHO_TRS_894/en /.,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/dddt-9-3405.PMC4492638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/2c/vhrm-11-361.PMC4492639.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 361–371Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  361ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S8483 2Physical activity in patients with type  2 diabetes  and hypertension – insights into motivations and  barriers from the MOBile study Martine Duclos1,2 sylvie Dejager3,4 nicolas Postel-Vinay5 sylvie di nicola6 stéphane Quéré7 Béatrice Fiquet4,5 1Department of sport Medicine and  Functional explorations, University- Hospital ( cHU), g Montpied  Hospital; inRa, UnH, cRnH  auvergne, 2nutrition Department,   University of auvergne, clermont- Ferrand, auvergne,  3Department  of endocrinology and Metabolism,   la Pitié-salpétrière Hospital,   Paris,  4clinical and scientific  affairs, novartis Pharma sas,   Rueil-Malmaison,  5Department of  Hypertension, georges Pompidou  european Hospital, Paris,  6Biostatistics,   inferential, Paris,  7Biostatistics,   novartis Pharma sas, Rueil- Malmaison, France correspondence: sylvie Dejager   Department of endocrinology and  Metabolism, la Pitié-salpétrière Hospital,  47-83 Boulevard de l’Hôpital,  75013 Paris, France   Tel +33 1 4217 7832   email sylvie.dejager@psl.aphp.f rBackground:  Although physical activity (PA) is key in the management of type  2 diabetes  (T2DM) and hypertension, it is difficult to implement in practice.",Non-OADS,/arxiv_data1/oa_pdf/64/2c/vhrm-11-361.PMC4492639.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/64/2c/vhrm-11-361.PMC4492639.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/2c/vhrm-11-361.PMC4492639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3393–3404Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3393Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8563 3scientometrics of drug discovery efforts:  pain-related molecular targets igor Kissin Department of anesthesiology,   Perioperative and Pain Medicine,   Brigham and Women’s hospital,   harvard Medical school, Boston,   Ma, UsaAbstract:  The aim of this study was to make a scientometric assessment of drug discovery  efforts centered on pain-related molecular targets.",Non-OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
"However, there is currently the feeling that success in the devel - opment of new analgesic drugs has been quite limited despite improvements in our correspondence: igor Kissin Department of anesthesiology, Brigham  and Women’s hospital, 75 Francis street,  Boston, Ma 02115, Usa Tel +1 617 732 5052 Fax +1 617 734 0682 email kissin@zeus.bwh.harvard.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kissin Running head recto: Molecular targets for treatment of pain DOI: http://dx.doi.org/10.2147/DDDT.S85633",Non-OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
"searches The above indices related to published articles were calcu - lated on the basis of the results obtained via searches of the  PubMed database, ie, the National Library of Medicine’s  PubMed website ( http://www.ncbi.nlm.nih.gov/pubme d).",OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
"In addition to publications in biomedical journals, the  intensity of efforts associated with the development of pain- related molecular targets was also assessed using the number  of related patents in the US Patent and Trademark Office data - base ( http://partft1.uspto.gov/netahtml/PTO/search-adv.htl m).",OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/09/dddt-9-3393.PMC4492640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/69/jmdh-8-307.PMC4492641.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 307–320Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  307Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S8280 9Development of a self-management program for  employees with complaints of the arm, neck, and/ or shoulder: an intervention mapping approach nathan Hutting1,2 sarah i Detaille2,3 Josephine a engels2 Yvonne F Heerkens2 J Bart staal1,4 Maria W g nijhuis-van   der sanden1 1radboud University Medical center,   radboud institute for Health sciences,   the scientific institute for Quality of  Healthcare, 2Hogeschool van arnhem  en nijmegen (H an) University of  applied sciences, Faculty of Health  and social studies, research group  Occupation and Health, 3Han   University of applied sciences,   Department Han  seneca, 4Han   University of applied sciences, Faculty  of Health and social studies, research  group Musculoskeletal rehabilitation,   nijmegen, the netherlands correspondence: nathan Hutting, Han  University of applied sciences, PO Box   6960, 6503 gl nijmegen,   the netherlands   Tel +31 64 789 2426  email n athan.",Non-OADS,/arxiv_data1/oa_pdf/9c/69/jmdh-8-307.PMC4492641.pdf
The RCT is registered with the Dutch Trial  Register ( http://www.trialregister.n l; registration number  NTR3816).,Non-OADS,/arxiv_data1/oa_pdf/9c/69/jmdh-8-307.PMC4492641.pdf
1994; Available from: http://userpage.fu-berlin.,Non-OADS,/arxiv_data1/oa_pdf/9c/69/jmdh-8-307.PMC4492641.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/9c/69/jmdh-8-307.PMC4492641.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/69/jmdh-8-307.PMC4492641.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 321–333Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  321ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8297 0Multivariate proteomic analysis of the  cerebrospinal fluid of patients with peripheral  neuropathic pain and healthy controls –   a hypothesis-generating pilot study emmanuel Bäckryd1,2 Bijar ghafouri1,2 anders K carlsson1,2 Patrik Olausson1,2 Björn gerdle1,2 1Division of community Medicine,   Department of Medical and health  sciences, Faculty of health sciences,   linköping University, linköping,   sweden; 2Pain and Rehabilitation  centre, anaesthetics, Operations  and specialty surgery centre, Region  Östergötland, linköping, sweden correspondence: emmanuel Bäckryd   Division of community Medicine,  Department of Medical and health  sciences, Faculty of health sciences,  linköping University,   se-581 85 linköping, sweden   Tel +46 10 103 3661   email emmanuel.backryd@ regionostergotland.s eAbstract:  Pain medicine lacks objective biomarkers to guide diagnosis and treatment.",Non-OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
"Journal of Pain Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press 324Bäckryd et al et al.42 The samples were applied onto the target plate, ana - lyzed using MALDI-TOF MS (V oyager-DE PRO; Thermo  Fisher Scientific) with a 337 nm N2 laser set in positive mode,  reflector mode, delayed extraction, and instruments settings  as defined previously.42 LC-MS/MS spectra were processed  by Bruker Daltonik DataAnalysis 3.4, and resulting MS/MS  data were searched in NCBInr and SwissProt databases on  the MASCOT server ( http://www.matrixscience.com/cgi/ search_form.pl?FORMVER=2&SEARCH=MI S).",OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
"Pain networks interaction analysis In order to analyze our results from a systems biology  perspective,45 the four genes coding for the above-mentioned  seven proteins were entered into a human Pain Networks  search ( http://www.painnetworks.org , accessed June 9,  A 10,000 8,000 6,000Spot optical density (ppm)4,000 2,000 Patients Healthy controls*15 O19O4 oo19160B 17,500 15,000 12,500Spot optical density (ppm)10,000 7,500 5000 Patients Healthy controlsC 4,000 3,000 2,000 1,000 0Spot optical density (ppm) Patients Healthy controls D 10,000 8,000 6,000Spot optical density (ppm)4,000 2,000 Patients Healthy controls0E 10,000 8,000 6,000Spot optical density (ppm)4,000 2,000 0 Patients Healthy controlsF 12,000 10,000 8,000 6,000 4,000 2,000 0Spot optical density (ppm) Patients Healthy controlsG 6,000 5,000 4,000 3,000 2,000Spot optical density (ppm) Patients Healthy controls Figure 2 spot optical densities in parts per million (ppm) for the seven most discriminating protein spots (patients vs healthy controls).",Non-OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
"The online  tool Pain networks was used ( http://www.painnetworks.org ), accessed June 9,  2015, and the “physical” filtering option was chosen, ie, the map displays only  interactions with evidence of the proteins physically touching.",OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/7f/jpr-8-321.PMC4492642.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/88/idr-8-181.PMC4492643.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 181–187Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  181ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S6138 1histopathological changes induced in an animal  model by potentially pathogenic Enterococcus  faecalis  strains recovered from ready-to-eat   food outlets in Osun state, nigeria adetunji Kola Olawale1,2  Oluwole Moses David2,3 adekemi Olubukunola  Oluyege2 Richard Temitope  Osuntoyinbo4 solomon anjuwon laleye5 Oladiran Famurewa2 1Department of applied sciences,  Osun state Polytechnic, Iree,   2Department of Microbiology,  University of ado-ekiti, ado-ekiti,  nigeria;  3Phytomedicine Research  centre, Department of Botany,  University of Fort hare, alice,  south africa;  4Department of  Microbiology, Waterford Regional  hospital, Waterford, Republic of  Ireland;  5Department of Microbiology,  adekunle ajasin University, akungba- akoko, nigeria correspondence: O Famurewa   Department of Microbiology,   University of ado-ekiti, PMB  5363,   ado-ekiti  360001, nigeria   email ofamurewa@eksu.edu.n gAbstract:  Enterococci have been implicated as an emerging important cause of several diseases  and multiple antibiotic resistance.",Non-OADS,/arxiv_data1/oa_pdf/56/88/idr-8-181.PMC4492643.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/56/88/idr-8-181.PMC4492643.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/88/idr-8-181.PMC4492643.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/18/dmso-8-295.PMC4492644.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 295–302Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  295Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6129 6Epigenetic and developmental influences on the  risk of obesity, diabetes, and metabolic syndrome Caitlin J Smith Kelli K Ryckman Department of epidemiology,   University of iowa, College of Public  Health, iowa City, iA, USA Correspondence: Kelli K Ryckman   Department of epidemiology, University  of iowa, College of Public Health,   145 Riverside Drive, S414 CPHB,   iowa City, iA 52242, USA   Tel +1 319 384 1562   Fax +1 319 384 4155   email kelli-ryckman@uiowa.ed uAbstract:  Metabolic syndrome is a growing cause of morbidity and mortality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/49/18/dmso-8-295.PMC4492644.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/49/18/dmso-8-295.PMC4492644.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/18/dmso-8-295.PMC4492644.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/44/oajsm-6-209.PMC4492645.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 209–217Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  209OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7918 9Muscle and intensity based hamstring exercise  classification in elite female track and field  athletes: implications for exercise selection   during rehabilitation Panagiotis Tsaklis1,2 Nikos Malliaropoulos3–5,10 Jurdan Mendiguchia6 Vasileios Korakakis7–9 Kyriakos Tsapralis11 Debasish Pyne5 Peter Malliaras10 1Department of Physiotherapy,  laboratory of Biomechanics and  ergonomics, Alexander Technological  Educational Institute of Thessaloniki,  Thessaloniki, Greece;  2Department  of Mechanical engineering,  Bioengineering, Massachusetts  institute of Technology, cambridge,  MA, USA;  3National Track and  Field centre, Sports injury clinic,  Sports Medicine clinic of SegAS,   4Thessaloniki Sports Medicine  Clinic, Thessaloniki, Greece;   5rheumatology Department, Sports  Medicine clinic, Mile end hospital,  London, UK;  6Department of Physical  Therapy, Zentrum rehabilitation  and Performance center, Pamplona,  Spain;  7Aspetar, Orthopaedic and  Sports Medicine hospital, Doha,  Qatar;  8Faculty of Physical education  and Sport Science, University  of Thessaly, Trikala,  9hellenic  Orthopaedic Manipulative Therapy  Diploma, Athens, Greece;  10centre  for Sports and exercise Medicine,  Queen Mary, University of london,  London, UK; 11K Tsapralis Isokinetic  Medical group, Bologna, italy Correspondence: Nikos Malliaropoulos   rheumatology Department, Sports  Medicine clinic, Mile end hospital,  Bancroft road, london e1 4Dg, UK   email contact@sportsmed.g rBackground:  Hamstring injuries are common in many sports, including track and field.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/oajsm-6-209.PMC4492645.pdf
"These muscles were chosen because they cover  the most commonly affected components of hamstring  injury.9,13,14  Disposable pregelled self-adhesive bipolar sur - face electrodes (Ag/AgCl,  0.8 cm in diameter, Blue Sensor  N-00-S,  Medicotest A/S, Ølstykke, Denmark) were placed  on the dominant leg with an interelectrode distance of  2 cm  in accordance with SENIAM (Surface ElectroMyoGraphy  for the Non-Invasive Assessment of Muscle) guidelines  (http://www.seniam.or g).",Non-OADS,/arxiv_data1/oa_pdf/c0/44/oajsm-6-209.PMC4492645.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/oajsm-6-209.PMC4492645.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/44/oajsm-6-209.PMC4492645.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1549–1560Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1549Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6747 7T ranscranial magnetic stimulation for the treatment  of major depression Philip G Janicak Mehmet e Dokucu Department of Psychiatry and  Behavioral Sciences, Feinberg School  of Medicine, Northwestern University,   Chicago, iL, USAAbstract:  Major depression is often difficult to diagnose accurately.",Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
"In terms of alternative treatment approaches, one option is therapeutic neuromodula - tion, which involves the use of various devices to alter electrical activity in the central  nervous system.3 This approach is based on the premise that the brain is an electro - chemical organ and therefore can be modulated by electrical as well as pharmacological Correspondence: Philip G Janicak Department of Psychiatry and Behavioral  Sciences, Feinberg School of Medicine,  Northwestern University, 446 east  Ontario Street, Suite7-100, Chicago iL  60611, USA email pjanicak@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Janicak and Dokucu Running head recto: Transcranial magnetic stimulation for the treatment of major depression DOI: http://dx.doi.org/10.2147/NDT.S67477",Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
Available  from: https://clinicaltrials.gov/ct2/s how/results/NCT01909232.,Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
Available from: http://cervel.com/cervel- announces -successful - depression-clinical-study-results /.,Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/5d/ndt-11-1549.PMC4492646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/fe/ndt-11-1561.PMC4492647.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1561–1571Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1561Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S86552Korean Medication Algorithm for Bipolar  Disorder  2014: comparisons with other treatment  guidelines Jong-Hyun Jeong,1 Jeong Goo  Lee,2,3 Moon-Doo Kim,4 inki  Sohn,5 Se-Hoon Shim,6 Hee Ryung  wang,1 Y oung Sup woo,1 Duk-in  Jon,7 Jeong Seok Seo,8 Young-Chul  Shin,9 Kyung Joon Min,10 Bo-Hyun  Y oon,11 won-Myong Bahk1 1Department of Psychiatry, College of  Medicine, The Catholic University of  Korea, Seoul, 2Department of Psychiatry,   Haeundae Paik Hospital, College of  Medicine, Paik institute for Clinical  Research, inje University, 3Department  of Health Science and T echnology,   Graduate School of inje University, Busan,   4Department of Psychiatry, Jeju National  University Hospital, Jeju, 5Department of  Psychiatry, Keyo Hospital, Keyo Medical  Foundation, Uiwang, 6Department of  Psychiatry, Soonchunhyang University  Cheonan Hospital, College of Medicine,   Soonchunhyang University, Cheonan,   7Department of Psychiatry, Sacred Heart  Hospital, College of Medicine, Hallym  University, Anyang, 8Department of  Psychiatry, Konkuk University Chungju  Hospital, School of Medicine, Konkuk  University, Chungju, 9Department of  Psychiatry, Kangbuk Samsung Hospital,   School of Medicine, Sungkyunkwan  University, Seoul, 10Department of  Psychiatry, Chung-Ang University Hospital,   College of Medicine, Chung-Ang University,   Seoul, 11Department of Psychiatry, Naju  National Hospital, Naju, KoreaAbstract:  Our goal was to compare the recommendations of the Korean Medication Algorithm  Project for Bipolar Disorder 2014 (KMAP-BP 2014) with other recently published guidelines for  the treatment of bipolar disorder.",Non-OADS,/arxiv_data1/oa_pdf/76/fe/ndt-11-1561.PMC4492647.pdf
"In Korea, a medication algorithm project (Korean Medication Algorithm Project for  Bipolar Disorder, KMAP-BP) was initiated in 2001 and KMAP-BP was published in  2002 (KMAP-BP 2002), with its feasibility confirmed.8 Revised versions of KMAP-BP  were released in 2006 and 2010.9–11 However, newer atypical antipsychotics (AAPs) and Correspondence: Bo-Hyun Yoon Department of Psychiatry, Naju National  Hospital, 1328-31, Senam-ro, Sanpo-myeon,  Naju 520-833, Korea   Tel +82 61 313 4114   Fax +82 61 330 4150   email yoonbh@chol.co m  won-Myong Bahk Department of Psychiatry, Yeouido St  Mary’s Hospital, College of Medicine, The  Catholic University of Korea, 10, 63-ro,  Yeongdeungpo-gu, Seoul 150-713, Korea   Tel +82 2 3779 1051   Fax +82 2 780 6577   email wmbahk@catholic.ac.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Jeong et al Running head recto: Comparison of KMAP-BP 2014 DOI: http://dx.doi.org/10.2147/NDT.S86552",Non-OADS,/arxiv_data1/oa_pdf/76/fe/ndt-11-1561.PMC4492647.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/76/fe/ndt-11-1561.PMC4492647.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/fe/ndt-11-1561.PMC4492647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/4a/lra-8-015.PMC4492648.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 15–19Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  15CAse seRiesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S8236 2separation of stimulating catheters for continuous  peripheral regional anesthesia during their  removal – two case reports and a critical  appraisal of the use of steel-coil containing  stimulating catheters Thomas Wiesmann1 Pascal Wallot1 Laura Nentwig1 Alisha-Viktoria Beermann1 Hinnerk Wulf1 Martin Zoremba1 T urfa Al-Dahna1 Daphne eschbach2 Thorsten steinfeldt1 1Department of Anesthesia and  intensive Care Medicine, University  Hospital Marburg, Marburg, Germany;   2Department of Trauma, Hand and  Reconstructive surgery, University  Hospital Marburg, Marburg, Germany Correspondence: Thomas Wiesmann   Department of Anesthesia and intensive  Care Medicine, University Hospital  Giessen and Marburg, Campus   Marburg, Baldinger strasse 35033  Marburg, Germany   T el +49 6421 5869 362   Fax +49 6421 5865 971   email wiesmann@med.uni-marburg.d ePurpose:  Stimulating catheters are widely used for continuous peripheral nerve block techniques  in regional anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/b7/4a/lra-8-015.PMC4492648.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/b7/4a/lra-8-015.PMC4492648.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/4a/lra-8-015.PMC4492648.pdf
"Available from: http://www.ak-regionalanaesthesie.dgai.de/ empfehlungen- links/empfehlungen/doc_details/86-hygieneempfehlungen-fuer-die- regionalanaesthesie.htm l. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b7/4a/lra-8-015.PMC4492648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/41/opth-9-1155.PMC4492649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1155–1157Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1155Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S8108 9Differentiating type 1 from type 2 big bubbles  in deep anterior lamellar keratoplasty Harminder S Dua1 tarek Katamish2 Dalia G Said1 Lana A Faraj1 1Section of Academic Ophthalmology,  Division of Clinical Neuroscience,  University of Nottingham, Nottingham,  UK; 2Department of Ophthalmology,  Cairo University, Cairo, egyptDear editor We read with interest the paper by Anwar et al.1 The authors have described a tech - nique to bare Descemet’s membrane (DM) by multiple lamellar dissection of the deep  corneal stroma when stromal injection of air fails to achieve a big bubble (BB) in deep  anterior lamellar keratoplasty (DALK).",Non-OADS,/arxiv_data1/oa_pdf/8c/41/opth-9-1155.PMC4492649.pdf
"Moreover, in Correspondence: Harminder S Dua Academic section of Ophthalmology,  Division of Clinical Neuroscience,  University of Nottingham, B Floor,  eye eNt Centre, Queens Medical  Centre, Derby road, Nottingham,  NG7 2UH, UK tel +44 115 924 9924 ext 62537 email harminder.dua@nottingham.ac.u k Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2015 Volume: 9 Running head verso: Dua et al Running head recto: Difference between type 1 and type 2 big bubbles in deep anterior lamellar keratoplasty DOI: http://dx.doi.org/10.2147/OPTH.S81089",Non-OADS,/arxiv_data1/oa_pdf/8c/41/opth-9-1155.PMC4492649.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8c/41/opth-9-1155.PMC4492649.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/41/opth-9-1155.PMC4492649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/49/cia-10-1063.PMC4492650.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1063–1067Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1063OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8503 9Is cemented bipolar hemiarthroplasty a safe  treatment for femoral neck fracture in elderly  patients?,Non-OADS,/arxiv_data1/oa_pdf/0d/49/cia-10-1063.PMC4492650.pdf
"While femoral neck fractures treated via cemented  hemiarthroplasty may be less prone to periprosthetic fracture and prosthetic loosening,  they are also more likely to trigger embolisms and decreased cardiac output during Correspondence: Fatih Karaaslan Department of Orthopedics and  Traumatology, Faculty of Medicine, Bozok  University, 18 Madrasa Adnan Menderes,  Boulevard, Yozgat 66200, Turkey Tel +90 354 212 70 60 email fkaraaslan@gmail.co mJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Yurdakul et al Running head recto: Cemented bipolar hemiarthroplasty and neck fracture DOI: http://dx.doi.org/10.2147/CIA.S85039",Non-OADS,/arxiv_data1/oa_pdf/0d/49/cia-10-1063.PMC4492650.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0d/49/cia-10-1063.PMC4492650.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0d/49/cia-10-1063.PMC4492650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/98/dddt-9-3377.PMC4492651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3377–3391Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3377Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8473 1Discovery of 3- n-butyl-2,3-dihydro- 1H-isoindol-1- one as a potential anti-ischemic stroke agent Zujian lan Xiaoyu Xu Wenkai Xu Jin li Zengrong liang Xuefei Zhang Ming lei chunshun Zhao school of Pharmaceutical sciences,   sun Yat-sen University, guangzhou,   People’s republic of chinaAbstract:  To develop novel anti-ischemic stroke agents with better therapeutic efficacy and  bioavailability, we designed and synthesized a series of 3-alkyl-2,3-dihydro- 1H-isoindol-1-ones  compounds (3a –i) derivatives, one of which (3d) exhibited the strongest inhibitory activity for  the adenosine diphosphate-induced and arachidonic acid-induced platelet aggregation.",Non-OADS,/arxiv_data1/oa_pdf/31/98/dddt-9-3377.PMC4492651.pdf
"What is worse,  about 90% of all stroke patients are excluded from t-PA treatment due to numerous  contraindications and its extremely narrow therapeutic window.9,10 Previous studies have demonstrated that mechanisms leading to the develop - ment of ischemic damage include apoptosis, calcium ion [Ca2+] overload, necrosis, correspondence: chunshun Zhao school of Pharmaceutical sciences, sun  Yat-sen University, 132 Waihuan east  road, guangzhou higher education Mega  center, guangzhou 510006, People’s  republic of china Tel +86 20 3994 3118 Fax +86 20 3994 3118 email zhaocs@mail.sysu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lan et al Running head recto: Discovery of isoindoline as anti-ischemic stroke agent DOI: http://dx.doi.org/10.2147/DDDT.S84731",Non-OADS,/arxiv_data1/oa_pdf/31/98/dddt-9-3377.PMC4492651.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/31/98/dddt-9-3377.PMC4492651.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/98/dddt-9-3377.PMC4492651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 369–375ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  369ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8127 7Cost and effectiveness of omega-3 fatty acid  supplementation in Chinese iCU patients  receiving parenteral nutrition guo hao Wu1 Jian gao2 Chun Yan Ji2 lorenzo Pradelli3 Qiu lei Xi1 Qiu lin Zhuang1 1Department of general surgery,   2Department of n utrition, Zhongshan  hospital, Fudan University, shanghai,   People’s Republic of China; 3adRes  health Economics and Outcomes  Research, Piazza Carlo Emanuele ii,   T orino, italy Correspondence: guo hao Wu   Department of general surgery,  Zhongshan hospital, Fudan University,  138 Yixueyuan Road, shanghai 200032,  People’s Republic of China   Email prowugh@163.co m    Jian gao   Department of nutrition, Zhongshan  hospital, Fudan University, 138 Yixueyuan  Road, shanghai 200032, People’s Republic  of China   Email gao.jian@zs-hospital.sh.c nBackground and objectives:  Clinical evidence supports the use of omega-3 polyunsaturated  fatty acid (PUFA)-enriched lipid emulsions in place of standard lipid emulsions in parenteral  nutrition (PN) for intensive care unit (ICU) patients, but uptake may be limited by higher costs.",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
Available from: http://www.bapen.org.,Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
"Available from: http://www.bapen.org.uk/ professionals/ publications-and-resources/bapen-report s. Accessed May 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
"Available from: http://www.bapen.org.uk/profession - als/publications-and-resources/bapen-report s. Accessed May 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
Available from: http://www.bapen.org.,Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
"Available from: http://www.bapen.org.uk/ professionals/ publications-and-resources/bapen-report s. Accessed May 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/c8/ceor-7-369.PMC4492652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/89/dddt-9-3341.PMC4492653.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3341–3348Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3341Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8594 3The role of gliadel wafers in the treatment  of newly diagnosed gBM: a meta-analysis Wei-kang Xing1 chuan shao2 Zhen-yu Qi1 chao Yang1 Zhong Wang1 1Department of n eurosurgery,   The First affiliated hospital of  soochow University, suzhou, Jiangsu,   2Department of neurosurgery, The  second clinical Medical college  of north sichuan Medical college,   nanchong, sichuan, People’s republic  of chinaBackground:  Standard treatment for high-grade glioma (HGG) includes surgery followed by  radiotherapy and/or chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/bf/89/dddt-9-3341.PMC4492653.pdf
"These wafers could supply a  controlled release of 7.7 mg BCNU for around 5 days.4 BCNU may alkylate the  nucleoprotein and interfere with the DNA synthesis and repair, and the carbonylation correspondence: Zhen-yu Qi Department of neurosurgery, The First  Affiliated Hospital of Soochow University,  188 shizi street, suzhou, Jiangsu 215006,  People’s republic of china email qizhenyu@suda.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Xing et al Running head recto: Gliadel wafers and glioblastoma multiforme DOI: http://dx.doi.org/10.2147/DDDT.S85943",Non-OADS,/arxiv_data1/oa_pdf/bf/89/dddt-9-3341.PMC4492653.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bf/89/dddt-9-3341.PMC4492653.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/89/dddt-9-3341.PMC4492653.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 655–661International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  655OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7780 7Determinants of use of insecticide-treated nets  among pregnant women in nigeria Onoriode ezire1 samson B adebayo2 Omokhudu Idogho3 elijah a Bamgboye4 ernest nwokolo5 1research and evaluation Division,   society for Family Health, abuja,   2national agency for Food and Drug  administration and control, abuja,   3enhancing n igeria’s response  to HIV & aIDs, abuja, 4Medical  statistics, University of Ibadan,   Ibadan,  5society for Family Health,   abuja, nigeriaBackground:  Malaria in pregnancy is still a major health issue in Nigeria, accounting for  about 33% of cause of maternal death.",Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
"It is transmitted from bites of an infected female Anopheles  mosquito to correspondence: Onoriode ezire research and evaluation Division,  society for Family Health, no 8, Port  Harcourt crescent, Off gimbiya street,  area 11, garki, Federal capital Territory,  abuja, nigeria Mobile +234 80 6008 7524 email oeziree@yahoo.co mJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Ezire et al Running head recto: Insecticide-treated nets among pregnant women DOI: http://dx.doi.org/10.2147/IJWH.S77807",Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
Available from: http://www.lagosstateministryofhealth.com/ programme_info.php?programme_id =6.,Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
"Available from: http://ghf.g2hp.net/2013/07/19/the-use-of-insecticide- treated-nets-among-pregnant-women-in-nigeria/#.VE-j7NhOUl Y.  Accessed October 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/39/51/ijwh-7-655.PMC4492654.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 995–1001Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  995ExpERT OpiniO nopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6422 2Managing infertility with the follitropin alfa prefilled   pen injector – patient considerations Klaus Bühler Centre for Gynaecological  Endocrinology and Reproductive  Medicine, Stuttgart, GermanyAbstract:  Gonadotropin treatment has been used in fertility treatment since the 1930s.",Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
"Furthermore, it must  be taken into account that within the last decades a reduction in general child-seeking Correspondence: Klaus Bühler Centre for Gynaecological Endocrinology  and Reproductive Medicine,  Friedrichstraße 45, D-70174 Stuttgart,  Germany Email buehler@ivf-zentru mJournal name: Therapeutics and Clinical Risk Management Article Designation: Expert Opinion Y ear: 2015 Volume: 11 Running head verso: Bühler Running head recto: Follitropin alfa prefilled pen injector for management of infertility DOI: http://dx.doi.org/10.2147/TCRM.S64222 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
Or use: http://youtu.be/Ft00KfgvOi 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
Available from: http://webarchive.nationalarchives.gov.,Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
"uk/20130107105354 /http://www.dh.gov.uk/prod_consum_dh/groups/ dh_digitalassets/documents/digitalasset/dh_101068.pd f. Accessed  April 4, 2015.",OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
"Available  from: http://ec.europa.eu/health/archive/ph_risk/committees/scmp/ documents/out12_en.pd f. Accessed April 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
"Available from:  http://www.deutsches-ivf-register.de/jahrbuch-archiv.ph p. Accessed  April 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/79/tcrm-11-995.PMC4492655.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/a8/tcrm-11-1003.PMC4492656.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1003–1013Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1003Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7696 4OnabotulinumtoxinA for chronic migraine:  a critical appraisal Rubesh Gooriah Fayyaz Ahmed Department of Neurology, Hull Royal  infirmary, Kingston Upon Hull, UKAbstract:  Chronic migraine (CM) is a severe disabling condition with a few available  evidence-based management options.",Non-OADS,/arxiv_data1/oa_pdf/97/a8/tcrm-11-1003.PMC4492656.pdf
"It was approved by the Medicines and Healthcare  Products Regulatory Agency (MHRA) in July 2010 followed by the US Food and Correspondence: Fayyaz Ahmed Department of Neurology, Hull Royal  Infirmary, Anlaby Road, Kingston Upon  Hull HU3 2JZ, UK email fayyaz.ahmed@hey.nhs.u k Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Gooriah and Ahmed Running head recto: OnabotulinumtoxinA for chronic migraine DOI: http://dx.doi.org/10.2147/TCRM.S76964",Non-OADS,/arxiv_data1/oa_pdf/97/a8/tcrm-11-1003.PMC4492656.pdf
Available from: http://publications.nice.org.uk/botulinum-toxin-type- a-for-the-prevention-ofheadaches-n-adults-with-chronic-migraine- ta260  14.,Non-OADS,/arxiv_data1/oa_pdf/97/a8/tcrm-11-1003.PMC4492656.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/97/a8/tcrm-11-1003.PMC4492656.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/a8/tcrm-11-1003.PMC4492656.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 847–855Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  847OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7955 9Preferences of patients undergoing hemodialysis –  results from a questionnaire-based study with  4,518 patients  inger Miriam Janssen1 Ansgar gerhardus2,3 gero D von gersdorff4 conrad August Baldamus4 Mathias schaller4 claudia Barth5 Fueloep scheibler6 1Department of epidemiology  and international Public health,   Bielefeld University, Bielefeld,   germany; 2Department for health  services research, University  of Bremen, Bremen, germany;   3health sciences Bremen,   University of Bremen,  Bremen,   germany; 4Department of internal  Medicine ii, University hospital  of cologne, cologne, germany;   5Kfh Kuratorium fuer Dialyse  und nierentransplantation e.V.,   neu-isenburg, germany; 6Department  of non-Drug interventions, institute  for Quality and efficiency in health  care, cologne, germanyBackground:  Chronic kidney disease is an increasing health problem worldwide and in its  final stage (stage V) can only be treated by renal replacement therapy, mostly hemodialysis.",Non-OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
"Keywords:  patient-centered outcomes, preference elicitation, chronic disease, patient-centered  research, rating scale Introduction Chronic kidney disease (CKD) is an increasing health problem worldwide.1,2 The  increase seems eminent when looking at just a few risk factors for CKD stage V:  hypertension, increasing age, diabetes, or obesity.3 In Germany, the prevalence of  dialysis patients increased from 769 to 808 cases per million between 2005 and 2006.4  A high prevalence of CKD is also observable in other European countries.5 In the US,  the prevalence of patients with CKD increased from 290 to 1,738 cases per million  between 1980 and 2009 and more than 870,000 patients were being treated in 2009.2  In stage V, CKD can only be treated with renal replacement therapy, either dialysis or  transplantation.6 About 65% of patients receive hemodialysis, 25% receive a kidney  transplant, and 10% are treated by peritoneal dialysis.3 Patients treated with hemodialysis correspondence: inger Miriam Janssen Department of epidemiology and  international Public health, Bielefeld  University, PO Box 10 01 31, 33501 Bielefeld, germany Tel +49 521 106 4455 Fax +49 521 106 2987 email inger.scheike@uni-bielefeld.d eJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Janssen et al Running head recto: Preferences of patients undergoing hemodialysis DOI: http://dx.doi.org/10.2147/PPA.S79559",Non-OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
"Available  from: http://www.niddk.nih.gov/health-information/health-statistics/Docu - ments/KU_Diseases_Stats_508.pd f. Accessed November 10, 2014.",OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
"Available from:  http://www.usrds.org/atlas13.asp x. Accessed November 10, 2014.",OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
"Available from: http://www.pcori.org/assets/2013/11/PCORI-Meth - odology-Report-Appendix-A.pd f. Accessed November 10, 2014.",OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/70/70/ppa-9-847.PMC4492657.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/e8/copd-10-1219.PMC4492658.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1219–1224International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1219OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7708 5COPD in patients with stable heart failure   in the primary care setting Mark J Valk1 Berna D Broekhuizen1 arend Mosterd1,2 nicolaas P Zuithoff1 arno W hoes1 Frans h rutten1 1Julius Center for health sciences  and Primary Care, University Medical  Center Utrecht, 2Department of  Cardiology, Meander Medical Center,   amersfoort, the n etherlandsBackground:  Presence of chronic obstructive pulmonary disease (COPD) in heart failure (HF)  has prognostic and therapeutic implications.",Non-OADS,/arxiv_data1/oa_pdf/2f/e8/copd-10-1219.PMC4492658.pdf
"Spirometry at discharge in that situation would show – caused  by pulmonary congestion – a larger reduction in forced expiratory volume in 1  second (FEV1) than in forced vital capacity (FVC), resulting in a risk of over- diagnosing COPD.13,14 When patients with HF are stable and euvolemic, the FEV1/Correspondence: Mark J Valk University Medical Center Utrecht,  Julius Center for health sciences  and Primary Care, stratenum 6.138,  PO Box 85500, 3508 aB Utrecht, the  netherlands Tel +31 65 131 1485 Fax +31 33 465 3491 email m.j.m.valk-7@umcutrecht.n lJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Valk et al Running head recto: COPD in patients with heart failure in primary care setting DOI: http://dx.doi.org/10.2147/COPD.S77085",Non-OADS,/arxiv_data1/oa_pdf/2f/e8/copd-10-1219.PMC4492658.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2f/e8/copd-10-1219.PMC4492658.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/e8/copd-10-1219.PMC4492658.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/94/ott-8-1589.PMC4492659.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1589–1595OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1589Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8430 8Clinicopathological significance of fascin-1  expression in patients with non-small cell lung  cancer Xiao-Ling Ling* Tao Zhang* Xiao-Ming Hou Da Zhao Department of Oncology, The First  Hospital of Lanzhou University  (The Branch Hospital of Donggang),   Lanzhou, Gansu Province,    People’s Republic of China *These authors contributed equally  to this workPurpose:  Fascin-1 promotes the formation of filopodia, lamellipodia, and microspikes of  cell membrane after its cross-linking with F-actin, thereby enhancing the cell movement and  metastasis and invasion of tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/20/94/ott-8-1589.PMC4492659.pdf
"Therefore, it is especially important to  explore the etiology and pathogenesis of NSCLC, and to search for new therapeutic  targets and markers.correspondence: Da Zhao Department of Oncology, The First  Hospital of Lanzhou University,  Donggang West Road, Chengguan  District, Lanzhou 730000, Gansu  Province, People’s Republic of China Tel +86 931 8356547 email ldyyzd@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ling et al Running head recto: Fascin-1 expression in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S84308",Non-OADS,/arxiv_data1/oa_pdf/20/94/ott-8-1589.PMC4492659.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/20/94/ott-8-1589.PMC4492659.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/94/ott-8-1589.PMC4492659.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 75–80Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  75LetteRopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/SAR.S8600 7Nalmefene and alcohol dependence: a new  approach or the same old unacceptable  marketing?,Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
The Drug Evaluation German Agency (IQWIG) made  its conclusion on December 1: “Nalmefene for alcohol  dependence: no benefit evidenced” ( https://www.iqwig.,Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
Such restriction  is rarely used by the Commission ( http://www.has-sante.,Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/1e/fc/sar-6-075.PMC4492660.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/f5/dddt-9-3279.PMC4492661.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3279–3292Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3279Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7099 3Animal models of polymicrobial pneumonia Sami Hraiech1,2 Laurent Papazian1,2 Jean-Marc Rolain1 Fabienne Bregeon1,3 1iHU Méditerranée infection, URM iTe  CNRS iRD iNSeRM UMR 7278,   Marseille, France; 2Réanimation –  Détresses Respiratoires et infections  Sévères, APHM, CHU Nord, Marseille,   France; 3Service d’ explorations  Fonctionnelles Respiratoires, APHM,   CHU Nord, Marseille, FranceAbstract:  Pneumonia is one of the leading causes of severe and occasionally life-threatening  infections.",Non-OADS,/arxiv_data1/oa_pdf/16/f5/dddt-9-3279.PMC4492661.pdf
"What is the Correspondence: Jean-Marc Rolain iHU Méditerranée infection, URMiTe  CNRS iRD iNSeRM UMR 7278, 27 Bd  J Moulin, 13385 Marseille Cedex 05,  France email jean-marc.rolain@univ-amu.f rJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Hraiech et al Running head recto: Animal models of polymicrobial pneumonia DOI: http://dx.doi.org/10.2147/DDDT.S70993",Non-OADS,/arxiv_data1/oa_pdf/16/f5/dddt-9-3279.PMC4492661.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/f5/dddt-9-3279.PMC4492661.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/f5/dddt-9-3279.PMC4492661.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/60/imcrj-8-137.PMC4492662.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 137–139International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  137Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8375 5Bilateral simultaneous intertrochanteric fractures  of femur without major trauma Ekrem Aydın turan Cihan Dülgero ğlu Hasan Metineren Department of orthopedics and  traumatology, Dumlupinar University  school of Medicine, Kutahya, turkey Correspondence:  turan Cihan  Dülgeroğlu  Department of orthopedics and  traumatology, Dumlupinar University  school of Medicine, 43270 Kutahya,  turkey   tel +90 505 834 6753   email dr_turancihan@hotmail.co mAbstract:  Bilateral simultaneous intertrochanteric femur fractures are rare and usually occur  as a result of major trauma.",Non-OADS,/arxiv_data1/oa_pdf/83/60/imcrj-8-137.PMC4492662.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international­medical­case­reports­journal­journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/83/60/imcrj-8-137.PMC4492662.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/60/imcrj-8-137.PMC4492662.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/c2/vhrm-11-373.PMC4492663.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 373–378Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  373ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S8553 4Role of diclofenac in the prevention of  postpericardiotomy syndrome after cardiac  surgery Utkan sevuk1 erkan Baysal2 Rojhat altindag2 Baris Yaylak2 Mehmet sahin adiyaman2 nurettin ay3 Vahhac alp3 Unal Beyazit3 1Department of cardiovascular  surgery, 2Department of cardiology,   3Department of general surgery,   Diyarbakir gazi Yasargil education and  Research Hospital, Diyarbakir, T urkey correspondence: Utkan sevuk   Diyarbakir Gazi Yaşargil Egitim ve  arastirma Hastanesi, Kalp ve Damar  cerrahisi Klinigi, 3 kat, Uckuyular  Diyarbakir, 21010, Turkey   Tel +90 505 530 7095   email utkansevuk@gmail.co mObjective:  Postpericardiotomy syndrome (PPS), which is thought to be related to autoimmune  phenomena, represents a common postoperative complication in cardiac surgery.",Non-OADS,/arxiv_data1/oa_pdf/97/c2/vhrm-11-373.PMC4492663.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/97/c2/vhrm-11-373.PMC4492663.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/c2/vhrm-11-373.PMC4492663.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/49/dddt-9-3325.PMC4492664.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3325–3339Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3325Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6943 3enzalutamide for the treatment of metastatic  castration-resistant prostate cancer Alejo Rodriguez-vida1 Myria Galazi1 Sarah Rudman1 Simon Chowdhury1 Cora N Sternberg2 1Medical Oncology Department, Guy’s  and St Thomas’ NHS Foundation  Trust, London, UK; 2Medical Oncology  Department, San Camillo and  Forlanini Hospitals, Rome, italyAbstract:  In recent years, several nonhormonal and hormonal agents, including enzalutamide,  have been approved for the treatment of metastatic castration-resistant prostate cancer (CRPC)  on the basis of improved overall survival in prospective clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/4c/49/dddt-9-3325.PMC4492664.pdf
"This article reviews  the pharmacological characteristics of enzalutamide, the efficacy studies which led Correspondence: Alejo Rodriguez-vida Medical Oncology Department, Guy’s  Hospital, Great Maze Pond, London  Se1 9RT, UK email arodriguezvida@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Rodriguez-Vida et al Running head recto: Enzalutamide for the treatment of metastatic CRPC DOI: http://dx.doi.org/10.2147/DDDT.S69433",Non-OADS,/arxiv_data1/oa_pdf/4c/49/dddt-9-3325.PMC4492664.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4c/49/dddt-9-3325.PMC4492664.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/49/dddt-9-3325.PMC4492664.pdf
Available from: http://www.astellas.,Non-OADS,/arxiv_data1/oa_pdf/4c/49/dddt-9-3325.PMC4492664.pdf
Available at http://investors.vrtx.com/ releasedetail.cfm?ReleaseID=856185 (Accessed 27 January2015).,Non-OADS,/arxiv_data1/oa_pdf/35/3f/prp20003-e00152.PMC4492728.pdf
"The expla-nation as to why seven of nine predicted 6F fragments(http://web.expasy.org/peptide_mass/; maximum 1 missed cleavage) were detected in the trypsin digests from Tg6F,but not from the 6F standard where six of the predictedfragments in the trypsin digests were detected, likely wasdue to the fact that 23 lg of 6F were subjected to trypsin treatment followed by reverse-phase LC and mass spec- trometry in the case of Tg6F, while in the case of the 6F standard we chose to analyze the 5 lg band (Fig.",Non-OADS,/arxiv_data1/oa_pdf/37/0c/prp20003-e00154.PMC4492730.pdf
"(1994) Reverse GCTGCTGCTGTGGTCTTGGTC Sequence, expected product length of the ampliﬁcate, and gene accession code (http://www.ncbi.nlm.nih.gov) of the primers used.",OADS,/arxiv_data1/oa_pdf/0d/2a/prp20003-e00139.PMC4492755.pdf
PCR primers (Table 1) were designed using Primer Pre-mier 5.0 software from the sequence identiﬁed by the Gen-Bank accession number (http://www.nvbi.nlm.nih.gov).The housekeeping gene b-actin was used as an internal con- trol.,OADS,/arxiv_data1/oa_pdf/53/dd/prp20003-e00145.PMC4492761.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncomme rcial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 32:875–892 (June 15, 2015) DOI: 10.1089/neu.2013.3321 875",Non-OADS,/arxiv_data1/oa_pdf/e4/7b/neu.2013.3321.PMC4492780.pdf
The intensity of the protein bands was determined using ImageJ software ( http://rsbweb.nih.gov/ij ) and expressed relative to the intensity of the α- tubulin band.,OADS,/arxiv_data1/oa_pdf/74/51/cmr-25-284.PMC4492793.pdf
doi:10.1136/openhrt-2014-000139 Accepted 21 July 2014 ▸http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e7/da/openhrt-2014-000139.PMC4493164.pdf
http://www.kaiserhealthnews.org/ stories/2011/january/13/aco-accountable-care-organization-faq.aspx(accessed 23 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/e7/da/openhrt-2014-000139.PMC4493164.pdf
"To address this (perhaps obvious but nevertheless iconoclasticnotion may not be entirely congruent with Federal Drug Administration (FDA) guidelines for treatment development —http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ ucm072063.pdf), JPB partnered with JTM and pro- posed a trial design which considers individuality byfocusing on clinical activity that is accompanied by acti- vation of a treatment-speci ﬁc, pharmacodynamic target.",Non-OADS,/arxiv_data1/oa_pdf/21/a7/lupus-2015-000087.PMC4493165.pdf
"24. http://en.wikipedia.org/wiki/It%27s_the_economy,_stupid (accessed Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/21/a7/lupus-2015-000087.PMC4493165.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/80/68/openhrt-2014-000102.PMC4493166.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/80/68/openhrt-2014-000102.PMC4493166.pdf
http://www.aimsworldrunning.org/articles/IMMDA_Sudden_death_and_how_to_avoid_it_3.20.10.pdf 45.,Non-OADS,/arxiv_data1/oa_pdf/80/68/openhrt-2014-000102.PMC4493166.pdf
Available at: http://www.immda.org 46.,Non-OADS,/arxiv_data1/oa_pdf/80/68/openhrt-2014-000102.PMC4493166.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.100 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):100-107PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION The Iron Status of Very Low Bi rth Weight Infants Receiving  Multiple Erythrocyte Transfus ions during Hospitalization  in the Neonatal Intensive Care Unit  Sook-Hyun Park and Heng-Mi Kim Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea Purpose:  We investigated the iron status of very low birth weight infants receiving multiple erythrocyte transfusions  during hospitalization in the neonatal intensive care unit (NICU).Methods:  We enrolled 46 very low birth weight infants w ho were admitted to the Kyungpook National University  Hospital between January 2012 and December 2013.",Non-OADS,/arxiv_data1/oa_pdf/b4/54/pghn-18-100.PMC4493242.pdf
"Tel: +82-53-200-2747, Fax: +82-53-425-668 3, E-mail: hmkim@knu.ac.kr Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Iron is essential for iron-containing enzymes in-volved in brain-energy metabolism, neurotransmitter  synthesis, and myelination, all of which are im-plicated in neurodevelopment during early infancy",Non-OADS,/arxiv_data1/oa_pdf/b4/54/pghn-18-100.PMC4493242.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.108 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):108-114PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Abdominal Subcutaneous Fat Thickness Measured  by Ultrasonography Correlates with Hyperlipidemia and Steatohepatitis in Obese Children Sung Hyun Lee, Dongwan Kim, Min Young Baek *, Hann Tchah, Yeon Sun Kim*, Eell Ryoo,  and Yun Mi Kim† Departments of Pediatrics and *Internal Medicine, Gachon University Gil Medical Center,  †Department of Nursing, Gachon University, Incheon, Korea Purpose:  The aim of this study is to evaluate the relationship between abdominal subcutaneous fat thickness meas- ured by ultrasonography (US) and serum lipid prof ile and liver transaminases in obese children.",Non-OADS,/arxiv_data1/oa_pdf/54/24/pghn-18-108.PMC4493243.pdf
"Tel: +82-32-460-8429, Fax: +82-32-460-3224, E-mail: onecar@gilh ospital.com Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/24/pghn-18-108.PMC4493243.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.115 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):115-120PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Pediatric Cholecystectomy: Clinical Significance of Cases  Unrelated to Hematologic Disorders Hae-Young Kim, Soo-Hong Kim, and Yong-Hoon Cho Division of Pediatric Surgery, Departme nt of Surgery, Pusan National Universi ty School of Medicine, Yangsan, Korea Purpose: Cholecystectomy is rarely performed in the child and adolescent.",Non-OADS,/arxiv_data1/oa_pdf/f7/73/pghn-18-115.PMC4493244.pdf
"Tel: +82-55-360-2471, Fax: +82-55-360-2124, E-m ail: choyh70@pusan.ac.kr Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Cholecystectomy in childr en is relatively un- common, despite being one of the most common surgical procedures in adults [1-3].",Non-OADS,/arxiv_data1/oa_pdf/f7/73/pghn-18-115.PMC4493244.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.121 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):121-127PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Wilson’s Disease in Bangladeshi Children: Analysis  of 100 Cases Md.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/pghn-18-121.PMC4493245.pdf
"Tel: +880-2-55165 760-95, Fax: +880-2-9661063, E-mail: dr.rukon@gmail.com Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Wilson’s disease (WD) is an autosomal recessive  condition affecting copper metabolism.",Non-OADS,/arxiv_data1/oa_pdf/cb/a2/pghn-18-121.PMC4493245.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.128 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):128-133PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION A Case of Visceral Autonomic Neuropathy Complicated  by Guillain-Barre Syndrome Accompanied with Cyclic Vomiting Syndrome-like Disorder in a Child Suk Jin Hong and Byung-Ho Choe* Department of Pediatrics, Catholic Un iversity of Daegu School of Medicine , *Department of Pediatrics, Kyungpook  National University School of Medicine, Daegu, Korea We present a case of an 8-year-old boy with visceral autonomic neuropathy complicated by Guillain-Barre syndrome.",Non-OADS,/arxiv_data1/oa_pdf/c6/a2/pghn-18-128.PMC4493246.pdf
"Tel: +82-53-420-5704, Fax: +82-53-425-6683, E-mail: bhcho i@knu.ac.k r Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Guillain-Barre syndrome (GBS) refers to an acute  demyelinating polyneuropathy with progressive as-cending motor weakness and decreased deep tendon  reflex [1], which is known to be accompanied by au- tonomic dysfunction in 2/3 of patients [2].",Non-OADS,/arxiv_data1/oa_pdf/c6/a2/pghn-18-128.PMC4493246.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.134 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):134-137PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION A Case of Intussusception with Acute Appendicitis Hyung Min Kee, Ji Young Park, Dae Yong Yi, and In Seok Lim Department of Pediatrics, Chung-Ang Univer sity College of Medicine, Seoul, Korea In children presenting to hospital with gastrointestinal symptoms, diseases such as intussusception and acute appen- dicitis require particular attention and careful examination.",Non-OADS,/arxiv_data1/oa_pdf/43/d7/pghn-18-134.PMC4493247.pdf
"Tel: +82-2-6299-1465, Fax: +82-6263-2167, E-mail: meltem p2@hanmail.net Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Children presenting to hospital with gastro- intestinal symptoms, such  as abdominal pain and  vomiting, require supportive treatment.",Non-OADS,/arxiv_data1/oa_pdf/43/d7/pghn-18-134.PMC4493247.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.138 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):138-143PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Clinical, Biochemical, and Genetic Characterization  of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly Jung Ah Kim, Ja Hye Kim, Beom Hee Lee, Gu-Hwan Kim*, Yoon S. Shin†, Han-Wook Yoo,  and Kyung Mo Kim Department of Pediatrics, *Medical Genetics Center, Asan Medical Center Children’s H ospital, University of Ulsan  College of Medicine, Seoul, Korea, †University Children's Hospital and Mole cular Genetics and Metabolism Laborator y, Munich, Germany Glycogen storage disease type IX (GSD IX) is caused by a defect in phosphorylase b kinase (PhK) that results from  mutations in the PHKA2 , PHKB , and PHKG2  genes.",Non-OADS,/arxiv_data1/oa_pdf/16/51/pghn-18-138.PMC4493248.pdf
"Tel: +82-2-3010-3380, Fax: +82-2-473-3725, E-mail: kmkim@amc.seoul.kr Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Glycogen storage disease (GSD) is a group of dis- eases caused by inborn errors of glycogen metabo- lism that affect the liver and/or muscle.",Non-OADS,/arxiv_data1/oa_pdf/16/51/pghn-18-138.PMC4493248.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.144 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):144-148PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Atypical β-Catenin Activated Child Hepatocellular Tumor Aynur Turan, Havva Akmaz Unlu1, Esra Karakus2, Arzu Yazal Erdem3, and Zeynep Ilerisoy Yakut4 Department of Radiology, Diskap i Yildirim Beyazit Training and Research Hospital, Departments of 1Radiology,  2Patology, and 3Pediatrics, Ankara Pediatric Hematology and Oncology Training and Research Hospital, 4Department of  Radiology, Ankara Atatürk Training and Research Hospital, Ankara, Turkey Hepatocellular adenomas are a benign, focal, hepatic neoplasm that have been divided into four subtypes according  to the genetic and pathological features.",Non-OADS,/arxiv_data1/oa_pdf/e5/10/pghn-18-144.PMC4493249.pdf
"Tel: +90-312-3198908 , Fax: +90-312-4414511, E-mail: aturanrad@gmail.com Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Hepatocellular adenomas (HCA) is a benign, rare  pediatric hepatic neoplasm  [1].",Non-OADS,/arxiv_data1/oa_pdf/e5/10/pghn-18-144.PMC4493249.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.73 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):73-84PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Characteristics of Pediatri c Pancreatitis on Magnetic  Resonance Cholangiopancreatography Jae-Yeon Hwang *,†, Hye-Kyung Yoon *,‡, and Kyung Mo Kim§ *Department of Radiology and Research Institute of Radiolog y, Asan Medical Center, University of Ulsan College of  Medicine, Seoul, †Department of Radiology, Pusan National  University Yangsan Hospital, Yangsan, ‡Department of  Radiology, Kangwon National University Hospital, Chuncheon, §Department of Pediatrics, Asan Medical Center  Children’s Hospital, University of Ul san College of Medicine, Seoul, Korea Pediatric pancreatitis is not uncommon and results in considerable morbidity and mortality in the affected children.",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/pghn-18-73.PMC4493250.pdf
"Tel: +82-33-258-9024, Fax: +82-33-258-9351, E-m ail: hk2005.yoon@gmail.com Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Pancreatitis is more commonly encountered in  children than ever before, although it remains unclear  if the incidence itself has increased or just detection [1-3].",Non-OADS,/arxiv_data1/oa_pdf/2b/4b/pghn-18-73.PMC4493250.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.85 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):85-93PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Differences in Clinical and La boratory Findings between Group D and Non-Group D Non-Typhoidal Salmonella  Gastroenteritis in Children Heung Keun Park, Kyuyol Rhie, Jung Sook Yeom , Ji Sook Park, Eun Sil Park, Ji-Hyun Seo,  Jae Young Lim, Chan-Hoo Park, Hyang-Ok  Woo, Hee-Shang Youn, Ki Ryeon Kang *, and Jung Je Park† Departments of Pediatri cs, *Biochemistry, and †Otolaryngology, Gyeongsang Institute of Health Science, G yeongsan g National University School of Medicine, Jinju, Korea Purpose:  To investigate the differences in clinical f eatures and laboratory findings between group D and non-group  D non-typhoidal Salmonella  (NTS) gastroenteritis in children.",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/pghn-18-85.PMC4493251.pdf
"Tel: +82-55-750-8731, Fax: +82-55-752-9339, E-m ail: seozee@gnu.ac.kr Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION Salmonella enterica  causes diseases in humans and can be divided into two groups: human-restricted ty- phoidal Salmonella  serovars (Typhi and Paratyphi)  causing typhoid fever, and non-typhoidal Salmonella",Non-OADS,/arxiv_data1/oa_pdf/b1/e1/pghn-18-85.PMC4493251.pdf
Available from: http://www.fsis.usda.gov/ophs/rpcong98/rpcong98.htm.,Non-OADS,/arxiv_data1/oa_pdf/b1/e1/pghn-18-85.PMC4493251.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2015.18.2.94 Pediatr Gastroenterol Hepatol Nutr 2015 June 18(2):94-99PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Benefits of a Dedicated Breas tfeeding Facility and Support  Program for Exclusive Brea stfeeding among Workers  in Indonesia Ray W Basrowi, Astrid B Sulistomo *, Nuri Purwito Adi *, and Yvan Vandenplas† Master of Occupational Medicine Study Program, *Division of Occupational Medicine, Department of Community  Medicine, Faculty of Medicine University  of Indonesia, Jakarta, Indonesia, †Department of Pediatrics, Universitair  Kinderziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium Purpose: A mother’s working environment is believed to be a major determinant of exclusive breastfeeding (EBF)  practice.",Non-OADS,/arxiv_data1/oa_pdf/9c/8a/pghn-18-94.PMC4493252.pdf
"Tel: +32-2-477-57-80,  Fax: +32-2-477-57-83, E-mail: yvan.vandenplas@uzbrussel.be  Copyright ⓒ 2015 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/8a/pghn-18-94.PMC4493252.pdf
"In addition to hereditary central and pe- ripheral nervous system tumors, somatic mutations of  Nf2 are also known to be associated with many other  tumors including schwannomas, meningiomas, ependy-momas, mesotheliomas, melanoma, glioma, renal cancer, and thyroid cancer ([3-6]  and http://www.sanger.ac.uk/ cosmic).",Non-OADS,/arxiv_data1/oa_pdf/25/ee/cr201569a.PMC4493278.pdf
806 Angiomotin acts upstream of Merlin in the Hippo pathwaynpg Cell Research | Vo 25 No 7 | July 2015 The auto-inhibited structure of Merlin is also valuable  for us to understand the mechanisms governing many  human disease-related mutations identified in Merlin ([39]   and http://www.hgmd.org).,Non-OADS,/arxiv_data1/oa_pdf/25/ee/cr201569a.PMC4493278.pdf
"Consistent with the critical roles of Merlin in the Hippo pathway, numerous Nf2 mutations have been  identified in Neurofibromatosis 2 or other cancer patients (http://www.sanger.ac.uk/cosmic).",Non-OADS,/arxiv_data1/oa_pdf/25/ee/cr201569a.PMC4493278.pdf
All structure figures were prepared using PyMOL (http://pymol.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/25/ee/cr201569a.PMC4493278.pdf
3′-end adaptors  and 5′-end 4 nt barcodes were removed using a FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit).,OADS,/arxiv_data1/oa_pdf/bb/f9/cr201577a.PMC4493284.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in   any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/8b/glu130.PMC4493315.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/0d/ehv117.PMC4493324.pdf
Radiation dose to patients from radiopharmaceuticals: A fourth addendum to ICRP Publication 53. http://www.icrp.org/docs/Radiation%20Dose%20to%20Patients% 20from%20Radiopharmaceuticals%20-%20A%20fourth%20addendum%20to%20 ICRP%20Publication%2053.pdf (25 November 2014).,Non-OADS,/arxiv_data1/oa_pdf/bb/0d/ehv117.PMC4493324.pdf
http://data.worldbank.org/ about/country-classiﬁcations (16 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/bb/0d/ehv117.PMC4493324.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.105 Clinical and Molecular Hepatology 2015;21:105-114 Review Corresponding author :  Yujin Hoshida Division of Liver Diseases, Department of Medicine, Liver Cancer Program,  Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1470  Madison Ave, New York, NY 10029, Box 1123, USA Tel: +1-212-824-8862, Fax: +1-646-537-9576 E-mail: yujin.hoshida@mssm.eduAbbreviations:   DAA, direct-acting antiviral; HBV, hepatitis B virus; HCC, hepatocellular  carcinoma; HCV, hepatitis C virus; SNP , single nucleotide polymorphysm;  SVR, sustained virological response; WHO, World Health Organization;  ROS, reactive oxygen species; PDGF, platelet-derived growth factor; PPAR,  peroxisome proliferator-activated receptor; EGF, epidermal growth factor;  EGFR, epidermal growth factor receptor Received :  Mar.",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"4, 2015 /  Accepted :  May 6, 2015INTRODUCTION  Hepatocellular carcinoma (HCC) is a growing clinical problem,  being the second leading cause of cancer deaths worldwide (GLO - BOCAN, http://globocan.iarc.fr ) and one of the only increasing  causes of cancer-related mortality in the U.S.1 In contrast to devel - oping countries in the Asia-Pacific regions and sub-Saharan Afri - ca, where hepatitis B virus (HBV) is the major risk factor for HCC,  chronic infection with hepatitis C virus (HCV) has been a leading  cause of HCC in developed countries2 and is the first indication for  liver transplantation for patients with HCC in the U.S.3 Worldwide,  the World Health Organization (WHO) estimates that 3% of the world’s population has been infected with HCV and that more  than 170 million people are currently chronic carriers of HCV  (WHO, www.who.int ).",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"(Clin Mol Hepatol 2015;21:105-114) Keywords:  Carcinogenesis; Hepatitis C; Hepatocellular carcinoma; Prevention Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"106 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105Clin Mol Hepatol Volume _21  Number _2  June 2015tive direct-acting antivirals (DAAs) for HCV is expected to reduce  the incidence of HCV-related HCC,8 the achievement of a sus - tained virological response (SVR) does not eliminate the risk of  HCC, especially when the patients have already developed ad - vanced liver fibrosis.9,10 Although molecular mechanisms of HCV- induced HCC development have not been fully elucidated, these  epidemiological observations suggest that the major role of HCV  in carcinogenesis is to create a cirrhotic tissue microenvironment  that serves as a carcinogenic milieu.",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"Hepatitis C virus-induced hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105HCV infection, inflammation and carcinogenesis.13,14  Interaction of HCV with cellular pathways The “field effect” or “field cancerization” refers to the cirrhotic  milieu/microenvironment that allows initiation and promotion of  neoplastic clones by facilitating genetic aberrations and cellular  transformation.15 Chronic damage to hepatocytes, such as HCV  infection, leads to a release of inflammatory and fibrotic media - tors such as reactive oxygen species, cell death signals, hedgehog  ligands and nucleotides.16 A complex series of mechanisms center - ing on the hepatic stellate cell, mediated through intracellular in - flammasome activation, the nuclear receptor family, (farsenoid-X- receptor, peroxisome proliferator-activated receptors and others)  and other transcriptional events contribute to stellate cell activa - tion.",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"108 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105Clin Mol Hepatol Volume _21  Number _2  June 2015generation accompanied by telomere shortening that triggers cel - lular senescence though ATM, TP53, and CDKN1A as a safeguard  to prevent carcinogenesis.60 HCV core protein overcomes stress- induced hepatocyte senescence by down-regulating CDKN2A ex - pression via DNA methylation.61  Host factors affecting susceptibility to HCV-related  HCC A multi-kinase inhibitor, sorafenib, is the only drug currently ap - proved for advanced HCC.62 Sorafenib showed anti-HCC effect by  blocking paracrine hepatocyte growth factor from stromal cells in  response to vascular endothelial growth factor-A secreted from  HCC cells.63 Interestingly it improved portal hypertension in cir - rhotic patients, supposedly due to its anti-angiogenic activity.64  Epidermal growth factor (EGF) is a mitogen involved in cellular  growth, proliferation, differentiation, and carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
Hepatitis C virus-induced hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105Molecular markers of HCC risk in HCV Molecular biomarkers of HCC risk and/or poor prognosis may  enable further enrichment of the high-risk population and may  significantly contribute to improvement of early HCC detection.,Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"110 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105Clin Mol Hepatol Volume _21  Number _2  June 2015ment with subjects at high risk of HCC.12 Until now, several large  phase 3 clinical trials have failed to show the usefulness of che - mopreventive strategies in HCC despite the enrollment of thou - sands of patients and a follow-up time approaching decade(s).97-99  Enrichment of high-risk patients with the use of HCC risk biomark - ers and/or prognostic indices is critical to increase HCC incidence  and keep required sample size and study duration within practi - cally feasible range.",Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
Hepatitis C virus-induced hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105al.,Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
112 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105Clin Mol Hepatol Volume _21  Number _2  June 2015C virus NS5B RNA-dependent RNA polymerase.,Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
Hepatitis C virus-induced hepatocellular carcinoma http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.1052014;59:1577-1590.,Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
114 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.105Clin Mol Hepatol Volume _21  Number _2  June 2015gene is associated with risk for hepatocellular carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/dc/70/cmh-21-105.PMC4493352.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.115 Clinical and Molecular Hepatology 2015;21:115-121 Review Corresponding author :  Jeong Heo Department of Internal Medicine, College of Medicine, Pusan National  University and Medical Research Institute, Pusan National University  Hospital, 179 Gudeok-ro, Seo-gu, Busan 602–739, Korea Tel: +82-51-240-7869, Fax: +82-51-244-8180 Email: jheo@pusan.ac.krAbbreviations:   BCLC, Barcelona Clinic Liver Cancer; HAIC, Hepatic arterial infusion  chemotherapy; HCC, hepatocellular carcinoma; PVT, portal vein  thrombosis; RCT, randomized controlled trial; TACE, Transarterial  chemoembolization; TTP , time to progression; VEGFRs, Vascular  endothelial growth factor receptors; 90Y, yttrium-90 Received :  Feb. 6, 2015 /  Accepted :  May 17, 2015INTRODUCTION  Hepatocellular carcinoma (HCC) is the sixth most prevalent can - cer, and the third most common cause of cancer-related death  worldwide.1 It is responsible for over 600,000 deaths annually.2  When patients with HCC have been detected early, curative treat - ment such as resection and percutaneous ablation are feasible.",Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
"(Clin Mol Hepatol 2015;21:115-121) Keywords:  Management; Hepatocellular carcinoma; Portal vein thrombosis  Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
116 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.115Clin Mol Hepatol Volume _21  Number _2  June 2015only one or two small tumors.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
"Management of hepatocellular carcinoma with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.115and China also reported that overall survival in patients receiving  radiotherapy was 10.9 months and 12.3 months and it is signifi - cantly better than in patients receiving sorafenib (4.8 months,  P=0.025) or undergoing surgery (10.3 months, P=0.029).27,28 In  other studies, when external radiation therapy is combined with  other modalities such as sorafenib or TACE , overall survival was  reported to be 10 months or more.29,30 Although these data of ra - diotherapy in advanced HCC, radiotherapy has not been incorpo - rated into the international guidelines for HCC because of lack of  prospective randomized trial.",Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
"118 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.115Clin Mol Hepatol Volume _21  Number _2  June 2015patic portal invasion and extrahepatic spread who were treated  with sorafenib was 10.7 months, which was significantly higher  than the median survival period (7.9 months) of the control group,  who were treated with palliative medicine alone ( P=0.00058).",Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
"Management of hepatocellular carcinoma with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.115(Hazard radio, 0.64, 90% confidence interval, 0.43-0.94; P=0.04)  and patients with high MET expression had showed substantial  benefit from tivanitinib in terms of median overall survival (7.2  months vs. 3.8 months, P=0.01).58 Furthermore, in a phase 3 trial  of the vascular endothelial growth factor receptor-2 antibody,  ramucirumab, median survival was significantly improved in pa - tients with baseline alpha-fetoprotein more than 400 ng/mL.",Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
120 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.115Clin Mol Hepatol Volume _21  Number _2  June 201513.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
Management of hepatocellular carcinoma with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.11539.,Non-OADS,/arxiv_data1/oa_pdf/1e/91/cmh-21-115.PMC4493353.pdf
"pISSN 2287-2728        eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.122 Clinical and Molecular Hepatology 2015;21:122-124 Editorial Hepatitis C virus (HCV) infection is often observed in hemophilic  patients who received a blood transfusion of clotting factor con - centrates before the mid-1980s, and this increases comorbidity  and mortality rates.1 About 80% of HCV-infected patients have  chronic HCV infections, and at least 20% develop end-stage liver  disease (ESLD).2,3 In Korea, anti-HCV positivity in 1999 was reported to be 49.1%  and 47.9% for hemophilia A and B, respectively; since then, it has  steadily decreased to 40.1% and 34.1% in 2005 and 33% and  23.8% in 2012.4 However, among hemophilic patients with anti- HCV positivity, about 31% were positive in HCV RNA testing, and  about half remain untreated.5 A cross-sectional study on the prev - alence of hepatitis C and the use of antiviral treatment among  patients with hemophilia in the Netherlands showed that about  68% of patients remained untreated.",Non-OADS,/arxiv_data1/oa_pdf/7b/16/cmh-21-122.PMC4493354.pdf
"23, 2015 /  Revised :  May 10, 2015  Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/16/cmh-21-122.PMC4493354.pdf
"Hepatitis C virus infection in patients with hemophilia in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.122and unsuccessful treatment group, respectively.3 In addition, when  successful HCV treatment was carried out, hepatic fibrosis im - proved.13 In summary, the treatment effect and frequency of seri - ous side effects, including bleeding, were not different between  hemophilic patients and non-hemophilic patients receiving PegIFN  plus ribavirin; furthermore, hepatic fibrosis improved, and the rate  of developing ESLD was reduced in the treatment group.",Non-OADS,/arxiv_data1/oa_pdf/7b/16/cmh-21-122.PMC4493354.pdf
124 Clin Mol Hepatol Volume _21  Number _2  June 2015 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.1222014;20:e356-e358.,Non-OADS,/arxiv_data1/oa_pdf/7b/16/cmh-21-122.PMC4493354.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.125 Clinical and Molecular Hepatology 2015;21:125-130 Original Article Corresponding author :  Hyung Joon Kim Department of Gastrohepatology, Chung-Ang University Hospital,   Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak- gu, Seoul 156-755, Korea Tel: +82-2-6299-1399, Fax: +82-2-825-7571 E-mail: mdjoon@cau.ac.krAbbreviations:   ALT, alanine aminotransferase; CHC, chronic hepatitis C; ETR, end of  treatment response; EVR, early virologic response; HBsAg, hepatitis  B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; Hgb,  hemoglobin; HIV, human immunodeficiency virus; RVR, rapid virologic  response; SVR, sustained virologic response Received :  Nov. 7, 2014 /  Revised :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
"(Clin Mol Hepatol 2015;21:125-130) Keywords:  Chronic hepatitis C; Hemophilia; Peginterferon; Ribavirin Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
"126 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.125Clin Mol Hepatol Volume _21  Number _2  June 2015is 19.5% in hemophiliacs in Korea.7,8 However, there are no  known reports of long-term treatment outcome including the late  relapse.",Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
"Combination therapy and chronic hepatitis C in hemophilia http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.125life-threatening, according to a modified World Health Organiza - tion grading system.",Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
"128 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.125Clin Mol Hepatol Volume _21  Number _2  June 2015had jaundice (bilirubin increased to 18 mg/dL), one patient had an  infection and one suffered from dizziness.",Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
"Combination therapy and chronic hepatitis C in hemophilia http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.125was 5.8%, anemia (Hgb <8 g/dL) 7.7% and thrombocytopenia  (<30,000/mm3) 1%.",Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
130 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.125Clin Mol Hepatol Volume _21  Number _2  June 2015men.,Non-OADS,/arxiv_data1/oa_pdf/df/93/cmh-21-125.PMC4493355.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.131 Clinical and Molecular Hepatology 2015;21:131-140 Original Article Corresponding author :  Soon Sun Kim Department of Gastroenterology, Ajou University School of Medicine,   164 World cup-ro, Yeongtong-gu, Suwon 443-380, Korea Tel: +82-31-219-6939, Fax: +82-31-219-5999 E-mail: cocorico99@gmail.comAbbreviations:   ALT, alanine aminotransferase; CI, confidence interval; ETV, entecavir;  HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HR, hazard ratio;  LAM, lamivudine; NA, nucleos(t)ide analogue; PCR, polymerase chain  reaction; VR, virologic response Received :  Mar.",Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
"(Clin Mol Hepatol 2015;21:131-140) Keywords:  Chronic hepatitis B; Entecavir; Lamivudine; Resistance Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
"132 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131Clin Mol Hepatol Volume _21  Number _2  June 2015often associated with exacerbation of hepatitis.6  Entecavir (ETV) is a potent and highly selective inhibitor of HBV  DNA polymerase.7 Compared to LAM, ETV has been shown to  have a high genetic barrier to resistance.",Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
Entecavir in patients with lamivudine experience http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131tion or median (range) where appropriate.,Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
134 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131Clin Mol Hepatol Volume _21  Number _2  June 2015pared to those without LAM refractoriness.,Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
"Entecavir in patients with lamivudine experience http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.13148, and 60 were 8.5%, 12.1%, 16.4%, 19.0%, and 26.6% in the  NA-naïve group and 8.8%, 11.8%, 11.8%, 11.8%, and 11.8% in  the LAM-use group ( P=0.295), respectively.",Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
136 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131Clin Mol Hepatol Volume _21  Number _2  June 2015LAM-use group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
Entecavir in patients with lamivudine experience http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131refractory subjects.,Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
138 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131Clin Mol Hepatol Volume _21  Number _2  June 2015who were refractory to LAM therapy without developing LAM re - sistance showed no statistical difference between the two ETV  resistance groups.,OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
"Entecavir in patients with lamivudine experience http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131Acknowledgements  This study was supported by a grant of the Korean Health Tech - nology R&D Project, Ministry of Health & Welfare, Republic of Ko - rea (A121776).",Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
140 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.131Clin Mol Hepatol Volume _21  Number _2  June 2015resistance to tenofovir disoproxil fumarate through 96 weeks of  treatment in patients with lamivudine-resistant chronic hepatitis B.  Clin Gastroenterol Hepatol 2014;12:2106-2112.e1.,Non-OADS,/arxiv_data1/oa_pdf/ce/91/cmh-21-131.PMC4493356.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.141 Clinical and Molecular Hepatology 2015;21:141-149 Original Article Corresponding author :  Soon Koo Baik Department of Internal Medicine, Yonsei University, Wonju College of  Medicine, 20 Ilsan-ro, Wonju 220-701, Korea Tel:  +82-33-741-1223, Fax: +82-33-745-6782 E-mail: baiksk@yonsei.ac.kr *These authors contributed equally to this work.Abbreviations:   BM, bone marrow; MSCs, mesenchymal stem cells; BM-MSCs, bone  marrow-derived mesenchymal stem cells; TGF- β1, transforming growth  factor-beta 1; α-SMA, alpha-smooth muscle actin; IL, interleukin; HGF,  hepatocyte growth factor; SD, standard deviation Received :  Mar.",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"(Clin Mol Hepatol 2015;21:141-149) Keywords:  Bone-marrow-derived mesenchymal stem cell; Cirrhosis; Hepatic fibrosis Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"142 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141Clin Mol Hepatol Volume _21  Number _2  June 2015have physiological functions as vitamin A storage, production of  ECM in the space of Disse and a role in the regulation of the si - nusoidal microcirculatory flow.5 However, during liver fibrogene - sis, HSCs activate or transdifferentiate into myofibroblast-like  cells, acquiring contractile and fibrogenic properties, secreting  cytokines and expressing alpha-smooth muscle actin ( α-SMA).6,7 The transforming growth factor- β1 (TGF-β1) is recognized as  one of the main profibrogenic mediators8,9 and plays a key role in  the HSC activation and subsequent hepatic fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"Bone marrow-derived mesenchymal stem cells for hepatic fibrosis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141Grand Island, NY, USA) supplemented with 10% FBS, 10 mM  β-glycerophosphate, 10-7 M dexamethasone, and 0.2 mM ascor - bic acid (Sigma-Aldrich).20 The osteogenic differentiation was  quantified from the release of p-nitrophenol from p-nitrophenyl  phosphate by the enzyme alkaline phosphatase.21 For adipogenic  differentiation, BM-MSCs were plated at 2×104 cells/cm2 in six- well plates and cultured for 1 week; then, differentiation was  induced with adipogenic medium  (10% FBS, 1 μM dexametha - sone, 0.5 mM 3-isobutyl-1-methylxanthine, 10 μg/mL insulin, and  100 μM indomethacin in high-glucose DMEM) for an additional 3  weeks.",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"144 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141Clin Mol Hepatol Volume _21  Number _2  June 2015Inc., Corning, NY, USA).",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
Bone marrow-derived mesenchymal stem cells for hepatic fibrosis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141 Figure 2  Expression of α-SMA in the direct co-culture system of activated HSCs with BM-MSCs as measured by immunocytochemistry.,Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"146 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141Clin Mol Hepatol Volume _21  Number _2  June 2015RESULTS Immunophenotypes and differentiation potentials  of the BM-MSCs The immunophenotypes for CD14, CD34, CD45, CD73, and  CD105 cells were determined and osteogenic or adipogenic differ - entiation was induced on experimental the day (Fig.",OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"Bone marrow-derived mesenchymal stem cells for hepatic fibrosis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141Inhibition of viability and induction apoptosis in  activated HSCs by BM-MSCs  At a 1:1 co-culture ratio, to determine whether BM-MSCs have  the capacity to inhibit activated HSCs viability, we quantified the  CellTiter 96® AQueous One Solution Reagent ELISA kit.",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"148 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141Clin Mol Hepatol Volume _21  Number _2  June 2015IL-6 and increasing production of HGF, IL-10.",Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
Bone marrow-derived mesenchymal stem cells for hepatic fibrosis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.141marrow-derived cells mobilization in patients with end stage liver  disease.,Non-OADS,/arxiv_data1/oa_pdf/12/e4/cmh-21-141.PMC4493357.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.150 Clinical and Molecular Hepatology 2015;21:150-157 Original Article Corresponding author :  Yoon Jun Kim Department of Internal Medicine and Liver Research Institute, Seoul  National University College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-799, Korea  Tel: +82-2-2072-3081, Fax: +82-2-743-6701 Email: yoonjun@snu.ac.krAbbreviations:   AIH, autoimmune hepatitis; ALP, alkaline phosphatase; ALT, alanine transaminase;   AMA, anti-mitochondrial antibody; ANA, antinuclear antibody; AST, aspartate  transaminase; CO criteria, Corpechot’s criteria; GGT, gamma-glutamyl  transpeptidase; IAIHG, International Autoimmune Hepatitis Group; IgG,  immunoglobulin G; IgM, immunoglobulin M; INR, international normalized  ratio; LKM-1, liver kidney microsomal type 1 antibody; PBC, primary biliary  cirrhosis; PT, prothrombin time; SMA, anti-smooth muscle antibody; UDCA,  ursodeoxycholic acid; ULN, upper limit of normal Received :  Feb. 2, 2015 /  Revised :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
"(Clin Mol Hepatol 2015;21:150-157) Keywords:  Autoimmune hepatitis; Primary biliary cirrhosis; Overlap syndrome Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
"Overlap syndrome patients in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150ence of serum anti-mitochondrial antibody (AMA), has been pro - posed.",Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
"152 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150Clin Mol Hepatol Volume _21  Number _2  June 2015other immunosuppressant (steroid-based therapy), or UDCA and  steroid combination therapy.",Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
Overlap syndrome patients in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150Statistical analysis The differences in proportion were assessed with Fisher’s exact  test.,Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
154 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150Clin Mol Hepatol Volume _21  Number _2  June 2015with overlap syndrome are presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
"Overlap syndrome patients in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150with initially non-cirrhotic liver, 24.1% (15/62) of the PBC patients  and 13.2% (7/53) of the AIH patients progressed to liver cirrhosis  during the follow-up period, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
"156 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150Clin Mol Hepatol Volume _21  Number _2  June 2015PBC patients; 2.9% and 7.6% for the AIH patients; and both  0.0% for the overlap syndrome patients, respectively.",Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
Overlap syndrome patients in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.150Conflicts of Interest There is no conflict of interest or financial support to be declared.,Non-OADS,/arxiv_data1/oa_pdf/a0/e0/cmh-21-150.PMC4493358.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.158 Clinical and Molecular Hepatology 2015;21:158-164 Original Article Corresponding author :  Soung Won Jeong  Institute for Digestive Research, and Digestive Disease Center,  Department of Internal Medicine, Soonchunhyang University Hospital,   59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea  Tel: +82-2-709-3076, Fax: +82-2-709-9696  E-mail: jeongsw@schmc.ac.krAbbreviations:   CEUS, contrast-enhanced ultrasonography; CT, computed tomography;  DSA, digital subtraction angiography; HCC, hepatocellular carcinoma;  KLCSG-NCC, Korean Liver Cancer Study Group-National Cancer  Center; MI, mechanical index; mUICC, Modified Union for International  Cancer Control; MRI, magnetic resonance imaging; TACE, transarterial  chemoembolization; US, ultrasonography; UCA, ultrasound contrast  agent Received :  Feb. 6, 2015 /  Revised :  May 6, 2015 /  Accepted :  May 7, 2015INTRODUCTION  Hepatocellular carcinoma (HCC) is the fifth most frequently di - agnosed cancer and the third cause of cancer-related mortality worldwide.1,2 Most patients with HCC are diagnosed late, and cu - rative treatments cannot be applied.",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
"(Clin Mol Hepatol 2015;21:158-164) Keywords:  Transarterial chemoembolization; Contrast-enhanced ultrasonography; Hepatocellular carcinoma; Tumor  size; Feeding artery Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
"Predictive factors for the response of TACE on CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.158sectable HCC, and is recommended as first-line treatment for pa - tients at intermediate stage of the disease by Barcelona Clinic  Liver Cancer (BCLC) Staging System (B).4 HCC exhibits intense  neoangiogenic activity during its progression.5 The rationale for  TACE is that the intra-arterial infusion of a chemotherapeutic  agent followed by embolization of the tumor-feeding artery will  result in a strong cytotoxic and ischemic effect.6,7 Therefore, iden - tification of the correct tumor-feeding artery is of definite impor - tance on superselective (chemo) embolization.",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
"160 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.158Clin Mol Hepatol Volume _21  Number _2  June 2015The chemoembolic mixture consisted of a suspension of preload - ed, drug-eluting microspheres (DC Beads Biocompatibles Ltd, Sur - rey, UK).",OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
"Predictive factors for the response of TACE on CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.158time, arterial enhancing duration, intensity of arterial enhance - ment, presence of hypoenhanced pattern, and feeding artery to the  tumor were analyzed using Fisher’s exact test.",OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
162 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.158Clin Mol Hepatol Volume _21  Number _2  June 2015frequency energy.17 Imaging in the harmonic range will eliminate  much of the near-filed artifacts such as reverberation and scatter - ing.,Non-OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
"Predictive factors for the response of TACE on CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.158not show enhancement in contrast-enhanced CT and MRI.23,24 So  we can infer that CEUS is more effective for showing feeding ar - tery than contrast-enhanced CT and MRI.",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
164 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.158Clin Mol Hepatol Volume _21  Number _2  June 2015Characterization of focal liver lesions with SonoVue-enhanced so - nography: international multicenter-study in comparison to CT and  MRI.,Non-OADS,/arxiv_data1/oa_pdf/b9/6b/cmh-21-158.PMC4493359.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.165 Clinical and Molecular Hepatology 2015;21:165-174 Original Article Corresponding author :  Moon Young Kim Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei  University Wonju College of Medicine, 20 Ilsan-ro, Wonju 220-701,  Korea Tel: +82-33-741-1229, Fax: +82-33-745-1228 E-mail: drkimmy@yonsei.ac.kr Co-corresponding author :  Seung Hwan Cha Department of Radiology, Wonju Severance Christian Hospital, Yonsei  University Wonju College of Medicine, 20 Ilsan-ro, Wonju 220-701,  Korea Tel: +82-33-741-1229, Fax: +82-33-745-1228 E-mail: peace22@yonsei.ac.krAbbreviations:   TACE, transarterial chemoembolization; HCC, hepatocellular carcinoma;  MDCT, multidetector computer tomography; CEUS, contrast-enhanced  ultrasonography; RFA, radiofrequency ablation; UCA, ultrasonography  contrast agent; MRI, magnetic resonance imaging; AFP , alpha- fetoprotein; CT, computed tomography * Youn Zoo Cho and So Yeon Park contributed equally.",Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
"(Clin Mol Hepatol 2015;21:165-174) Keywords:  Hepatocellular carcinoma; Transarterial chemoembolization; Contrast-enhanced ultrasonography; Computed  tomography; Magnetic resonance imaging Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
"166 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165Clin Mol Hepatol Volume _21  Number _2  June 2015INTRODUCTION  Hepatocellular carcinoma (HCC) accounts for more than 5% of  all cancers worldwide and has an increasing incidence.1 HCC is  the second-leading cause of cancer-related death worldwide.2 The  long-term prognosis of HCC remains poor due to a high incidence  of recurrence (68-96%); thus, effective therapeutic strategies  aimed at controlling tumor recurrence are critical for prolonging  survival after HCC treatment.3,4 When HCC is diagnosed at an  early stage, patients may undergo surgical resection and liver  transplantation.",Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
Estimation of viability of HCC using CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165MDCT and MRI evaluation at 4 and 12 weeks after receiving  TACE.,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
168 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165Clin Mol Hepatol Volume _21  Number _2  June 2015necrosis of <50% and a well-delineated margin and superficial  location.,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
"Estimation of viability of HCC using CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165my, to check for arteriovenous shunt, and to identify arterial feed - ers of the tumor.",Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
170 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165Clin Mol Hepatol Volume _21  Number _2  June 2015 Figure 3 .,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
"Estimation of viability of HCC using CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165(50%) and 3 patients (37.5%), respectively.",Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
172 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165Clin Mol Hepatol Volume _21  Number _2  June 2015of repeated applications of MDCT among patients with HCC.,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
Estimation of viability of HCC using CEUS http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165Conflicts of Interest The authors have no conflicts to disclose.,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
Practice guidelines for management of hepato - cellular carcinoma 2014. http://www.klcsg.or.kr/html/sub03_02.,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
174 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.165Clin Mol Hepatol Volume _21  Number _2  June 2015and after treatment by transcatheter arterial embolization.,Non-OADS,/arxiv_data1/oa_pdf/c7/d2/cmh-21-165.PMC4493360.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.175 Clinical and Molecular Hepatology 2015;21:175-179 Case Report Corresponding author :  Yeon Seok Seo Department of Internal Medicine, Korea University College of Medicine,  73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82-2-920-6608, Fax: +82-2-953-1943 E-mail: drseo@korea.ac.krAbbreviations:   CT, computed tomography; IPNB, intraductal papillary neoplasm of the  bile duct; MRCP , magnetic resonance cholangiopancreatography;   MRI, magnetic resonance imaging Received :  Aug. 22, 2013 /  Revised :  Oct. 9, 2013 /  Accepted :  Oct. 15, 2013INTRODUCTION  Caroli’s disease belongs to a group of hepatic fibropolycystic  diseases.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/cmh-21-175.PMC4493361.pdf
"(Clin Mol Hepatol 2015;21:175-179) Keywords:  Caroli’s disease; Intraductal papillary neoplasm of the bile duct; Segmentectomy Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/cmh-21-175.PMC4493361.pdf
"176 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.175Clin Mol Hepatol Volume _21  Number _2  June 2015cm and 93.4 kg, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/cmh-21-175.PMC4493361.pdf
Caroli’s disease limited to 1 liver segment http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.175site was very limited and could not find any evidence of other bile  duct disease.,Non-OADS,/arxiv_data1/oa_pdf/ac/85/cmh-21-175.PMC4493361.pdf
"178 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.175Clin Mol Hepatol Volume _21  Number _2  June 2015DISCUSSION Caroli’s disease, a congenital cystic dilatation of the hepatic  ducts, has been reported steadily wordwide since the first report  in 1958 by Caroli et al.5 The incidence worldwide is 1 case per  million, and most patients are diagnosed before the age of 30  years.6 It is clinically complicated with recurrent cholangitis, intra - hepatic cholelithiasis, or liver abscess; cancer also can be found in  7–24% of cases.7,8 Caroli’s disease can be divided into the diffuse  type, which involves both lobes, and the localized type, which oc - curs in a single lobe.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/cmh-21-175.PMC4493361.pdf
Caroli’s disease limited to 1 liver segment http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.175best choice in our situation.,Non-OADS,/arxiv_data1/oa_pdf/ac/85/cmh-21-175.PMC4493361.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.180 Clinical and Molecular Hepatology 2015;21:180-182 Case Report Corresponding author :  Sun Hong Yoo Hepatology Center, Bundang Jesaeng General Hospital, Seohyeon-ro  180beon-gil, Bundang-gu, Seongnam, 463-774, Korea Tel: +82-31-779-5065, Fax: +82-31-779-0164 E-mail: calla0108@catholic.ac.krAbbreviations:   ALT, alanine aminotransferase; AST, aspartate aminotransferase; HAV- IgM, hepatitis A virus-immunoglobulin M; HBsAg, hepatitis B surface  antigen; HCV, hepatitis C virus; HCV-RNA, hepatitis C virus-ribonucleic  acid; HIV, human immunodeficiency virus; INR, international normalized  ratio; VCA-IgM, viral capsid antigen-immunoglobulin M; VPA, valproic  acid Received :  Jul.",Non-OADS,/arxiv_data1/oa_pdf/36/7a/cmh-21-180.PMC4493362.pdf
"(Clin Mol Hepatol 2015;21:180-182) Keywords:  Lamotrigine; Hypersensitivity; Hepatotoxicity Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/7a/cmh-21-180.PMC4493362.pdf
Lamitrigine induced liver dysfunction http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.180brain syndrome.,Non-OADS,/arxiv_data1/oa_pdf/36/7a/cmh-21-180.PMC4493362.pdf
"182 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.180Clin Mol Hepatol Volume _21  Number _2  June 2015tion, and the metabolite is formed by cytochrome P450 enzyme,  which increases hepatotoxicity when it is used with anticonvul - sant inducing liver enzyme.",Non-OADS,/arxiv_data1/oa_pdf/36/7a/cmh-21-180.PMC4493362.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.183 Clinical and Molecular Hepatology 2015;21:183-186 Liver Pathology Corresponding author :  Baek-hui Kim Department of Pathology, Korea University Guro Hospital, Korea  University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 152- 703, Korea Tel: +82-2-2626-3255, Fax: +82-2-2626-1486 E-mail: maelstrom@naver.comAbbreviations:   EpCAM, epithelial cell adhesion molecule; HepPar-1, hepatocyte  paraffin 1; WHO, World Health OrganizationINTRODUCTION  Cholangiolocellular carcinoma, a rare type of primary malignant  tumor of liver, is thought to originate from cholangioles or canals  of Hering, where hepatic progenitor or stem cells are located,1,2  and has characteristic histologic features of tubular, cord-like and  ‘antler-like’ pattern with marked fibrous stroma.3 Cholangiolocel - lular carcinoma was previously classified as one type of intrahe - patic cholangiocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/8c/11/cmh-21-183.PMC4493363.pdf
"Most of other satellite Cholangiolocellular carcinoma with satellite nodules  showing intermediate differentiation Wonkyung Jung and Baek-hui Kim Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea Keywords:  Cholangiolocellular carcinoma; Combined hepatocellular cholangiocarcinoma Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/11/cmh-21-183.PMC4493363.pdf
184 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.183Clin Mol Hepatol Volume _21  Number _2  June 2015nodules showed same histologic findings.,Non-OADS,/arxiv_data1/oa_pdf/8c/11/cmh-21-183.PMC4493363.pdf
"Cholangiolocellular carcinoma with intermediate differentiation component http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.183findings of cholangiolocellular carcinoma with tumor cells ar - ranged in tubular, cord-like and “antler-like” pattern in the marked fibrous stroma, and small portion of stem cell-like inter - mediate differentiation.",Non-OADS,/arxiv_data1/oa_pdf/8c/11/cmh-21-183.PMC4493363.pdf
186 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.183Clin Mol Hepatol Volume _21  Number _2  June 2015tin 19 showed positive reactivity in typical cholangiolocellular car - cinoma component but negative reactivity in intermediate  component.,Non-OADS,/arxiv_data1/oa_pdf/8c/11/cmh-21-183.PMC4493363.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.21.2.187 Clinical and Molecular Hepatology 2015;21:187-191 Liver Imaging Corresponding author :  Woo Kyoung Jeong Department of Radiology and Center for Imaging Science, Samsung  Medical Center, Sungkyunkwan University School of Medicine,   81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-1923, Fax: +82-2-3410-0049 Email: jeongwk@gmail.comAbbreviations:   HCC, hepatocellular carcinoma;CT, computed tomography; MRI,  magnetic resonance imaging; SI, signal intensity; T1WI, T1-weighted  images; T2WI, T2-weighted images; DWI, diffusion-weighted images;  ADC, apparent diffusion coefficient; AST, aspartate aminotransferase;  ALT, alanine aminotransferase; AFP , α-fetoprotein; US, ultrasoundINTRODUCTION  Tissue confirmation is a gold standard for diagnosing most ma - lignant tumors.",Non-OADS,/arxiv_data1/oa_pdf/20/2b/cmh-21-187.PMC4493364.pdf
"Our Benign nodules mimicking hepatocellular carcinoma  on gadoxetic acid-enhanced liver MRI Kyoung Doo Song and Woo Kyoung Jeong Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine,  Seoul, Korea Keywords:  Hepatocelluar carcinoam; Mimicker; Bile duct adenoma; Angiomyolipoma; Pseudolymphoma Copyright © 2015 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/2b/cmh-21-187.PMC4493364.pdf
188 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.187Clin Mol Hepatol Volume _21  Number _2  June 2015impression was HCC.,Non-OADS,/arxiv_data1/oa_pdf/20/2b/cmh-21-187.PMC4493364.pdf
Benign nodules mimicking HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.187Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/20/2b/cmh-21-187.PMC4493364.pdf
"190 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.187Clin Mol Hepatol Volume _21  Number _2  June 2015doxetic acid-enhance MRI, the mass showed low SI on T1WI, high  SI on T2WI, and high SI on DWI.",OADS,/arxiv_data1/oa_pdf/20/2b/cmh-21-187.PMC4493364.pdf
"Benign nodules mimicking HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.21.2.187portal tracts.12  Pseudolymphoma tends to show low density on precontrast CT  images, slight early enhancement in the arterial phase, and low to  isodensity in the delayed phase.",Non-OADS,/arxiv_data1/oa_pdf/20/2b/cmh-21-187.PMC4493364.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1371/journal.pbio.003011 3 Godfrey, D.I., S. Stankovic, and A.G. Baxter.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/ni.184 1 Gold, M.C., S. Cerri, S. Smyk-Pearson, M.E.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1371/journal.pbio.100040 7 Gold, M.C., J.E.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1084/jem.2014050 7 Kawachi, I., J. Maldonado, C. Strader, and S. Gilfillan.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.4049/jimmunol.176.3.161 8 Kjer-Nielsen, L., O. Patel, A.J.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/nature1160 5 Kovalovsky, D., O.U.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/ni.164 1 Kreslavsky, T., A.K.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"11:969) http://dx.doi   .org/10.1038/ni.189 0 Le Bourhis, L., Y.K.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1016/j.coi.2013.01.00 5 Lee, Y.J., K.L.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/ni.273 1 Leeansyah, E., L. Loh, D.F .",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"5:3143. http://dx.doi.org/10   .1038/ncomms414 3 Lepore, M., A. Kalinichenko, A. Colone, B. Paleja, A. Singhal, A. Tschumi,   B. Lee, M. Poidinger, F .",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"5:4493) http://dx.doi.org/10.1038/ncomms486 6 Martin, E., E. Treiner, L. Duban, L. Guerri, H. Laude, C. T oly, V .",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/   10.1371/journal.pbio.100005 4 McWilliam, H.E., R.W .",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1016/   j.coi.2014.12.00 4 Meierovics, A., W .J.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1016/j.coi.2013.09.00 7 Corbett, A.J., S.B.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/nature1316 0 Croxford, J.L., S. Miyake, Y.Y.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/ni137 0 Dash, P., J.L.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1172/   JCI4475 2 Dusseaux, M., E. Martin, N. Serriari, I. Péguillet, V. Premel, D. Louis, M.  Milder, L. Le Bourhis, C. Soudais, E. Treiner, and O. Lantz.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10   .1182/blood-2010-08-30333 9 Eckle, S.B., R.W .",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1093/intimm/dxr04 7 Okamoto, N., O. Kanie, Y.Y.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1016/   j.chembiol.2005.04.01 4 Patel, O., L. Kjer-Nielsen, J.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"4:2142. http://dx.doi.org/10.1038/ncomms314 2 Pellicci, D.G., K.J.L.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1084/   jem.2001154 4 Pellicci, D.G., O. Patel, L. Kjer-Nielsen, S.S. Pang, L.C.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.04.01 8 Prince, A.L., L.B.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/   10.4049/jimmunol.130205 8 Reantragoon, R., L. Kjer-Nielsen, O. Patel, Z. Chen, P.T.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"210:2305– 2320. http://dx.doi.org/10.1084/jem.2013095 8 Rossjohn, J., S. Gras, J.J.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1146/annurev-   immunol-032414-11233 4Savage, A.K., M.G.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.07.01 1 Seach, N., L. Guerri, L. Le Bourhis, Y .",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.4049/   jimmunol.130121 2 Tang, X.Z., J. Jo, A.T. Tan, E. Sandalova, A. Chia, K.C.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.4049/jimmunol   .120321 8 Teunissen, M.B., N.G.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/jid.2014.26 1 Tilloy, F., E. Treiner, S.H.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1084/jem.189   .12.190 7 Treiner, E., L. Duban, S. Bahram, M. Radosavljevic, V. Wanner, F. Tilloy,  P. Affaticati, S. Gilfillan, and O. Lantz.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1038/nature0143 3 Ussher, J.E., P. Klenerman, and C.B.",OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"5:450. http://dx.doi.org/10.3389/fimmu.2014.0045 0 Walker, L.J., Y .H.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
"http://dx.doi.org/10.1182/   blood-2011-05-35378 9 Weigmann, B., I. Tubbe, D. Seidel, A. Nicolaev, C. Becker, and M.F.",Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
http://dx.doi.org/10.1038/nprot.2007.31 5,Non-OADS,/arxiv_data1/oa_pdf/87/b6/JEM_20142110.PMC4493408.pdf
This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.05.00 4 Heltemes-Harris, L.M., M.J. Willette, L.B.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1084/jem.2010194 7 Hillhouse, E.E., and S. Lesage.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/j.jaut   .2012.07.01 0 Höflinger, S., K. Kesavan, M. Fuxa, C. Hutter, B. Heavey, F. Radtke,  and M. Busslinger.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.4049/jimmunol.173.6.393 5 Izon, D.J., J.C. Aster, Y.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/S1074-   7613(02) 00271- 6 Langmead, B., C. Trapnell, M. Pop, and S.L.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1186/gb-2009-   10-3-r2 5 Lin, H., and R. Grosschedl.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1002/eji.20104113 7 Maier, M.M., and M. Gessler.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1006/bbrc   .2000.335 4 Mansson, R., S. Zandi, K. Anderson, I.L.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1182/blood-2007-11-12538 5 Mansson, R., S. Zandi, E. Welinder, P. Tsapogas, N. Sakaguchi, D. Bryder,  and M. Sigvardsson.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1182/blood-2009-08-   23639 8 Mullighan, C.G., S. Goorha, I. Radtke, C.B.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1038/nature0569 0 Nechanitzky, R., D. Akbas, S. Scherer, I. Györy, T. Hoyler, S. Ramamoorthy,  A. Diefenbach, and R. Grosschedl.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
http://dx.doi.org/10.1101/gad.11.4.47 6was cloned upsteam of the IRES and GFP reporter gene.,OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
Online supplemental material is available at http://www.jem.org/cgi/   content/full/jem.20132100/DC1.,Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1074/jbc.M113   .50626 1 Banerjee, A., D. Northrup, H. Boukarabila, S.E.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/j.immuni   .2013.01.01 4 Caton, M.L., M.R.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1084/jem.2006264 8 Cobaleda, C., W. Jochum, and M. Busslinger.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1038/nature0615 9 Decker, T., M. Pasca di Magliano, S. McManus, Q.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/j.immuni   .2009.01.01 2 Deftos, M.L., E. Huang, E.W.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/S1074-   7613(00)00009- 1 Di Tullio, A., T.P.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1093/intimm/11.7.101 7 Harjes, U., E. Bridges, A. McIntyre, B.A.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1074/jbc.M114.57651 2 Heavey, B., C. Charalambous, C. Cobaleda, and M. Busslinger.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
http://dx.doi.org/10.1093/emboj/cdg38 0,Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1038/4407 6 O’Riordan, M., and R. Grosschedl.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80078- 3 Pongubala, J.M., D.L.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1038/ni155 5 Radtke, F., A. Wilson, G. Stark, M. Bauer, J. van Meerwijk, H.R.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80054- 0 Revilla-I-Domingo, R., I. Bilic, B. Vilagos, H. Tagoh, A. Ebert, I.M.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1038/emboj.2012.15 5 Roessler, S., I. Györy, S. Imhof, M. Spivakov, R.R.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1128/MCB.01192-0 6 Rolink, A.G., S.L.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1038/4416 4 Saldanha, A.J.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1093/   bioinformatics/bth34 9 Schlissel, M.S., L.M.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"173:711– 720. http://dx.doi.org/10.1084/jem.173.3.71 1 Schmitt, T.M., and J.C. Zúñiga-Pflücker.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/S1074-7613(02)00474- 0 Schmitt, T.M., M. Ciofani, H.T.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"106:1995– 2001. http://dx.doi.org/10.1182/blood-2004-12-474 4 Souabni, A., C. Cobaleda, M. Schebesta, and M. Busslinger.",Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/S1074-   7613(02)00472- 7 Treiber, T., E.M. Mandel, S. Pott, I. Györy, S. Firner, E.T.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/j.immuni   .2010.04.01 3 Urbánek, P., Z.-Q.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90079- 5 Vilagos, B., M. Hoffmann, A. Souabni, Q.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1084/jem   .2011242 2 Weber, B.N., A.W.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/   10.1038/nature1027 9 Wilson, A., H.R.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.1084/jem.194.7.100 3 Xie, H., M. Ye, R. Feng, and T. Graf.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10   .1016/S0092-8674(04)00419- 2 Zandi, S., R. Mansson, P. Tsapogas, J. Zetterblad, D. Bryder, and M. Sigvardsson.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
"http://dx.doi.org/10.4049/jimmunol.181.5.336 4 Zandi, S., J. Ahsberg, P. Tsapogas, J. Stjernberg, H. Qian, and M. Sigvardsson.",OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
http://dx.doi.org/10.1073/   pnas.121014410 9,Non-OADS,/arxiv_data1/oa_pdf/80/d4/JEM_20132100.PMC4493409.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six   months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
http://dx.doi.org/10.1034/j.1600-065X.2003.00041.,Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"22:4478– 4488. http://dx.doi.org/10.1093/emboj/cdg43 4 Fahl, S.P., R.B.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.4049/jimmunol.090118 7 Flynn, K.J., G.T.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80573- 7 Greig, K.T., C.A.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1182/blood-2009-08-   23921 0 Hargreaves, D.C., P.L.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1084/jem.194.1.4 5 Hart, G.T., X. Wang, K.A.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.4049/jimmunol.169.3.127 7 Kabashima, K., N.M. Haynes, Y .",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1084/jem.2006128 9 Kallies, A., J. Hasbold, D.M.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.04.01 4 Lefebvre, C., P. Rajbhandari, M.J. Alvarez, P. Bandaru, W.K.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"6:377. http://dx.doi   .org/10.1038/msb.2010.3 1 Lieu, Y .K., and E.P .",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1038/ni.252 7 Quintana, A.M., F. Liu, J.P. O’Rourke, and S.A. Ness.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"11:30. http://dx.doi.org/10.1186/1471-2407-11-3 0 Severinson, E., C. Fernandez, and J. Stavnezer.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi   .org/10.1038/ni110 0 Belz, G.T., W .",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10   .1128/JVI.74.8.3486-3493.200 0 Brochet, X., M.P.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1093/nar/gkn31 6 Collins, J.T., and W.A.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1093/intimm/5.8.88 5 Cortés, M., and K. Georgopoulos.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
http://dx.doi.org/10.1084/jem.2003157 1,Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1002/eji.183020052 0 Tarlinton, D., and K. Good-Jacobson.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi   .org/10.1126/science.124114 6 Thomas, M.D., C.S.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10   .1016/j.immuni.2005.08.00 5 Underhill, G.H., K.P.",OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1146/annurev-immunol-   020711-07503 2 Wehrli, N., D.F.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
"http://dx.doi.org/10.1002/1521-4141(200102)   31:2<609::AID-IMMU609>3.0.CO;2- 9 Zotos, D., J.M.",Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
http://dx.doi   .org/10.1084/jem.2009177 7,Non-OADS,/arxiv_data1/oa_pdf/a1/13/JEM_20150191.PMC4493410.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1038/sj.npp.130028 3 Guo, S., and L.A. Dipietro.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1177/002203450935912 5 Hino, S., S. Kishida, T. Michiue, A. Fukui, I. Sakamoto, S. Takada, M.  Asashima, and A. Kikuchi.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1128/MCB.21.1.330-342.200 1 Kabashima, K., J. Sakabe, R. Yoshiki, Y. Tabata, K. Kohno, and Y. Tokura.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.2353/ajpath.2010.09045 4 Kähäri, V .M., J. Heino, T. Vuorio, and E. Vuorio.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1016/0167-4889(88)90042- 0 Kasper, M., V. Jaks, A.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1096/fj.13-23621 6 Kim, M.S., S.K.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1074/jbc   .M109.09433 4 Kim, M.S., H.J.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1111/jocd.1207 3 Kim, T.H., H. Xiong, Z. Zhang, and B. Ren.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1038/sj.onc.120823 7 Kim, Y.S., D.H. Lew, K.C.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.3346/jkms.2010.25.4.58 9 Krieg, T., J.S.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1007/   BF0050923 6 Labus, M.B., C.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
http://dx.doi.org/10.1046/j.1524-475X.1998.60109.,Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
http://dx.doi.org/   10.1046/j.1524-475X.1995.30106.,Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1631/ jzus.B140015 8 Lee, S.H., M. Zahoor, J.K. Hwang, S. Min, and K.Y.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1371/jour nal  .pone.004879 1 Li, C.H., and S. Amar.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1177/   15440591060850041 8 Liao, D.J., A. Thakur, J. Wu, H. Biliran, and F.H.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1615/CritRevOncog.v13.i2.1 0Submitted: 19 August 2014 Accepted: 14 May 2015 REFERENCES Akhmetshina, A., K. Palumbo, C. Dees, C. Bergmann, P. Venalis, P. Zerr,  A. Horn, T. Kireva, C. Beyer, J. Zwerina, et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"3:735. http://dx.doi.org/10.1038/ncomms173 4 Amini Nik, S., R.P .",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1016/   j.yexcr.2007.05.02 4 Andersson, T., E. Södersten, J.K. Duckworth, A. Cascante, N. Fritz, P .",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1074/jbc.M80811920 0 Barker, N. 2008.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1007/978-1-59745-249-6_ 1 Bergmann, C., A. Akhmetshina, C. Dees, K. Palumbo, P .",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/   10.1136/ard.2010.14714 0 Carthy, J.M., F.S.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1371/journal.pone.001980 9 Chen, S., S. McLean, D.E.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1007/s12079-007-0015- x Chen, X., Y .",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1111/j.1524-475X.2012   .00792. x Cheon, S.S., P. Nadesan, R. Poon, and B.A.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1016/j.yexcr.2003.09.02 9 Cheon, S., R. Poon, C. Yu, M. Khoury, R. Shenker, J.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1038/labinvest.370023 7 Chipev, C.C., and M. Simon.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"2:13. http://dx.doi.org/10.1186/   1471-5945-2-1 3 Chua, A.W ., S.U.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1016/j.jdermsci.2011.09.00 8 Diegelmann, R.F., and M.C.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10   .1242/jcs.0038 4 Eisenmann, D.M.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1002/   jcp.2063 7 Gay, D., O. Kwon, Z. Zhang, M. Spata, M.V .",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1038/nm.318 1 Gould, T.D., and H.K.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
http://dx.doi.org/10.1177/   10738580223717 6,Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1016/j.bbrc.2004.07.11 3 Matsushita, M., and H. Matsui.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1007/s00109-004-0633- 1 Niida, A., T. Hiroko, M. Kasai, Y. Furukawa, Y. Nakamura, Y. Suzuki,  S. Sugano, and T. Akiyama.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"23:8520– 8526. http://dx.doi.org/10.1038/sj.onc.120789 2 Özyazgan, I., and O. Konta ş.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1080/0284431031000588 3 Rizvi, M.A., L. Katwa, D.P.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1006/jmcc.1996.002 3 Sato, M. 2006.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.2340/00015555-010 1 Singer, A.J., and R.A. Clark.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1056/NEJM19990902341100 6 T ang, J., H. Liu, C. Gao, L. Mu, S. Y ang, M. Rong, Z. Zhang, J. Liu, Q. Ding, and R.  Lai.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1371/journal.pone.009208 2Wei, J., D. Melichian, K. Komura, M. Hinchcliff, A.P.",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1371/journal.pone.007688 3 Yamaguchi, Y ., and K. Y oshikawa.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
http://dx.doi.org/10.1111/j.1346-8138.2001.,Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1016/j.bbrc   .2008.11.01 1 Zhang, M., R. Wang, Y. Wang, F. Diao, F. Lu, D. Gao, D. Chen, Z. Zhai,  and H. Shu.",OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
"http://dx.doi.org/10.1007/s11427-009-0083- 7 Zhang, S., W .",Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
http://dx.doi.org/10.7150/ijms.746 3,Non-OADS,/arxiv_data1/oa_pdf/4d/6e/JEM_20141601.PMC4493411.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Un - ported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.4049/jimmunol.0803872 Arechiga, A.F., T. Habib, Y.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.4049/jimmunol.071337 0 Baccala, R., R. Gonzalez­Quintial, R.D.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.4049/jimmunol.1201477 Baechler, E.C., F .M.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.2174/   187431290130701008 7 Begovich, A.B., V.E.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10   .1191/09612030067449906 4 Bottini, N., and E.J.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1146/annurev ­  immunol­032713­120249 Bottini, N., L. Musumeci, A. Alonso, S. Rahmouni, K. Nika, M.  Rostamkhani, J. MacMurray, G.F. Meloni, P. Lucarelli, M. Pellecchia,  et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/   10.1038/ng132 3 Bovolenta, C., P.H.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/ng.8 1 Hasegawa, K., F. Martin, G. Huang, D. Tumas, L. Diehl, and A.C. Chan.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10   .1126/science.109213 8 Heremans, H., A. Billiau, A. Colombatti, J. Hilgers, and P. de Somer.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1146/annurev.immunol.21.120601.14094 6 Hillyer, P., N. Raviv, D.M.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1002/   eji.20124328 8 Ho, V., A. Mclean, and S. Terry.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1097/RHU.0b013e3181775e8 0 Hom, G., R.R.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/cmi.2014.4 9 Irie­Sasaki, J., T. Sasaki, W .",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/3505308 6 Jørgensen, T.N., E. Roper, J.M.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/sj.gene.636443 0 Kalunian, K.C., J.T.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10   .1136/annrheumdis­2014­206090 Kariuki, S.N., M.K.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"75:504– 507. http://dx.doi.org/10.1086/42379 0 Lessard, C.J., I. Adrianto, J.A.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10   .1016/j.ajhg.2012.02.02 3 Liu, J., L. Wang, J. Harvey­White, D. Osei­Hyiaman, R. Razdan, Q. Gong,  A.C. Chan, Z. Zhou, B.X.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1530/rep.1.0015 8 Mathian, A., A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1002/art.178015030 2 Carpenter, D.F ., A.D. Steinberg, P .H.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1371/journal.pgen.100132 3 Cloutier, J.F., and A. Veillette.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1172/   JCI6696 3 de Weerd, N.A., J.P. Vivian, T.K.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/   10.1038/ni.266 7 Essers, M.A., S. Offner, W.E.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/   10.1038/nature0781 5 García ­Valladares, I., Y. Atisha ­Fregoso, Y. Richaud ­Patin, J. Jakez ­Ocampo,  E. Soto ­V ega, D. Elías ­López, E. Carrillo ­Maravilla, J. Cabiedes, A. Ruiz ­ Argüelles, and L. Llorente.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/ng.46 8 Gjörloff­Wingren, A., M. Saxena, S. Williams, D. Hammi, and T. Mustelin.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1002/(SICI)1521­ 4141(199912)29:12<3845::AID­IMMU3845>3.0.CO;2­ U Habib, T., A. Funk, M. Rieck, A. Brahmandam, X. Dai, A.K.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/nrrheum.2009.23 7 Han, J.W., H.F. Zheng, Y. Cui, L.D.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi   .org/10.1038/ng.47 2 Harley, J.B., M.E.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.4049/jimmunol.174.5.249 9 Menard, L., D. Saadoun, I. Isnardi, Y.S.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1172/JCI4579 0 Mittal, K.K., R.D.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/2251255a 0 Penninger, J.M., J. Irie­Sasaki, T. Sasaki, and A.J.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi   .org/10.4049/jimmunol.140303 4 Rhee, I., and A. Veillette.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.4049/jimmunol.179.7.470 4 Salmond, R.J., R.J. Brownlie, V .L.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/   10.1038/ni.295 8 Santiago ­Raber, M.L., R. Baccala, K.M.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1084/jem.2002199 6 Sato, T., N. Onai, H. Yoshihara, F. Arai, T. Suda, and T. Ohteki.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"15:696– 700. http://dx.doi.org/10.1038/nm.197 3 Shenoi, H., J. Seavitt, A. Zheleznyak, M.L.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1053/j.gastro.2013.01.04 8 Stanford, S.M., and N. Bottini.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/   10.1038/nrrheum.2014.10 9 Vang, T., M. Congia, M.D.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/ng167 3 Vang, T., W.H.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1038/nchembio.91 6 Velaga, M.R., V. Wilson, C.E.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1210/   jc.2004­110 8 Voulgarelis, M., S. Giannouli, A. Tasidou, D. Anagnostou, P.D.",Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
"http://dx.doi.org/10.1016/j.immuni.2013.06.01 3 Zhang, J., N. Zahir, Q. Jiang, H. Miliotis, S. Heyraud, X. Meng, B. Dong,  G. Xie, F. Qiu, Z. Hao, et al.",OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
http://dx.doi.org/10.4049/jimmunol.080331 7,Non-OADS,/arxiv_data1/oa_pdf/3b/39/JEM_20142130.PMC4493413.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1016/0014-5793(93)81724- E Blankman, J.L., J.Z.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi   .org/10.1073/pnas.121712111 0 Bollrath, J., and F.M.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1038/nri291 6 Chu, X., M. Shen, F. Xie, X.J.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1136/   jmedgenet-2013-10159 5 Geuking, M.B., J. Cahenzli, M.A.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"34:794– 806. http://dx.doi.org/10.1016/j.immuni.2011.03.02 1 Grzelczyk, A., and E. Gendaszewska-Darmach.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1016/j.biochi   .2012.10.00 9 Hall, J.A., J.R. Grainger, S.P.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"199:303– 313. http://dx.doi.org/10.1084/jem.2003156 2 Inoue, A., J. Ishiguro, H. Kitamura, N. Arima, M. Okutani, A. Shuto, S.  Higashiyama, T. Ohwada, H. Arai, K. Makide, and J. Aoki.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/   10.1038/nmeth.217 2 Josefowicz, S.Z., L.F. Lu, and A.Y.",Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"30:531– 564. http://dx.doi.org/10.1146/annurev.immunol.25.022106.14162 3 Kamat, S.S., K. Camara, W.H.",Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1038/nchembio.172 1 Kitamura, H., K. Makide, A. Shuto, M. Ikubo, A. Inoue, K. Suzuki, Y.  Sato, S. Nakamura, Y. Otani, T. Ohwada, and J. Aoki.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1093/jb/mvs01 1 Lehmann, J., J. Huehn, M. de la Rosa, F. Maszyna, U. Kretschmer, V.  Krenn, M. Brunner, A. Scheffold, and A. Hamann.",Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1074/jbc   .M110.19665 9 Liu, G., S. Burns, G. Huang, K. Boyd, R.L.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1038/ni.284 9 Martin, T.W., and D. Lagunoff.",Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1038/279250a 0 McHugh, R.S., M.J. Whitters, C.A.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi   .org/10.1016/S1074-7613(02)00280- 7 Moran, A.E., K.L.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1084/   jem.2011030 8 Okada, Y ., D. Wu, G. Trynka, T. Raj, C. T erao, K. Ikari, Y .",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1038/nature1287 3 Pham, T.H., T. Okada, M. Matloubian, C.G.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1038/ni.264 9 Regard, J.B., I.T.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.08.04 0 Sato, T., J. Aoki, Y. Nagai, N. Dohmae, K. Takio, T. Doi, H. Arai, and K.  Inoue.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1074/jbc.272.4.219 2 Smith, P.M., M.R.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1126/science   .124116 5 Stromnes, I.M., and J.M.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi   .org/10.1038/nprot.2006.28 5 Suffia, I., S.K.",Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.4049/   jimmunol .174.9.544 4 Sugita, K., C. Yamamura, K. Tabata, and N. Fujita.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2012.11.04 6 Thomas, G., J.L.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.08   .047 Thorburn, A.N., L. Macia, and C.R.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi.org/10.1016/j.immuni.2014.05.01 4 Thornton, A.M., and E.M. Shevach.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
"http://dx.doi   .org/10.1084/jem.188.2.28 7 Zhao, S.X., L.Q.",OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
http://dx.doi.org/10   .1093/hmg/ddt18 3,Non-OADS,/arxiv_data1/oa_pdf/08/51/JEM_20141827.PMC4493414.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1097/QAD.0b013e328361d05 9 Chen, Q., X.H.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/   j.ccr.2011.08.02 5 Dairaghi, D.J., P. Zhang, Y. Wang, L.C.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/clpt.2011.3 3 Dairaghi, D.J., B.O.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1182/   blood-2011-10-38478 4 Davies, L.C., S.J.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/   ni.270 5 Eis, V., B. Luckow, V. Vielhauer, J.T.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1097/01   .ASN.0000111246.87175.3 2 Ewens, A., E. Mihich, and M.J. Ehrke.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/sj.onc   .120856 1 Finak, G., N. Bertos, F. Pepin, S. Sadekova, M. Souleimanova, H. Zhao, H.  Chen, G. Omeroglu, S. Meterissian, A. Omeroglu, et al.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/nm176 4 Fischer, F.R., Y. Luo, M. Luo, L. Santambrogio, and M.E.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.4049/jimmunol.167.3.163 7 Franklin, R.A., W. Liao, A. Sarkar, M.V.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1126/   science.125251 0 Hanahan, D., and L.M.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.02.02 2 Huffnagle, G.B., R.M.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10   .1038/nri360 0 Iida, N., Y. Nakamoto, T. Baba, K. Kakinoki, Y.Y.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/   10.3322/caac.2010 7 Joyce, J.A., and J.W.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/   nrc261 8 Kaufmann, A., R. Salentin, D. Gemsa, and H. Sprenger.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20141836/DC1.,Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1182/   blood-2007-08-10620 3 Bingle, L., N.J. Brown, and C.E.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1002/path.102 7 Bonapace, L., M.M.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"515:130– 133. http://dx.doi.org/10.1038/nature1386 2 Borowsky, A.D., R. Namba, L.J.T.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1007/s10585-005-2908- 5 Cain, D.W ., P .B.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1371/   journal.pone.001995 7 Cassetta, L., A. Kajaste-Rudnitski, T. Coradin, E. Saba, G. Della Chiara,  M. Barbagallo, F. Graziano, M. Alfano, E. Cassol, E. Vicenzi, and G.  Poli.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/   10.1023/A:100665710986 6 Qian, B.-Z., and J.W.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.03.01 4 Qian, B., Y. Deng, J.H.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1371/journal.pone.000656 2 Qian, B.-Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"475:222– 225. http://dx.doi.org/10.1038/nature1013 8 Ramos, C.D.L., C. Canetti, J.T.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1189/jlb.040423 7 Roca, H., Z.S.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1074/   jbc.M109.04267 1 Rodero, M.P., C. Auvynet, L. Poupel, B. Combadière, and C. Combadière.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1593/neo.12186 6 Sandhu, S.K., K. Papadopoulos, P.C.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1007/s00280-013-2099- 8 Schall, T.J., and A.E.I.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/nri297 2 Schaller, M.A., L.E.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.2353/ajpath.2008.07053 7 Serbina, N.V ., T. Jia, T.M.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607.09032 6 Suehiro, Y., K. Muta, T. Umemura, Y. Abe, J. Nishimura, and H. Nawata.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"27:1637– 1645. http://dx.doi.org/10.1016/S0301-472X(99)00103- 4 Tak, P.P., A. Balanescu, V. Tseluyko, S. Bojin, E. Drescher, D. Dairaghi, S.  Miao, V. Marchesin, J. Jaen, T.J. Schall, and P. Bekker.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1136/annrheumdis-2011-20160 5 Tanaka, T., M. Terada, K. Ariyoshi, and K. Morimoto.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/j.bbrc.2010.07.14 1 Tushinski, R.J., I.T.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/0092-8674(82)90376- 2 Wang, M.J., K.C.G.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1006/   cimm.2000.169 7 Weber, C., K.S.C.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10   .1073/pnas.100237210 7 Knowles, H.J., and A.L.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi   .org/10.2741/238 9 Leek, R.D., C.E.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1002/dvg.2021 9 Lin, E.Y., A.V.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1084/   jem.193.6.72 7 Lin, E.Y., J.G.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/   S0002-9440(10)63568- 7 Lloyd, A.R., J.J. Oppenheim, D.J.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/   10.1074/jbc.M109.03589 9 Luo, Y., F.R.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/   10.4049/jimmunol.165.7.401 5 Matsushima, K., C.G.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1084/jem.169.4.148 5 Minn, A.J., G.P.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi   .org/10.1038/nature0379 9 Nakasone, Y., M. Fujimoto, T. Matsushita, Y. Hamaguchi, D.L.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1016/j.exphem.2004.11.01 5 Ojalvo, L.S., W. King, D. Cox, and J.W.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10   .2353/ajpath.2009.08067 6 Pollard, J.W.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1038/nri252 8 Prest, S.J., R.C.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1182/blood.V97.4.114 4 Wu, Y., Y.-Y.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.4049/jimmunol.181   .9.638 4Youngs, S.J., S.A. Ali, D.D.",Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
"http://dx.doi.org/10.1002/(SICI)1097- 0215(19970410)71:2<257::AID-IJC22>3.0.CO;2- D Zhu, X., M. Fujita, L.A. Snyder, and H. Okada.",OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
http://dx.doi.org/10.1007/s11060-010-0473- 5,Non-OADS,/arxiv_data1/oa_pdf/09/8a/JEM_20141836.PMC4493415.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1080/1073968080227389 2 Ali, J., F .",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.3109/1073968970914679 0 Alva, J.A., A.C. Zovein, A. Monvoisin, T. Murphy, A. Salazar, N.L.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10   .1002/dvdy.2064 3 Ancuta, P., R. Rao, A. Moses, A. Mehle, S.K.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/   10.1084/jem.2002215 6 Banting, G.S., B. Pym, S.M.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/0161-5890(89)90100- 4 Bastaki, S.M., I.S.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1074/jbc.M01169820 0 Jarnaess, E., and K. Taskén.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1042/BST035093 1 Kim, C., N.H. Xuong, and S.S. Taylor.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1126/science.110460 7 Kim, I., O.H.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1038/nri215 6 Liao, F., H.K.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1084/jem.182.5.133 7 Lim, Y .C., G. Garcia-Cardena, J.R. Allport, M. Zervoglos, A.J.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)64293- 9 Lou, O., P. Alcaide, F.W.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.4049/jimmunol.178.2.113 6 Mamdouh, Z., X. Chen, L.M.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi   .org/10.1038/nature0130 0 Mamdouh, Z., G.E.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1084/jem.2007232 8 Mamdouh, Z., A. Mikhailov, and W .A.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10   .1084/jem.2008274 5 Manes, T.D., and J.S.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.4049/jimmunol.100283 5 Muller, W .A.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1146/annurev-pathol-   011110-13022 4 Muller, W.A., and F.W.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10   .1016/S0076-6879(08)02009- 0 Muller, W .A., and S.A. Weigl.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1084/   jem.176.3.81 9 Muller, W.A., C.M.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1091/mbc.E09-07-058 0 Osawa, H., C.A.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1215/   15228517-2008-11 0Bitterman, J.L., L. Ramos-Espiritu, A. Diaz, L.R.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/   10.1124/jpet.113.20849 6 Bixel, G., S. Kloep, S. Butz, B. Petri, B. Engelhardt, and D. Vestweber.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1182/blood-2004-03-118 4 Bixel, M.G., H. Li, B. Petri, A.G. Khandoga, A. Khandoga, A. Zarbock,  K. Wolburg-Buchholz, H. Wolburg, L. Sorokin, D. Zeuschner, et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1002/iub.16 8 Cauthron, R.D., K.B.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/j.brainres.2013.04.02 7 Dufour, E.M., A. Deroche, Y. Bae, and W.A.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1080/1541906080244219 1 Ellis, N.A., T.Z.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1038/ng0494-39 4 Farrell, J., L. Ramos, M. Tresguerres, M. Kamenetsky, L.R.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1371/journal.pone.000325 1 Feng, D., J.A.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1084/jem.183.5.198 1 Feng, G., D.P .",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/   10.1073/pnas.22265979 9 Forte, J.G., and L. Zhu.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10   .1146/annurev-physiol-021909-13574 4 Fukuhra, S., A. Sakurai, A. Yamagishi, K. Sako, and N. Mochizuki.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10   .1152/ajpcell.00584.200 4 Gonzalez, G.A., and M.R.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/0092-8674(89)90013- 5 Howe, A.K., L.C.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/j.gene.2005.04.02 3 Paunescu, T.G., N. Da Silva, L.M.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1152/ajprenal.00406.200 7 Schenkel, A.R., Z. Mamdouh, X. Chen, R.M.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10   .1038/ni74 9 Schenkel, A.R., T.W.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"173:6403– 6408. http://dx.doi.org/10.4049/jimmunol.173.10.640 3 Schnoor, M., F.P.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"208:1721– 1735. http://dx.doi.org/10.1084/jem.2010192 0 Seidman, M.A., T.W.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/   10.1371/journal.pone.000431 6 Suh, Y.H., Y.K.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/S0378-   1119(03)00401- 3 Sullivan, D.P., M.A.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/   j.ajpath.2012.11.03 7 Taylor, S.S., P. Zhang, J.M.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1016/j.bbapap.2013.03.00 7Tresguerres, M., L.R.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1002/cbic   .20080021 6 Wang, J., I. Shiratori, J. Uehori, M. Ikawa, and H. Arase.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/   10.1038/ni.245 6 Wong, W., and J.D.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi   .org/10.1038/nrm152 7 Wright, S.D., P .E.",OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1182/blood-2004-12-494 2 Zaccolo, M. 2009. cAMP signal transduction in the heart: understanding  spatial control for the development of novel therapeutic strategies.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/10.1111/j.1476-5381.2009   .00185. x Zhang, Y., K. Ma, P. Sadana, F. Chowdhury, S. Gaillard, F. Wang, D.P.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
"http://dx.doi.org/   10.1074/jbc.M60865720 0 Zippin, J.H., Y. Chen, P. Nahirney, M. Kamenetsky, M.S.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/JEM_20150354.PMC4493416.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10   .1056/NEJMoa120069 4 Buggert, M., J. Tauriainen, T. Yamamoto, J. Frederiksen, M.A.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1371/journal.ppat.100425 1 Butte, M.J., M.E.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"27:111– 122. http://dx.doi.org/10.1016/j.immuni.2007.05.01 6 Day, C.L., D.E.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi   .org/10.1038/nature0511 5 Frebel, H., V. Nindl, R.A. Schuepbach, T. Braunschweiler, K. Richter, J.  Vogel, C.A.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"209:2485– 2499. http://dx.doi.org/10.1084/jem.2012101 5 Gallimore, A., A. Glithero, A. Godkin, A.C. Tissot, A. Plückthun, T. Elliott,  H. Hengartner, and R. Zinkernagel.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi   .org/10.1084/jem.187.9.138 3 Grupp, S.A., M. Kalos, D. Barrett, R. Aplenc, D.L.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1056/NEJMoa121513 4 Iwai, Y., S. Terawaki, and T. Honjo.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi   .org/10.1093/intimm/dxh19 4 James, E.S., S. Harney, B.P.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10   .1038/ni.204 6 Kassu, A., R.A. Marcus, M.B.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"185:3007– 3018. http://dx.doi.org/10.4049/jimmunol.100015 6 Keir, M.E., G.J.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.4049/jimmunol.179.8   .5064 Keir, M.E., M.J. Butte, G.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607.09033 1 Martinez, G.J., R.M.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1016/j.immuni   .2015.01.00 6 Matloubian, M., R.J. Concepcion, and R. Ahmed.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1073/   pnas.080149710 5 Blackburn, S.D., H. Shin, W.N.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1158/0008­5472.CAN­03­325 9 Blattman, J.N., E.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
http://dx.doi.org/10.1128/JVI   .02844­0 6,Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1172/JCI864 7 Muenst, S., S. Hoeller, N. Willi, S. Dirnhofera, and A. Tzankov.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1155/2010/40406 9 Muenst, S., S.D.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1126/science.122962 0 Pardoll, D.M.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10   .1038/nrc323 9 Parry, R.V., J.M.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1128/   MCB.25.21.9543­9553.200 5 Patsoukis, N., J.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1126/scisignal.200279 6 Petrovas, C., J.P. Casazza, J.M.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi   .org/10.1084/jem.2006149 6 Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10   .1038/342559a 0 Restifo, N.P., M.E.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1038/nri319 1 Riley, J.L.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
229:114– 125. http://dx.doi.org/10.1111/j.1600­065X.2009.00767.,Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1084/jem.2010064 3 Shin, H., S.D.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10   .1084/jem.2006193 7 Shin, H., S.D.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.01 9Staron, M.M., S.M.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1016/j.immuni.2014.10.01 3 Topalian, S.L., F.S.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/   10.1056/NEJMoa120069 0 Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale,  and C. Ferrari.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1128/JVI.01177­0 6 Velázquez ­Cruz, R., L. Orozco, F. Espinosa ­Rosales, R. Carreño ­Manjarrez,  E. Solís ­Vallejo, N.D. López ­Lara, I.K.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi   .org/10.1038/sj.ejhg.520176 7 Velu, V., K. Titanji, B. Zhu, S. Husain, A. Pladevega, L. Lai, T.H.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1038/nature0766 2 Virgin, H.W., E.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.03 6 Wherry, E.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1128/JVI.77   .8.4911­4927.200 3 Wherry, E.J., V. Teichgräber, T.C.",Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1038/ni88 9 Wherry, E.J., S.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1016/j.immuni   .2007.09.00 6 Yokosuka, T., M. Takamatsu, W. Kobayashi­Imanishi, A. Hashimoto­ Tane, M. Azuma, and T. Saito.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1084/jem.2011274 1 Zajac, A.J., J.N.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi.org/10.1084/jem.188.12.220 5 Zhang, G., Q. Han, S. Duan, Z. Li, N. Li, Q. Zhu, J. Chen, Y. Lv, X.  Zeng, Y. Chen, and Z. Liu.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
"http://dx.doi   .org/10.1016/j.humimm.2012.01.01 3 Zinselmeyer, B.H., S. Heydari, C. Sacristán, D. Nayak, M. Cammer, J. Herz, X.  Cheng, S.J.",OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
http://dx.doi.org/10.1084/jem.2012141 6,Non-OADS,/arxiv_data1/oa_pdf/37/a5/JEM_20142237.PMC4493417.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-12-453 9 Andres, K.H., M. von Düring, K. Muszynski, and R.F .",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1007/BF0030984 3 Aspelund, A., T. Tammela, S. Antila, H. Nurmi, V .-M. Leppänen, G. Zarkada, L.  Stanczuk, M. Francois, T .",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
http://dx.doi.org/10.1172/JCI7539 5Vectashield mounting medium containing DAPI (Vector Laboratories).,OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1679/aohc.61.27 7 Mondin, V ., A. Ferlito, K.O.",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/   10.1007/s00405-010-1357- 1 Oliver, G., and R.S.",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"137:363– 372. http://dx.doi.org/10.1242/dev.03536 0 Petrova, T.V ., A. Nykänen, C. Norrmén, K.I.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1016/j.ccr.2008.02.02 0 Plog, B.A., M.L.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3742-14.201 5 Pollay, M. 2010.",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"7:9. http://dx.doi.org/10.1186/1743-   8454-7- 9 Proulx, S.T., P. Luciani, A. Christiansen, S. Karaman, K.S.",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1016/j.biomaterials.2013.03.03 4 Radjavi, A., I. Smirnov, N. Derecki, and J. Kipnis.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1038/mp.2013.7 9 Secker, G.A., and N.L.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1002/dvdy.2422 7 Si, J., L. Chen, and Z. Xia.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.01.04 5 W eller, R.O., E. Djuanda, H.-Y .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1007/s00401-008-0457- 0 Wick, N., P .",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10   .1152/physiolgenomics.00037.200 6 Wiig, H., and R.K. Reed.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/   10.1126/science.124122 4 Zhao, Z., A.P .",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1038/nn.402 5 Zlokovic, B.V .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1038/mrm311 4Choi, I., H.K.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.2174/   13816120878470548 7 Dumont, D.J., L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, K.  Pajusola, M. Breitman, and K. Alitalo.",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1126/science.282.5390.94 6 Furukawa, M., H. Shimoda, T. Kajiwara, S. Kato, and S. Yanagisawa.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.2220/biomedres   .29.28 9 Gausas, R.E., T. Daly, and F .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1097/01   .iop.0000249431.04116.a 8 Hong, Y .-K., N. Harvey, Y .-H. Noh, V .",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi   .org/10.1002/dvdy.1016 3 Huang, Y ., and L. Mucke.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1016/j.cell.2012.02.04 0 Iliff, J.J., and M. Nedergaard.",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi   .org/10.1161/STROKEAHA.112.67869 8 Iliff, J.J., M. W ang, Y .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1126/scitranslmed.300374 8 Karkkainen, M.J., P .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/   10.1038/ni101 3 Kida, S., A. Pantazis, and R.O.",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
http://dx.doi.org/10.1111/j.1365-2990.1993.tb00476.,Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"2:6. http://dx.doi   .org/10.1186/1743-8454-2- 6 Li, Y ., Y .",Non-OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/10.1038/nprot   .2008.17 2 Liao, S., and P .Y .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
"http://dx.doi.org/   10.1016/j.semcdb.2014.11.01 2 Lukić, I.K., V .",OADS,/arxiv_data1/oa_pdf/ea/64/JEM_20142290.PMC4493418.pdf
This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/cdd.2013.2 1 Berger, Z., B. Ravikumar, F.M.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1093/hmg/ddi45 8 Bird, S.W., N.D. Maynard, M.W.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1242/jcs.12612 8 Birmingham, C.L., V. Canadien, N.A.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nature0647 9 Bjørkøy, G., T. Lamark, A. Brech, H. Outzen, M. Perander, A. Overvatn, H.  Stenmark, and T. Johansen.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1083/   jcb.20050700 2 Borel, S., V. Robert-Hebmann, J. Alfaisal, A. Jain, M. Faure, L. Espert,  L. Chaloin, J.C. Paillart, T. Johansen, and M. Biard-Piechaczyk.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1128/MCB.25.3.1025-1040.200 5 Bruns, H., F. Stegelmann, M. Fabri, K. Döhner, G. van Zandbergen, M.  Wagner, M. Skinner, R.L.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/   j.cub.2014.02.00 8 Ejlerskov, P., I. Rasmussen, T.T.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/jbc.M112   .40117 4 El-Hage, N., M. Rodriguez, S.M.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1128/   JVI.02022-1 4 Ertmer, A., V. Huber, S. Gilch, T. Yoshimori, V. Erfle, J. Duyster, H.P.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3121-   13.201 4 Fecto, F., J. Yan, S.P.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1001/archneurol.2011.25 0 Fields, J., W. Dumaop, S. Elueteri, S. Campos, E. Serger, M. Trejo, K.  Kosberg, A. Adame, B. Spencer, E. Rockenstein, et al.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.3207-14.201 5 Filimonenko, M., P. Isakson, K.D.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.04.00 7 Frake, R.A., T. Ricketts, F.M.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/   nn.400 0 Frost, B., R.L.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"284:12845– 12852. http://dx.doi.org/10.1074/jbc.M80875920 0 Furuya, N., J. Yu, M. Byfield, S. Pattingre, and B. Levine.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.7554/eLife.0094 7 Ge, L., M. Zhang, and R. Schekman.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.7554/   eLife.0413 5 Gomes, L.C., and I. Dikic.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.molcel.2014.03.00 9 Gutierrez, M.G., S.S. Master, S.B.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.cell.2004.11.03 8 Hamasaki, M., N. Furuta, A. Matsuda, A. Nezu, A. Yamamoto, N.  Fujita, H. Oomori, T. Noda, T. Haraguchi, Y. Hiraoka, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.4049/jimmunol.120153 8 Campbell, G.R., R.S.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/jbc   .M114.60542 8 Cárdenas, C., R.A. Miller, I. Smith, T. Bui, J. Molgó, M. Müller, H. Vais,  K.H.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.cell.2010.06.00 7 Castillo, E.F., A. Dekonenko, J. Arko-Mensah, M.A.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.molcel.2015.03.02 0 Chen, R., Y. Zou, D. Mao, D. Sun, G. Gao, J. Shi, X. Liu, C. Zhu, M.  Yang, W. Ye, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1083/jcb.20140300 9 Choi, J., S. Park, S.B.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.immuni.2014.05.00 6 Choy, A., J. Dancourt, B. Mugo, T.J. O’Connor, R.R.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"338:1072– 1076. http://dx.doi.org/10.1126/science.122702 6 Chuang, S.Y., C.H.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.6189-11.201 2 Cuervo, A.M., and E. Wong.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/   cr.2013.15 3 Czirr, E., and T. Wyss-Coray.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1172/JCI5865 6 Deretic, V., T. Saitoh, and S. Akira.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1038/nri353 2 Deretic, V., T. Kimura, G. Timmins, P. Moseley, S. Chauhan, and M.  Mandell.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1172/JCI7394 5 Desplats, P., H.J.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1073/pnas.090369110 6 Dooley, H.C., M. Razi, H.E.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/molcel.2014.05.021 Dupont, N., S. Lacas-Gervais, J. Bertout, I. Paz, B. Freche, G.T.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.chom.2009.07.00 5 Dupont, N., S. Jiang, M. Pilli, W. Ornatowski, D. Bhattacharya, and V.  Deretic.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
http://dx.doi   .org/10.1038/emboj.2011.39 8,Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1083/   jcb.20090307 0 Lam, K.K., X. Zheng, R. Forestieri, A.D. Balgi, M. Nodwell, S. Vollett,  H.J.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1371/journal.ppat.100269 1 Lee, S.J., P. Desplats, C. Sigurdson, I. Tsigelny, and E. Masliah.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nrneurol.2010.14 5 Lee, H.J., E.D.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/   emm.2013.4 5 Li, W., Y. Tang, Z.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"8:27. http://dx.doi.org/   10.1186/1750-1326-8-2 7 Liang, Q., G.J.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1371/journal.pgen.100498 7 Longatti, A., C.A.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.cell   .2014.05.04 8 Lupfer, C., P.G.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1038/ni.256 3 Lussignol, M., C. Queval, M.F.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1128/JVI.01158-1 2 Mandell, M.A., A. Jain, J. Arko-Mensah, S. Chauhan, T. Kimura, C.  Dinkins, G. Silvestri, J. Münch, F. Kirchhoff, A. Simonsen, et al.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1016/j.devcel.2014.06.01 3 Manzanillo, P.S., J.S.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nature1256 6 Maruyama, H., H. Morino, H. Ito, Y. Izumi, H. Kato, Y. Watanabe, Y.  Kinoshita, M. Kamada, H. Nodera, H. Suzuki, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.07.03 9 Maurer, K., T. Reyes-Robles, F. Alonzo III, J. Durbin, V.J.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/   10.1016/j.chom.2015.03.00 1 Mealer, R.G., A.J.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nature1191 0 Hardie, D.G., F.A.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nrm331 1 Harris, J., M. Hartman, C. Roche, S.G. Zeng, A. O’Shea, F.A.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/ jbc.M110.20291 1 Hayashi-Nishino, M., N. Fujita, T. Noda, A. Yamaguchi, T. Yoshimori,  and A. Yamamoto.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"11:1433– 1437. http://dx.doi.org/10.1038/ncb199 1 Hebron, M.L., I. Lonskaya, and C.E.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1093/hmg/ddt19 2 Hosokawa, N., T. Hara, T. Kaizuka, C. Kishi, A. Takamura, Y. Miura, S.  Iemura, T. Natsume, K. Takehana, N. Yamada, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.4161/auto.6.7.1303 8 Huang, J., and J.H.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/   nrmicro316 0 Huett, A., R.J. Heath, J.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.chom.2012.10.01 9 Itakura, E., and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1083/jcb.20100906 7 Jayaswal, S., M.A.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100083 9 Jounai, N., F. Takeshita, K. Kobiyama, A. Sawano, A. Miyawaki, K.Q.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1073/pnas.070401410 4 Jung, C.H., C.B.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1091/mbc.E08-12-124 9 Juris, L., M. Montino, P. Rube, P. Schlotterhose, M. Thumm, and R.  Krick.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.15252/embj.20148895 7 Kirkin, V., T. Lamark, Y.S.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.01.02 0 Konno, H., K. Konno, and G.N.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10   .1016/j.cell.2013.09.04 9 Korac, J., V .",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1242/jcs.11492 6 Kyei, G.B., C. Dinkins, A.S. Davis, E. Roberts, S.B.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.4049/jimmunol.130321 3 Orvedahl, A., D. Alexander, Z. Tallóczy, Q.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.chom.2006.12.00 1 Owen, K.A., C.B.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100415 9 Pankiv, S., T.H.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1074/jbc.M70282420 0 Parihar, S.P., R. Guler, R. Khutlang, D.M.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1093/infdis/jit55 0 Paul, S., A.K.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/   10.1016/j.immuni.2012.04.00 8 Pickford, F., E. Masliah, M. Britschgi, K. Lucin, R. Narasimhan, P.A.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.ceb.2015.04.01 6 Pottier, C., K.F.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1007/s00401-015-1436- x Pozueta, J., R. Lefort, E.M. Ribe, C.M.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"4:1939. http://dx.doi   .org/10.1038/ncomms292 7 Puri, C., M. Renna, C.F.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.cell.2013   .08.04 4 Py, B.F., M.M.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.4161/auto.361 8 Ravikumar, B., R. Duden, and D.C. Rubinsztein.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1093/hmg/11.9.110 7 Ravikumar, B., Z. Berger, C. Vacher, C.J.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"15:1209-1216. http://dx.doi.org/10.1093/hmg/ddl036 Ravikumar, B., C. Vacher, Z. Berger, J.E.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
http://dx.doi.org/10.1038/ng136 2binds beclin-1 and activates autophagy.,Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/jbc.M113.53691 2 Menzies, F.M., J. Huebener, M. Renna, M. Bonin, O. Riess, and D.C.  Rubinsztein.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1093/brain/awp29 2 Menzies, F.M., A. Fleming, and D.C. Rubinsztein.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"16:345– 357. http://dx.doi.org/10.1038/nrn396 1 Mesquita, F.S., M. Thomas, M. Sachse, A.J.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1097/COH.000000000000010 6 Meunier, E., M.S.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1038/nature1315 7 Moreau, K., B. Ravikumar, M. Renna, C. Puri, and D.C. Rubinsztein.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.cell.2011.06.02 3 Moreau, K., A. Fleming, S. Imarisio, A. Lopez Ramirez, J.L.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"5:4998. http://dx.doi.org/10.1038/ncomms599 8 Mostowy, S., V. Sancho-Shimizu, M.A.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/jbc.M111.22361 0 Nakagawa, I., A. Amano, N. Mizushima, A. Yamamoto, H. Yamaguchi,  T. Kamimoto, A. Nara, J. Funao, M. Nakata, K. Tsuda, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1126/science.110396 6 Nakahira, K., J.A.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/ni.198 0 Napier, R.J., W. Rafi, M. Cheruvu, K.R.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.chom.2011.09.01 0 Niu, H., Q. Xiong, A. Yamamoto, M. Hayashi-Nishino, and Y. Rikihisa.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1126/science.110603 6 Ogawa, M., Y. Yoshikawa, T. Kobayashi, H. Mimuro, M. Fukumatsu, K.  Kiga, Z. Piao, H. Ashida, M. Yoshida, S. Kakuta, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.chom.2011   .04.01 0 Ohashi, Y., and S. Munro.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"21:3998– 4008. http://dx.doi.org/10.1091/mbc.E10-05-045 7 Öhman, T., L. Teirilä, A.M. Lahesmaa-Korpinen, W. Cypryk, V. Veckman,  S. Saijo, H. Wolff, S. Hautaniemi, T.A.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nature1186 6 Shpilka, T., E. Welter, N. Borovsky, N. Amar, M. Mari, F. Reggiori, and  Z. Elazar.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4390-09.200 9 Spilman, P., N. Podlutskaya, M.J. Hart, J. Debnath, O. Gorostiza, D.  Bredesen, A. Richardson, R. Strong, and V. Galvan.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1371/journal.pone.000997 9 Stanley, S.A., A.K.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1371/journal.ppat.100394 6 Starr, T., T.W.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2008.00718.,Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/cdd.2011.5 3 Stolz, A., A. Ernst, and I. Dikic.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1038/ncb297 9 Sundaramurthy, V., R. Barsacchi, N. Samusik, G. Marsico, J. Gilleron, I.  Kalaidzidis, F. Meyenhofer, M. Bickle, Y. Kalaidzidis, and M. Zerial.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.chom.2013.01.00 8 Tal, M.C., M. Sasai, H.K.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/ni.180 0 Thurston, T.L., M.P.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1038/nature1074 4 Tumbarello, D.A., B.J.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1038/ncb258 9 Vicinanza, M., V.I.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/   10.1016/j.molcel.2014.12.00 7 Wang, L.J., H.Y.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/jbc   .M114.55915 3Ravikumar, B., K. Moreau, L. Jahreiss, C. Puri, and D.C. Rubinsztein.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/   ncb207 8 Renna, M., C. Schaffner, K. Brown, S. Shang, M.H.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/   10.1172/JCI4609 5 Rohn, T.T., R.A. Rissman, M.C.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1006/nbdi.2002.054 9 Rubinsztein, D.C., T .",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/   j.cub.2011.11.03 4 Rubinsztein, D.C., P. Codogno, and B. Levine.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nrd380 2 Rui, Y.N., Z. Xu, B. Patel, Z. Chen, D. Chen, A. Tito, G. David, Y.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/ncb275 7 Sagnier, S., C.F.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1128/   JVI.02174-1 4 Saitoh, T., N. Fujita, M.H.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nature0738 3 Saitoh, T., N. Fujita, T. Hayashi, K. Takahara, T. Satoh, H. Lee, K. Matsunaga,  S. Kageyama, H. Omori, T. Noda, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/   10.1073/pnas.091126710 6 Sarkar, S., R.A. Floto, Z. Berger, S. Imarisio, A. Cordenier, M. Pasco, L.J.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"3:331– 338. http://dx.doi.org/10.1038/nchembio88 3 Sarkar, S., V.I.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.04.02 9 Sarkar, S., B. Carroll, Y. Buganim, D. Maetzel, A.H. Ng, J.P. Cassady, M.A.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/j.celrep   .2013.10.04 2 Schaeffer, V., I. Lavenir, S. Ozcelik, M. Tolnay, D.T.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
http://dx.doi   .org/10.15252/emmm.20140413 7,Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10   .1093/hmg/ddn13 9 Watson, R.O., P.S.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1016/   j.cell.2012.06.04 0 Webb, J.L., B. Ravikumar, J. Atkins, J.N.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1074/jbc   .M30022720 0 Wellington, C.L., L.M.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1126/   science.120540 5 Williams, A., S. Sarkar, P. Cuddon, E.K.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/nchembio.7 9Yoshikawa, Y., M. Ogawa, T. Hain, M. Yoshida, M. Fukumatsu, M. Kim,  H. Mimuro, I. Nakagawa, T. Yanagawa, T. Ishii, et al.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1038/ncb196 7 Young, A.R., E.Y.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi   .org/10.1242/jcs.0317 2 Zavodszky, E., M.N.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"5:3828. http://dx.doi   .org/10.1038/ncomms482 8 Zhang, L., J. Yu, H. Pan, P. Hu, Y. Hao, W. Cai, H. Zhu, A.D. Yu,  X. Xie, D. Ma, and J. Yuan.",OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"http://dx.doi.org/10.1073/   pnas.070969510 4 Zheng, Y.T., S. Shahnazari, A. Brech, T. Lamark, T. Johansen, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
http://dx.doi.org/10.1038/nature0966 3,Non-OADS,/arxiv_data1/oa_pdf/db/9c/JEM_20150956.PMC4493419.pdf
"Tel: +82-2-2650-5331, Fax: +82-2-2654-0363, E-mail: jihae.leee@ gmail.com CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):109-116 http://dx.doi.org/10.3857/roj.2015.33.2.109 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
"Yi-Jun Kim , et al 110 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109[2].",OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
111Prognostic analysis of cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109during each follow-up.,Non-OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
"Yi-Jun Kim , et al 112 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109aortic LN (n = 6), and peritoneum (n = 6).",OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
113Prognostic analysis of cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109resulted in improved OS [3].,Non-OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
"Yi-Jun Kim , et al 114 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109Table 3.",OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
"115Prognostic analysis of cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109chemotherapy for patients with positive RM did not improve  prognosis, especially for patients with positive PRMs.",Non-OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
"Yi-Jun Kim , et al 116 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.109Oncol 2000;18:1606-13.",OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/90/ba/roj-33-109.PMC4493422.pdf
"Tel: +82-2-2228-8114, Fax: +82-2-312-9033, E-mail:  CGLEE1023@yuhs.ac CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):117-125 http://dx.doi.org/10.3857/roj.2015.33.2.117 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"Joohwan Lee , et al 118 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117the start of any treatment to the end of radiation therapy  (SER) [5].",OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
119Treatment response in SCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.1172) Radiotherapy:  All patients were treated with 3DCRT.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"Joohwan Lee , et al 120 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117Results 1.",OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"121Treatment response in SCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117with median cutoff value, initial GTV, OVRR, ECVRR, and  ETVRR showed no prognostic impact on survival outcome (all  p > 0.05).",OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"Joohwan Lee , et al 122 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117We additionally analyzed the relationship between the  time interval from first chemotherapy to first RT and ETVRR.",OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"123Treatment response in SCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117Discussion and Conclusion The aim of this study was to determine prognostic factors  influencing CRT outcome for LS-SCLC, including tumor volume  parameters such as OVRR, ECVRR and ETVRR.",OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"Joohwan Lee , et al 124 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117statistically significant prognostic factors.",OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
125Treatment response in SCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.117survival of non-small-cell lung cancer patients treated with  chemoradiotherapy.,Non-OADS,/arxiv_data1/oa_pdf/ce/10/roj-33-117.PMC4493423.pdf
"Tel: +82-2-2228-8095, Fax: +82-2-2227-7823, E-mail:  ybkim3@yuhs.ac CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):126-133 http://dx.doi.org/10.3857/roj.2015.33.2.126 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"127Adjuvant RT in early stage cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126cervical cancer patients who undergo surgery range from 83%  to 91%, while those of patients treated with radiotherapy (RT)  alone range from 74% to 91% [1,2].",Non-OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"Hyun Ju Kim , et al 128 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126brachytherapy was performed to reduce external beam  radiotherapy (EBRT) dose to 41.4–45 Gy giving sufficient  dose for vaginal vault with brachytherapy in order to reduce  late complication of EBRT.",Non-OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"129Adjuvant RT in early stage cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126combination with vincristine (7.4%), 5-fluorouracil (6.7%),  or other regimens (2.7%).",Non-OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"Hyun Ju Kim , et al 130 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126respectively.",OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"131Adjuvant RT in early stage cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126TLG, we intended to analyze their prognostic value.",Non-OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"Hyun Ju Kim , et al 132 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126prognostic factor in either univariate or multivariate analysis.",OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
133Adjuvant RT in early stage cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.126Phys 2006;65:169-76.,Non-OADS,/arxiv_data1/oa_pdf/a6/68/roj-33-126.PMC4493424.pdf
"Tel: +82-2-2228-8116, Fax: +82-2-312-9033, E-mail:  mdgold@yuhs.ac CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):134-141 http://dx.doi.org/10.3857/roj.2015.33.2.134 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
135Morphologic change of rectosigmoid colon www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.134with non-irradiated bowel.,Non-OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
"Yeona Cho , et al 136 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.134the entire pelvis through a posterior portal and right and left  lateral treatment portals.",OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
137Morphologic change of rectosigmoid colon www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.134the pelvic cavity below the sacral promontory level by DRR  imaging.,Non-OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
"Yeona Cho , et al 138 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.134Results 1.",OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
139Morphologic change of rectosigmoid colon www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.1343.,Non-OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
"Yeona Cho , et al 140 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.134trial comparing preop CRT and postop CRT, the overall  incidence of A-leak was not significantly different between the  two groups (11% vs. 12%; p = 0.77) [18].",OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
141Morphologic change of rectosigmoid colon www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.134preoperative radiotherapy in patients with rectal carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/90/f7/roj-33-134.PMC4493425.pdf
The directory was placed in a sub-folder of the  homepage of KOSRO and its web address is http://www.kosro.or.kr/asda.,OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"Tel: +82-2-2072-2524, Fax: +82- 2-765-3317, E-mail: shin.kyunghwan@gmail.com CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):142-148 http://dx.doi.org/10.3857/roj.2015.33.2.142 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
143New on-line statistics for radiation oncology www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.142the first on-line statistic program and operated to collect data  to analyze status of department of radiation oncology after  then [5].,OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"System configuration The statistical program is totally a Web-based program and  merged into homepage of the KOSRO, http://www.kosro.or.kr.",OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
User can access to the statistical  pro gram by two ways: by clicking a link button of ‘Annual  Sta tistics’ in homepage of the KOSRO or directly by typing de- signated address http://www.kosro.or.kr/asda.,Non-OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"First, in  End userhttp://kosro.or .kr/asda Login ReportData input DBrequest Online DB Download Excel file Internet WebWebserver (Apache HTTP) Interpreter (PHP) RDMBS server (MySQL)DatabaseOperating system: LINUX Operating system: LINUX Fig.",OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"Si Yeol Song , et al 144 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.142the folder of input of statistics, there is five independent sub- categories: human resource, equipment, clinical statistics, spe- cialized treatment, and research achievement.",OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
145New on-line statistics for radiation oncology www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.142and analysis.,OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"Si Yeol Song , et al 146 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.142classification, the box of detailed classification should simply  be checked and new sub-list will be opened ( Fig.",OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
147New on-line statistics for radiation oncology www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.142with a permission of KOSRO.,Non-OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"Si Yeol Song , et al 148 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.142institute or hospitals and furthermore expect them be able  to be converted or processed as an invaluable materials for  advancing radiation oncology.",Non-OADS,/arxiv_data1/oa_pdf/4e/ef/roj-33-142.PMC4493426.pdf
"CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):149-154 http://dx.doi.org/10.3857/roj.2015.33.2.149 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/8d/92/roj-33-149.PMC4493427.pdf
"Jae Myoung Noh , et al 150 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.149[3,5].",OADS,/arxiv_data1/oa_pdf/8d/92/roj-33-149.PMC4493427.pdf
151Exome sequencing in breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.1493.,Non-OADS,/arxiv_data1/oa_pdf/8d/92/roj-33-149.PMC4493427.pdf
"Jae Myoung Noh , et al 152 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.149Results from the three different tools were compared, and we  identified that 7 variants were reported risky among all three  algorithms: XCR1, DLL1, TH, ACCS, SPPL3, CCNF , and SRL (Fig.",OADS,/arxiv_data1/oa_pdf/8d/92/roj-33-149.PMC4493427.pdf
153Exome sequencing in breast cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.149study could help explain non- BRCA  familial breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/8d/92/roj-33-149.PMC4493427.pdf
"Jae Myoung Noh , et al 154 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.149Cancer 2013;12:75-81.",OADS,/arxiv_data1/oa_pdf/8d/92/roj-33-149.PMC4493427.pdf
"Tel: +66-53945456, Fax: +66-53945491, E-mail:  paan_31@hotmail.com CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):155-159 http://dx.doi.org/10.3857/roj.2015.33.2.155 pISSN 2234-1900 · eISSN 2234-3156  Case Report",Non-OADS,/arxiv_data1/oa_pdf/19/3e/roj-33-155.PMC4493428.pdf
"Ekkasit Tharavichitkul , et al 156 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.1551.",OADS,/arxiv_data1/oa_pdf/19/3e/roj-33-155.PMC4493428.pdf
157MVCT in IGBT for cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.155of the applicators was checked before being transferred to  the planning system (Nucletron Oncentra).,Non-OADS,/arxiv_data1/oa_pdf/19/3e/roj-33-155.PMC4493428.pdf
"Ekkasit Tharavichitkul , et al 158 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.155impossible because of scatter artifact.",OADS,/arxiv_data1/oa_pdf/19/3e/roj-33-155.PMC4493428.pdf
159MVCT in IGBT for cervical cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.155Group (I): concepts and terms in 3D image based 3D treat- ment planning in cervix cancer brachytherapy with emphasis  on MRI assessment of GTV and CTV.,Non-OADS,/arxiv_data1/oa_pdf/19/3e/roj-33-155.PMC4493428.pdf
"Tel:  +39-011-6705352, Fax: + 39-011-6336614, E-mail: umberto.ricardi@unito.it CC  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):57-65 http://dx.doi.org/10.3857/roj.2015.33.2.57 pISSN 2234-1900 · eISSN 2234-3156  Review Article",Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
"Umberto Ricardi , et al 58 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57tumor control rates of 90% and higher, with rates of severe  toxicity below 10%).",Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
59Radiotherapy for stage I NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57dose of 60 Gy.,Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
"Umberto Ricardi , et al 60 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57studies and propensity score matched analyses suggest that  overall survival and disease-specific survival after SBRT are  similar to those after surgery [33-37].",OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
61Radiotherapy for stage I NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57ROSEL trials (that had similar entry criteria) has been published  [40].,Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
"Umberto Ricardi , et al 62 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57has been replaced by image-guidance (frameless SBRT).",Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
"63Radiotherapy for stage I NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57an efficient and safe therapy for stage I inoperable NSCLC  patients; being better tolerated than surgery, SBRT might also  be considered a valid therapeutic option for operable patients.",Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
"Umberto Ricardi , et al 64 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.5722.",Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
65Radiotherapy for stage I NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.57stereotactic lung radiotherapy: a matched analysis of three- dimensional conformal and volumetric-modulated arc therapy  techniques.,Non-OADS,/arxiv_data1/oa_pdf/ee/62/roj-33-57.PMC4493429.pdf
"Tel/Fax: +98-11-33543084, E-mail:  sjhosseinim@yahoo.com, sjhosseinim@mazums.ac.ir CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):66-74 http://dx.doi.org/10.3857/roj.2015.33.2.66 pISSN 2234-1900 · eISSN 2234-3156  Review Article",Non-OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
67Trace elements in genotoxicity www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66mination oxidative stress and cell protection against geno- toxicity induced by ionizing radiation.,OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
Seyed Jalal Hosseinimehr 68 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66investigated in the cohort study.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
"69Trace elements in genotoxicity www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66through the levels of MDA, GSH, SOD and catalase [56,57].",OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
"Seyed Jalal Hosseinimehr 70 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66observed with increasing of survival rate in irradiated mice  [73,74].",Non-OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
"71Trace elements in genotoxicity www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66instability induced by IR through various mechanisms are in- cluding enhancement of endogenous defense enzymes and  free radical scavenging proteins, medication of cell signaling  pathways for DNA repair, and anti-inflammatory.",OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
Seyed Jalal Hosseinimehr 72 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.6630.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
73Trace elements in genotoxicity www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66A review of metal-catalyzed molecular damage: protection by  melatonin.,Non-OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
"Seyed Jalal Hosseinimehr 74 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.66Grigoryan IE, Haroutiunian SG.",Non-OADS,/arxiv_data1/oa_pdf/96/7b/roj-33-66.PMC4493430.pdf
"Tel: +82-2-2019-3154, Fax: +82-2-2019-4821, E-mail:  ikjae412@yuhs.ac CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):75-82 http://dx.doi.org/10.3857/roj.2015.33.2.75 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
"Yunseon Choi , et al 76 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.75Introduction The role of adjuvant therapy in patients with resected non- small cell lung cancer (NSCLC) has been evaluated in many  randomized clinical trials and meta-analyses [1-3].",OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
77T3 subtypes & RT effects in pT3N0 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.75Institutional Review Board (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
"Yunseon Choi , et al 78 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.752.",OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
79T3 subtypes & RT effects in pT3N0 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.75subtypes in univariate analysis and multivariate analysis (Table  3).,OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
"Yunseon Choi , et al 80 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.75(84.6% vs. 55.6%) than those who also received radiotherapy  to the mediastinum (n = 11); in particular, a higher number  of distant metastases occurred in patients who received  radiotherapy only to the costal pleura (72.7% vs. 18.2%).",OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
81T3 subtypes & RT effects in pT3N0 NSCLC www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.75T3N0 NSCLC.,OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
"Yunseon Choi , et al 82 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.753.",OADS,/arxiv_data1/oa_pdf/68/7d/roj-33-75.PMC4493431.pdf
"Tel: +82-2-3410-2605, Fax: +82-2-3410-2619, E-mail:  jeongil.yu@samsung.com CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):83-88 http://dx.doi.org/10.3857/roj.2015.33.2.83 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/6c/00/roj-33-83.PMC4493432.pdf
"Hakyoung Kim , et al 84 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.83with regard to the 5-year overall survival (OS) between surgical  and non-surgical treatment (CCRT).",OADS,/arxiv_data1/oa_pdf/6c/00/roj-33-83.PMC4493432.pdf
"www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.83metastasis work-up, chest CT) scans were conducted.",Non-OADS,/arxiv_data1/oa_pdf/6c/00/roj-33-83.PMC4493432.pdf
"Hakyoung Kim , et al 86 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.83progression in this study.",OADS,/arxiv_data1/oa_pdf/6c/00/roj-33-83.PMC4493432.pdf
www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.83group [14] reported a retrospective study that analyzed the  outcome of 208 patients presenting with anal squamous  cell carcinoma treated in four cancer centers in the south of  France.,Non-OADS,/arxiv_data1/oa_pdf/6c/00/roj-33-83.PMC4493432.pdf
"Hakyoung Kim , et al 88 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.83and mitomycin.",OADS,/arxiv_data1/oa_pdf/6c/00/roj-33-83.PMC4493432.pdf
"Tel: +82-2-3010-4423, Fax: +82-2-3010-6950, E-mail: coocoori@gmail.com CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):89-97 http://dx.doi.org/10.3857/roj.2015.33.2.89 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
"In-Hye Jung , et al 90 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89as cardiac disease and cerebral disease.",OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
91Fiducial-less CyberKnife radiosurgery for stage I lung cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89Materials and Methods 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
"In-Hye Jung , et al 92 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89images before and after CKRS.",OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
93Fiducial-less CyberKnife radiosurgery for stage I lung cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89a planning CT with varying positions and orientations.,Non-OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
"In-Hye Jung , et al 94 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89were evaluated by chest CT within 1−2 month.",OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
95Fiducial-less CyberKnife radiosurgery for stage I lung cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89described at Table  4.,Non-OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
"In-Hye Jung , et al 96 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89medically inoperable early stage NSCLC.",OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
97Fiducial-less CyberKnife radiosurgery for stage I lung cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.89radiosurgery with real-time tumor motion tracking in the  treatment of small peripheral lung tumors.,Non-OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
http://dx.doi.org/10.1016/j.ijrobp.2015.02.055.,OADS,/arxiv_data1/oa_pdf/ce/47/roj-33-89.PMC4493433.pdf
"Tel: +82-2-2072-3177, Fax: +82-2-742-2073, E-mail: wuhg@snu.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Radiat Oncol J 2015;33(2):98-108 http://dx.doi.org/10.3857/roj.2015.33.2.98 pISSN 2234-1900 · eISSN 2234-3156  Original Article",Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"99CCRT with IMRT in stage III-IV nasopharyngeal carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98other H&N cancers, radiotherapy (RT) is the backbone of  treatment for NPC.",Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"Chan Woo Wee , et al 100 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98was clinical evidence of involvement.",OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"101CCRT with IMRT in stage III-IV nasopharyngeal carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98team after a face-to-face discussion between the radiation  oncologists, medical oncologists, and H&N surgeons.",Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"Chan Woo Wee , et al 102 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98presented with cervical nodal metastases (N0, 9.6%; N1–N2,  63.9%; N3b, 26.5%) but there were no patients with bulky  nodal metastases exceeding 6 cm (N3a).",OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
103CCRT with IMRT in stage III-IV nasopharyngeal carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98Table 3.,Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"Chan Woo Wee , et al 104 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98risk of severe hematologic toxicity at some point during  the treatment course compared to patients treated by CCRT  alone (30.1% vs. 6.0%, respectively; p = 0.005).",OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
105CCRT with IMRT in stage III-IV nasopharyngeal carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98LC and RC rates could not be analyzed by the log-rank test  because all cases were censored.,Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"Chan Woo Wee , et al 106 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98according to a meta-analysis [20], NCT did reduce distant  metastasis when added to RT alone.",OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"107CCRT with IMRT in stage III-IV nasopharyngeal carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98analysis, and the use of a heterogeneous NCT regimen in  the NCT plus CCRT cohort.",Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
Available from: http://www.nccn.org/professionals/physician_ gls/pdf/head-and-neck.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"Chan Woo Wee , et al 108 www.e-roj.org http://dx.doi.org/10.3857/roj.2015.33.2.98Oncol 2001;19:1350-7.",OADS,/arxiv_data1/oa_pdf/9e/10/roj-33-98.PMC4493434.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/0e/TOORTHJ-9-218.PMC4493627.pdf
"Avaiable from: http://www.who.int/mediacentre/factsheets/fs114/e n/index.html [13] Deintjer TR, Pallansch M, Cochi S, et al.",OADS,/arxiv_data1/oa_pdf/91/5e/TOORTHJ-9-204.PMC4493628.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/5e/TOORTHJ-9-204.PMC4493628.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/3b/TOORTHJ-9-198.PMC4493629.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/4e/TORJ-9-36.PMC4493630.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial Lice nse (http://creativecommons.org/ licenses/ - by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/1c/TOMICROJ-9-14.PMC4493631.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/6b/TOORTHJ-9-214.PMC4493632.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/94/TOORTHJ-9-210.PMC4493633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Impact of sodium reduction strategies on salt intake MAH Hendriksen et al 810 European Journal of Clinical Nutrition (2015) 805 –810 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3c/58/ejcn201515a.PMC4493647.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/TORJ-9-30.PMC4493649.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/07/TOORTHJ-9-226.PMC4493651.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)STAT3/NF-kB activation promotes sporadic colon cancer V De Simone et al 3503 © 2015 Macmillan Publishers Limited Oncogene (2015) 3493 –3503",Non-OADS,/arxiv_data1/oa_pdf/23/37/onc2014286a.PMC4493653.pdf
"Available from: http://www.amadeux.net/  sublimen/documenti/REF_clinicalguide.pdf  [8] Calomeni MR, Almeida M, Arêas NN, Silva VF.",Non-OADS,/arxiv_data1/oa_pdf/d4/bc/CPEMH-11-150.PMC4493659.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/- by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/34/TOMICROJ-9-8.PMC4493661.pdf
The FSE imageswere then aligned with the post-MRS localizer by rigid imageregistration (http://nitrc.org/projects/cmtk).,Non-OADS,/arxiv_data1/oa_pdf/1a/fa/BPA-24-654.PMC4493672.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ce/53/aapm-05-03-22786.PMC4493723.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/08/05/aapm-05-03-24376.PMC4493724.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/18/f1/aapm-05-03-24047.PMC4493725.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c3/ce/aapm-05-03-26141.PMC4493726.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.Several studies demonstrated that percutaneous dila - tational tracheostomy (PDT) is a safe, easy , low-cost and  minimally-invasive bedside method with numerous  known advantages more than surgical tracheostomy  such as fewer adjacent tissue injury , lesser bleeding risk,  wound infectivity (morbidity) and mortality (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/0c/72/aapm-05-03-24653.PMC4493727.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fd/06/aapm-05-03-24156.PMC4493728.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/56/a2/aapm-05-03-25032.PMC4493729.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ff/64/aapm-05-03-16163.PMC4493730.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/03/9d/aapm-05-03-26414.PMC4493731.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/70/eb/aapm-05-03-27966.PMC4493732.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ec/19/aapm-05-03-22568.PMC4493733.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5d/dc/aapm-05-03-22798.PMC4493734.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8b/6c/aapm-05-03-22236.PMC4493735.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b5/27/aapm-05-03-21960.PMC4493736.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/51/52/aapm-05-03-25085.PMC4493737.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/99/06/aapm-05-03-26866.PMC4493738.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/80/50/aapm-05-03-22723.PMC4493739.pdf
"This is an open-access article distributed under the terms of the Creative Com - mons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material  just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/83/c2/aapm-05-03-22367.PMC4493740.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"Direct link to deposited data Microarray: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE64487 Experimental design, materials and methods Tumor samples Tumor samples were collected from paired primary cell grafts from our previous work [2].",OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"Luminal and basal cell populations were isolated using ﬂuorescence acti- vated cell sorting (FACS) in the following scheme: CD24medCD49fhi mammary stem cells (MSCs), CD24medCD49flomature myoepithelial http://dx.doi.org/10.1016/j.gdata.2015.04.008 2213-5960/© 2015 The Authors.",OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"Cancer Cell 23 (2013) 647 –659, http://dx.doi.org/10.1016/j.ccr.2013.03.012 .",Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"7 (2006) 3, http://dx.doi.org/10.1186/1471- 2199-7-3 .",Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
(2015) http://dx.doi.org/10.1158/0008-5472.CAN-14-2761 .,Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"Methods 25 (2001) 402–408, http://dx.doi.org/10.1006/meth.2001.1262 .",Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"Nature 490 (2012) 61 –70,http://dx.doi.org/10.1038/nature11412 .",Non-OADS,/arxiv_data1/oa_pdf/c2/c6/main.PMC4493742.pdf
"Th is is an open  access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction to noncommercial entities, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/02/chest_148_1_138.PMC4493870.pdf
http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html .,Non-OADS,/arxiv_data1/oa_pdf/0d/02/chest_148_1_138.PMC4493870.pdf
http://www.lung.org/fi  nding-cures/ our-research/trend-reports/copd-trend-report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0d/02/chest_148_1_138.PMC4493870.pdf
http://harrisschool.uchicago.edu/sites/default/fi les/iHEA_Sydney_minicourse.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0d/02/chest_148_1_138.PMC4493870.pdf
[2004] and at http://www.getm.eu.,Non-OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
The salinity and temperature climatologies required at the start of the model integration were obtained from theMediterranean Data Archaeology and Rescue-MEDAR/MEDATLAS database (http://www.ifremer.fr/medar/).,OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
The ECMWF ERA reanalysis data are available from theECMWF data server (http://www.ecmwf.int).,OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
"In particular, total annual ﬁsh catches in the Mediterranean basin from 1960 to 2012 were obtained from the Food and Agriculture Organization (FAO) database, accessible at http://www.fao.org/ ﬁshery/statistics/global-capture-production/en (data were downloaded in January 2014).",OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
[Available at http://biogeosciences.net/6/139/2009/.],Non-OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
[Available at http://www.fao.org/ ﬁshery/org/GlobalRecord/en.],Non-OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
Fisheries data are publicly available at the FAO web-based database (http://www.fao.org/ ﬁshery/statistics/global- capture-production/en).Global Biogeochemical Cycles 10.1002/2014GB004846 MACIAS ET AL.,OADS,/arxiv_data1/oa_pdf/95/68/gbc0028-0897.PMC4493898.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/5e/nihms-700599.PMC4493902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/81/copd-10-1241.PMC4493967.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1241–1251International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1241OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8329 8Identification of genetic variants in the TNF  promoter associated with COPD secondary  to tobacco smoking and its severity Juan Manuel reséndiz- hernández,1,2 raúl h  sansores,3 rafael de Jesús  hernández-Zenteno,3 gilberto  Vargas-Alarcón,4 laura Colín- Barenque,5 Mónica Velázquez- Uncal,3 Angel Camarena,1  Alejandra Ramírez-Venegas,3  ramcés Falfán-Valencia1 1Laboratory HLA, Instituto Nacional  de enfermedades respiratorias Ismael  Cosío Villegas, Mexico City, Mexico;   2Graduate Program in Biological  sciences, Universidad nacional  Autónoma de México, Mexico City,   Mexico; 3Research Department in  smoking and COPD, Instituto Nacional  de enfermedades respiratorias Ismael  Cosío Villegas, Mexico City, Mexico;   4Department of Molecular Biology,   Instituto Nacional de Cardiología  Ignacio Chávez, Mexico City, Mexico;   5Department of neuroscience, Facultad  de estudios superiores Iztacala,   Universidad Nacional Autónoma de  México, Tlalnepantla de Baz, Mexico  state, MexicoAbstract:  Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that arises  in response to noxious particles or gases.",Non-OADS,/arxiv_data1/oa_pdf/55/81/copd-10-1241.PMC4493967.pdf
"TNF- α is a critical molecule in inflammation regulation because it induces  a cascade of other inflammatory cytokines, chemokines, and growth factors.7 In  addition, murine models have found increased levels of mRNA of TNF- α and some Correspondence: alejandra ramírez- Venegas Research Department in smoking and  COPD, Instituto nacional de enfermedades  Respiratorias Ismael Cosío Villegas, Calzada  de Tlalpan 4502, Sección XVI, Tlalpan,  Mexico City 14080, Mexico Tel +52 55 5487 1700 ext 5331 email aleravas@hotmail.co m  ramcés Falfán-Valencia Laboratory HLA, Instituto Nacional de  enfermedades respiratorias Ismael Cosío  Villegas, Calzada de Tlalpan 4502, Sección  XVI, Tlalpan, Mexico City 14080, Mexico Tel +52 55 5487 1700 ext 5152 Fax +52 55 5665 4623 email rfalfanv@iner.gob.m x Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Reséndiz-Hernández et al Running head recto: Genetic variants in the TNF promoter associated with COPD DOI: http://dx.doi.org/10.2147/COPD.S83298",Non-OADS,/arxiv_data1/oa_pdf/55/81/copd-10-1241.PMC4493967.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/55/81/copd-10-1241.PMC4493967.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/55/81/copd-10-1241.PMC4493967.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/81/copd-10-1241.PMC4493967.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/35/cia-10-1069.PMC4493968.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1069–1070Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1069Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S8869 4effect of proton pump inhibitor use on Helicobacter   pylori positivity and atrial fibrillation Kadri Atay1 Omer Kaya2 1Istanbul University, Cerrahpasa  School of Medicine, Division  of Gastroenterology, 2Medipol  University, Department of Internal  Medicine, Istanbul, turkeyDear editor We read with interest the report by Wang et al regarding the association between  Helicobacter pylori  infection and atrial fibrillation.1 One of our concerns about this  well designed study is the lack of reporting of proton pump inhibitor (PPI) use in the  patients and controls.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/cia-10-1069.PMC4493968.pdf
"34230,  turkey tel +90 53 1793 0386 email amerkaya@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Atay and Kaya Running head recto: Effect of PPI on H. pylori positivity  and AF DOI: http://dx.doi.org/10.2147/CIA.S88694",Non-OADS,/arxiv_data1/oa_pdf/4e/35/cia-10-1069.PMC4493968.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/cia-10-1069.PMC4493968.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/4e/35/cia-10-1069.PMC4493968.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/8d/ijwh-7-645.PMC4493969.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 645–653International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  645OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8470 9Menopausal symptoms and quality of life among  saudi women visiting primary care clinics  in riyadh, saudi arabia aida alDughaither1 Hind alMutairy2 Mohammed alateeq1 1college of Medicine, King saud  Bin abdul- aziz University for  Health sciences, 2Department  of Family Medicine and PHc ,   King abdul-aziz Medical city,   national guard Health affairs,   riyadh,  Kingdom of saudi arabiaObjectives:  Menopause is associated with somatic, vasomotor, psychological, and sexual  complaints that may affect quality of life.",Non-OADS,/arxiv_data1/oa_pdf/4e/8d/ijwh-7-645.PMC4493969.pdf
"Box 22490,  riyadh 11426, saudi arabia Tel +966 1 180 1111  ext 46585/46583/49187 email malateeq@hotmail.co mJournal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: AlDughaither et al Running head recto: Menopausal symptoms among Saudi women DOI: http://dx.doi.org/10.2147/IJWH.S84709",Non-OADS,/arxiv_data1/oa_pdf/4e/8d/ijwh-7-645.PMC4493969.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4e/8d/ijwh-7-645.PMC4493969.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/8d/ijwh-7-645.PMC4493969.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/clep-7-313.PMC4493970.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 313–323Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  313Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S8383 9Validity of self-reported body mass index among  middle-aged participants in the norwegian  Women and Cancer study guri skeie1 nicolle Mode1,2 Maria henningsen3 Kristin Benjaminsen Borch1 1Department of Community Medicine,   UiT The arctic University of norway,   Tromsø, norway;  2national institute  on aging, national institutes of  health, Baltimore, MD, Usa;  3Faculty  of Medicine, norwegian University of  science and T echnology, Trondheim,   norway Correspondence: guri skeie   Department of Community Medicine,  UiT The arctic University of norway,  PO Box 6020, langnes,   n-9037 Tromsø, norway   Tel +47 7776 6594  Fax +47 7764 4831  Email guri.skeie@uit.n oBackground:  Body mass index (BMI) based on self-reported height and weight has been  criticized as being biased because of an observed tendency for overweight and obese people  to overestimate height and underestimate weight, resulting in higher misclassification for  these groups.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/clep-7-313.PMC4493970.pdf
Available from:  http://www.who.int/features/factfiles/obesity/facts/en /.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/clep-7-313.PMC4493970.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/clep-7-313.PMC4493970.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/6c/copd-10-1233.PMC4493971.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1233–1239International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1233RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S6395 5Postural control in chronic obstructive pulmonary  disease: a systematic review eF Porto1,2 AAM Castro1,3 vGS Schmidt4 HM Rabelo4 C Kümpel2 OA Nascimento5 JR Jardim5 1Pulmonary Rehabilitation Center,   Federal University of São Paulo ,  2Adventist University, São Paulo,   3Federal University of Pampa,   Rio Grande do Sul, 4Pulmonary  Rehabilitation Center, Adventist  University, 5Respiratory Diseases,   Pulmonary Rehabilitation Center,   Federal University of São Paulo,   São Paulo, BrazilAbstract:  Patients with chronic obstructive pulmonary disease (COPD) fall frequently,  although the risk of falls may seem less important than the respiratory consequences of the  disease.",Non-OADS,/arxiv_data1/oa_pdf/e4/6c/copd-10-1233.PMC4493971.pdf
"According to some studies, impaired balance  may be one important extrarespiratory morbidity leading to loss of functional inde - pendence and falls.2 However, postural control does not figure in the GOLD report as Correspondence: José R Jardim Respiratory Diseases, Pulmonary  Rehabilitation Center, Federal University  of São Paulo, Rua Botucatu 740, 3o andar,  04023-062, São Paulo, Brazil Fax +55 11 5572 4301 email jardimpneumo@gmail.co m Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Porto et al Running head recto: Postural control in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S63955",Non-OADS,/arxiv_data1/oa_pdf/e4/6c/copd-10-1233.PMC4493971.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e4/6c/copd-10-1233.PMC4493971.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/6c/copd-10-1233.PMC4493971.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/0f/cia-10-1077.PMC4493972.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1077–1083Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1077OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8529 9Use of the Microsoft Kinect system to characterize  balance ability during balance training Dohyung lim1 ChoongYeon Kim2 hohyun Jung1 Dukyoung Jung3 Keyoung Jin Chun2 1Department of Mechanical  engineering, sejong University,   seoul, republic of Korea; 2Advanced  Biomedical engineering lab, Korea  Institute of Industrial T echnology,   Cheonan, republic of Korea; 3r&D  Team, senior Products Industrial  Center, Busan, republic of KoreaAbstract:  The risk of falling increases significantly in the elderly because of deterioration of the  neural musculature regulatory mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/09/0f/cia-10-1077.PMC4493972.pdf
"If such injuries are severe, they can  potentially result in social isolation, followed by mental health problems.5 Approxi - mately 30% of those aged 65 to 80 years and approximately 40% of those over 80 years  experience falling accidents.6 In two thirds of those over 85 years, falling accidents are  directly related to secondary injuries, which in some cases result in fatalities.6 In USA,  the annual medical costs associated with falling accidents for those aged over 65  years  total more than 20 billion dollars.7 In Korea, it has been estimated that more than 3 bil - lion dollars are spent annually on medical treatment related to falling accidents in the  elderly and, taking into consideration forecasts of changes in demographics and income  levels, these medical costs are expected to increase considerably in the near future.Correspondence: Keyoung Jin Chun Advanced Biomedical engineering lab,  Korea Institute of Industrial Technology,  89, Yangdaegiro, Ipjang, seobuk, Cheonan  331-822, republic of Korea Tel +82 41 5898 430 Fax +82 41 5898 413 email chun@kitech.re.k r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lim et al Running head recto: Use of the Microsoft Kinect system to characterize balance ability DOI: http://dx.doi.org/10.2147/CIA.S8529 9",Non-OADS,/arxiv_data1/oa_pdf/09/0f/cia-10-1077.PMC4493972.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/09/0f/cia-10-1077.PMC4493972.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/09/0f/cia-10-1077.PMC4493972.pdf
Available from: http://research.microsoft.com/pubs/145347/ BodyPartRecognition.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/0f/cia-10-1077.PMC4493972.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/02/copd-10-1253.PMC4493974.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1253–1263International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1253OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7727 4systemic signs of neutrophil mobilization during  clinically stable periods and during exacerbations  in smokers with obstructive pulmonary disease Kristina andelid1 anders andersson1 shigemi Y oshihara2 Christina Åhrén4 Pernilla Jirholt3 ann ekberg-Jansson1 anders lindén1,5 1Department of Internal Medicine  and Clinical nutrition, sahlgrenska  academy at the University of  gothenburg, gothenburg, sweden;   2Department of Pediatrics, Dokkyo  Medical University, Japan; 3Department  of rheumatology and Inflammation  research, Institute of Medicine,   4Department of Bacteriology, Institute  of laboratory Medicine, sahlgrenska  academy at the University of  gothenburg, gothenburg; 5Unit  for lung and airway research,   Institute of environmental Medicine,   Karolinska Institutet, stockholm,   swedenBackground:  It is still unclear whether signs of neutrophil mobilization in the blood of patients  with chronic obstructive pulmonary disease represent true systemic events and how these relate  to bacterial colonization in the airways.",Non-OADS,/arxiv_data1/oa_pdf/6d/02/copd-10-1253.PMC4493974.pdf
"Moreover, there is evidence suggesting  that systemic signs of inflammation are linked to the clinical course and comorbidity  of COPD.2,3 We believe that further investigation into the specific nature of systemic  signs of neutrophil mobilization in COPD is required.Correspondence: anders lindén Unit for lung and airway research,  Institute of environmental Medicine,  Karolinska Institutet, PO Box 210, se-171  77 stockholm, sweden Tel +467 0090 2286 email anders.linden@ki.s e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Andelid et al Running head recto: Neutrophil mobilization in COPD DOI: http://dx.doi.org/10.2147/COPD.S77274",Non-OADS,/arxiv_data1/oa_pdf/6d/02/copd-10-1253.PMC4493974.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6d/02/copd-10-1253.PMC4493974.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/02/copd-10-1253.PMC4493974.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/ee/cia-10-1071.PMC4493975.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1071–1076Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1071OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8538 7Analysis of spirometry results in hospitalized  patients aged over 65 years Izabela Wróblewska1 Piotr Oleśniewicz2 Donata Kurpas3 Mariusz Sołtysik2 Jerzy Błaszczuk4 1Faculty of health science, Wroclaw  Medical University, 2Institute of  Tourism and recreation, University  school of Physical education in  Wroclaw, 3Department of Family  Medicine, 4Faculty of Postgraduate  Medical Training, Wroclaw  Medical University, Wrocław,   lower silesia, PolandIntroduction and objective:  The growing population of the elderly, as well as the occurrence  of coexisting diseases and polypharmacy, is the reason why diseases of patients aged $65 years  belong to the major issues of the contemporary medicine.",Non-OADS,/arxiv_data1/oa_pdf/40/ee/cia-10-1071.PMC4493975.pdf
"The assess - ment of the clinical condition of an elderly patient should include the interactions  among the specific disease entities and the burden resulting from the superimposing  pathogens.1,2 Respiratory system diseases occurring in people aged $65 years constitute a  complex problem; the cases of paroxysmal or chronic dyspnea should be diagnosed  within the basic diagnostic process and should not be treated only as an iatrogenic  complication.Correspondence: Izabela Wróblewska Faculty of health science, Wroclaw  Medical University, ul Kazimierza Bartla 5, Wrocław 50996, Lower Silesia, Poland Tel +48 71 784 1839 Fax +48 71 7345 9324 email iz.wroblewska@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wróblewska et al Running head recto: Spirometry results in hospitalized patients over 65 years DOI: http://dx.doi.org/10.2147/CIA.S85387",Non-OADS,/arxiv_data1/oa_pdf/40/ee/cia-10-1071.PMC4493975.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/40/ee/cia-10-1071.PMC4493975.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/40/ee/cia-10-1071.PMC4493975.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS - Research and Palliative Care 2015:7 197–208HIV/AIDS - Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  197ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S8237 6Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Or use: http://youtu.be/xHIqf0L1S7 cFactors associated with HIV counseling and  testing and correlations with sexual behavior   of teachers in primary and secondary schools   in Addis Ababa, ethiopia Takele Menna Ahmed Ali Alemayehu Worku School of Public Health, College  of Health Sciences, Addis Ababa  University, Addis Ababa, ethiopia Correspondence: Takele Menna   School of Public Health, College of  Health Sciences, Addis Ababa University,  PO Box  33412, Addis Ababa, ethiopia   email admetakele@gmail.co mBackground:  The HIV/AIDS pandemic is a global crisis that affects the lives of millions of  people.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.ifpri.org/ sites/default/files/publications/pv07.pd f. Accessed April  20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.cdc.gov/ globalhealth/coun - tries/ethiopia/pdf/ethiopia-2013.pd f. Accessed April  20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.unaids.org/sites/default/ files/en/media/unaids/contentassets/documents/data-and-analysis/tools/ spectrum/Ethiopia2012report.pd f. Accessed April  20, 2015.",OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.unaids.org/ sites/default/files/country/documents/ETH_narrative_report_2014.pd f.  Accessed April  20, 2015.",OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from: http://dhsprogram.com/pubs/pdf/FR255/FR255.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.unaids.org/sites/default/files/country/ documents/ETH_narrative_report_2014.pd f. Accessed April  20,  2015.",OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from:  http://datad.aau.org/handle/123456789/4095?show =full.,OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://data.unaids.org/Publications/IRC-pub05/JC431- StratPlan4_en.pd f. Accessed April  20, 2015.",OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available  from: http://www.etharc.org/oromia/resources/kit/ARTInfotoolkit.pd f.  Accessed April 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"A vailable  from: http://apps.who.int/iris/bitstream/10665/75206/1/9789241593877_ eng.pd f. Accessed April  20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from: http://www.who.int/hiv/pub/ progress_ report2011/en /.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.unicef.org/eapro/HIV_handbook.pd f.  Accessed April 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from: http://www.vgregion.se/upload/skas/fou/hivtreatmen.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Visit http://www.dovepress.com/   testimonials.php  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from: http://www.csa.gov.et/index.php/2013-02-20-14-51- 51/2013-04-01-11-53-00/census-200 7.,OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"Available from: http://www.aabofed.gov.et/Documents/Addis%20 Ababa%20Profile%20%202004%20E.pd f. Accessed April  20, 2015 .",Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from:  https://bora.uib.no/handle/1956/1902.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
Available from: http://www.who.int/hiv/pub/ guidelines/9789241595568_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a2/d1/hiv-7-197.PMC4493976.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/7a/kwv020.PMC4493979.pdf
"New York, NY:Population Division; 2013. http://esa.un.org/unpd/wpp/ Excel-Data/mortality.htm .",Non-OADS,/arxiv_data1/oa_pdf/45/7a/kwv020.PMC4493979.pdf
http://www.who.int/ghodata/ .,Non-OADS,/arxiv_data1/oa_pdf/45/7a/kwv020.PMC4493979.pdf
R package version 3.2.0-3. http://cran.r-project.org/web/ packages/bda/index.html .,Non-OADS,/arxiv_data1/oa_pdf/45/7a/kwv020.PMC4493979.pdf
R package version 0.69. http://cran.r-project.org/web/packages/ICE/index.,Non-OADS,/arxiv_data1/oa_pdf/45/7a/kwv020.PMC4493979.pdf
http://wonder.cdc.gov/ ucd-icd10.html .,OADS,/arxiv_data1/oa_pdf/45/7a/kwv020.PMC4493979.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/36/ccid-8-329.PMC4493983.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 329–337Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  329OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S8385 7T opically applied ceramide accumulates in skin  glyphs Qihong Zhang1 Carol r Flach1 richard Mendelsohn1 guangru Mao2 apostolos Pappas2 M Catherine Mack2 russel M Walters2 Michael D southall2 1Department of Chemistry, rutgers  University, newark, 2Johnson &  Johnson Consumer Companies, Inc.,   skillman, nJ, UsaAbstract:  Ceramides (CERs), structural components of the stratum corneum (SC), impart  essential barrier properties to this thin outer layer of the epidermis.",Non-OADS,/arxiv_data1/oa_pdf/78/36/ccid-8-329.PMC4493983.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/78/36/ccid-8-329.PMC4493983.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/36/ccid-8-329.PMC4493983.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/73/ott-8-1597.PMC4493984.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1597–1601OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1597Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8721 9rapidly progressive stage IVB mycosis fungoides  treated with low-dose total skin electron beam  therapy Mudit Chowdhary1,2 ahmad a Kabbani1 parin rimtepathip1 David a Cole Jr2 David J Cohen1 1Division of Dermatology, Department  of Internal Medicine, 2Division of  radiation Oncology, Department  of radiology, Mercer University  school of Medicine, Macon, Ga, UsaAbstract:  Mycosis fungoides (MF) is the most common subtype of primary cutaneous T-cell  lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/e2/73/ott-8-1597.PMC4493984.pdf
"Overall prognosis in advanced disease is exceed - ingly poor with a median survival of only 2.47 years.2 Additionally, many of these  patients suffer from debilitating pruritus and a significantly decreased quality of life.3  Treatment options for advanced disease are often palliative, consisting of biologic Correspondence: Mudit Chowdhary Division of Dermatology, Department  of Internal Medicine, Mercer University  school of Medicine, 308 Hospital Drive,  suite 200, Macon, Ga 31217, Usa email mu.chowdhary@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Chowdhary et al Running head recto: Low-dose TSEB in stage IVB MF DOI: http://dx.doi.org/10.2147/OTT.S87219",Non-OADS,/arxiv_data1/oa_pdf/e2/73/ott-8-1597.PMC4493984.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e2/73/ott-8-1597.PMC4493984.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/73/ott-8-1597.PMC4493984.pdf
"Available from: http://www.nccn.org/ professionals /physician_gls/f_guidelines.as p. Accessed April 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e2/73/ott-8-1597.PMC4493984.pdf
"Our  findings imply that secretory granule exocytosis pathways in other cell types may also be more complex than previously  appreciated.VAMP8-dependent fusion of recycling endosomes  with the plasma membrane facilitates T lymphocyte  cytotoxicity Misty R. Marshall,1,4 Varsha Pattu,1 Mahantappa Halimani,1,6 Monika Maier -Peuschel,1 Martha -Lena Müller,4  Ute Becherer,1 Wanjin Hong,5 Markus Hoth,2 Thomas Tschernig,3 Yenan T. Bryceson,4* and Jens Rettig1* 1Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine, 2Department of Biophysics, and 3Department of Anatomy, Saarland University,  66421 Homburg, Germany 4Department of Medicine, Center For Infectious Medicine, 14186 Stockholm, Sweden 5Membrane Biology Laboratory, Institute of Molecular and Cell Biology, Singapore 138673 6Department of Pathology, Brigham and Woman’s Hospital, Boston, MA © 2015 Bryceson This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*Y.T.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201411093/DC1.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1093/emboj/19.23.6453 Antonin, W., C. Holroyd, R. Tikkanen, S. Höning, and R. Jahn.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1073/ pnas.0901444106 Bryceson, Y .T., M.E.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1182/blood-2007-02-074468 Campi, G., R. Varma, and M.L.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1084/ jem.20051182 Chavrier, P., R.G.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/35052017 Chiang, S.C., J. Theorell, M. Entesarian, M. Meeths, M. Mastafa, W. Al-Herz,  P. Frisk, K.C.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1084/ jem.20131131 Côte, M., M.M.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1172/JCI40732 Das, V ., B. Nal, A. Dujeancourt, M.I.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1016/ S1074-7613(04)00106-2 de Saint Basile, G., G. Ménasché, and A. Fischer.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/nri2803 Douglass, A.D., and R.D.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1016/j.cell.2005.04.009 Dressel, R., L. Elsner, P. Novota, N. Kanwar, and G. Fischer von Mollard.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.4049/ jimmunol.1000770 Dustin, M.L., and E.O.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1111/j.0105-2896.2010.00904.x Faroudi, M., C. Utzny, M. Salio, V .",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1073/ pnas.2334336100 Feldmann, J., I. Callebaut, G. Raposo, S. Certain, D. Bacq, C. Dumont, N.  Lambert, M. Ouachée-Chardin, G. Chedeville, H. Tamary, et al.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.org/10.1016/S0092-8674(03)00855-9,OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1073/ pnas.0406877102 Gustafsson, M.G., L. Shao, P.M. Carlton, C.J.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1529/ biophysj.107.120345 Halimani, M., V .",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/nrm2002 Jenkins, M.R., A. Tsun, J.C. Stinchcombe, and G.M.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/369031a0 Kanwar, N., A. Fayyazi, B. Backofen, M. Nitsche, R. Dressel, and G.F. von  Mollard.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1002/eji.201141582 Larghi, P., D.J.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1002/eji.200939378 Lopez, J.A., M.R.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.4049/jimmunol.1301205 Matti, U., V .",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"4:1439. http://dx.doi.org/10.1038/ncomms2467 Maul-Pavicic, A., S.C.C.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/ni1431 Miesenböck, G., D.A.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/28190 Pattu, V ., B. Qu, M. Marshall, U. Becherer, C. Junker, U. Matti, E.C.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1002/eji.201141915 Paumet, F., J.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.4049/ jimmunol.164.11.5850Purbhoo, M.A., D.J.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/ni1058 Puri, N., and P.A.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.4049/jimmunol.1003471 Rak, G.D., E.M. Mace, P.P.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"18:24– 33. http://dx.doi.org/10.1091/mbc.E06-09-0785 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1002/eji.200737634 Soares, H., R. Henriques, M. Sachse, L. Ventimiglia, M.A.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1084/jem.20130150 Stepp, S.E., R. Dufourcq-Lagelouse, F. Le Deist, S. Bhawan, S. Certain, P.A.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1126/ science.286.5446.1957 Stinchcombe, J.C., and G.M.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/nature05071 Stow, J.L.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/nri3564 Stow, J.L., A.P.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/nri1980 Südhof, T.C., and J.E.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1126/science.1161748 Sutton, R.B., D. Fasshauer, R. Jahn, and A.T. Brunger.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/26412 Sykulev, Y ., M. Joo, I. Vturina, T.J. Tsomides, and H.N.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80483-5 Trapani, J.A., and M.J. Smyth.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1038/nri911 Ullrich, O., S. Reinsch, S. Urbé, M. Zerial, and R.G.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1083/jcb.135.4.913 Ungermann, C., and D. Langosch.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1242/jcs.02561 Wang, C.C., C.P.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.org/10.1016/j.devcel.2004.08.002,OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1091/mbc.9.6.1549 Yokosuka, T., K. Sakata-Sogawa, W. Kobayashi, M. Hiroshima, A. Hashimoto- Tane, M. Tokunaga, M.L.",OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
"http://dx.doi.org/10.1093/hmg/ddi076 zur Stadt, U., J. Rohr, W. Seifert, F. Koch, S. Grieve, J. Pagel, J. Strauss, B.  Kasper, G. Nürnberg, C. Becker, et al.",Non-OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
http://dx.doi.org/10.1016/j.ajhg.2009.09.005,OADS,/arxiv_data1/oa_pdf/65/33/JCB_201411093.PMC4493996.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*C.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
Conserved motifs within CEP290 were identified by Meme (http://meme-suite.org/) and sequences were  aligned using MAFFT within Jalview (http://www.jalview.org).,OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
Online supplemental material is available at http://www.jcb  .org/cgi/content/full/jcb.201501013/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"24:2622– 2631. http://dx.doi.org/10.1016/j.cub.2014.09.047 Bayless, B.A., T.H.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1091/mbc.E12-08-0577 Benzing, T., P. Gerke, K. Höpker, F. Hildebrandt, E. Kim, and G. Walz.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1038/ncb2410Cole, D.G., D.R.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1083/jcb.141.4.993 Craige, B., C.C.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1083/jcb.201006105 Dammermann, A., T. Müller-Reichert, L. Pelletier, B. Habermann, A. Desai,  and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1101/gad.1810409 Delous, M., N.E.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1038/ nmeth.2641 Fan, S., T.W.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1038/ng.248 Fujiwara, M., T. Ishihara, and I. Katsura.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.057 Hodges, M.E., N. Scheumann, B. Wickstead, J.A.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1242/ jcs.064873 Huang, L., K. Szymanska, V .L.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1016/j.ajhg.2011.11.005 Inglis, P.N., G. Ou, M.R.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1895/wormbook.1.126.2 Kirszenblat, L., D. Pattabiraman, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1371/journal.pbio.1001157 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1006/jsbi.1996.0013 Kuhn, M., A.A. Hyman, and A. Beyer.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1371/journal.pcbi.1003657 Le, S.Q., and O. Gascuel.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1093/ molbev/msn067 Mastronarde, D.N.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1083/jcb.153.6.1209 Paridaen, J.T., M. Wilsch-Bräuninger, and W.B.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1016/0012-1606(86)90314-3 Reiter, J.F., O.E.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1038/nrm952 Sang, L., J.J. Miller, K.C.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1038/ncb1186 Sorokin, S. 1962.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1083/jcb.15.2.363 Sulston, J.E., E. Schierenberg, J.G.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1016/0012-1606(83)90201-4 Swoboda, P., H.T.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80436-0 Wan, X., R.P.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"137:672– 684. http://dx.doi.org/10.1016/j.cell.2009.03.035 Williams, C.L., M.E.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1091/mbc.E07-10-1070 Williams, C.L., C. Li, K. Kida, P.N.",Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
"http://dx.doi.org/10.1083/jcb.201012116 Wilsch-Bräuninger, M., J. Peters, J.T.",OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/86/JCB_201501013.PMC4493997.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Dongmin Kang: dkang@ewha.ac.kr; or Sue Goo Rhee:  rheesg@yuhs.ac Abbreviations used in this paper: APC/C, anaphase-promoting complex/ cyclosome; DPI, diphenyleneiodonium; MAFP, methyl arachidonyl fluorophos - phonate; MEF, mouse embryonic fibroblast; NDGA, nordihydroguaiaretic acid;  NEM, N-ethylmaleimide; OA, okadaic acid; PACT, pericentrin-AKAP450 cen - trosomal targeting; pHH3, phosphorylated histone H3; Prx, peroxiredoxin; PTP,  protein tyrosine phosphatase; SIM, structured illumination microscopy.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201412068/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
Additional data are available in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201412068.dv.,OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.4161/cc.7.13.6095 Bornens, M., M. Paintrand, J. Berges, M.C.",Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1002/cm.970080305 Chang, T.S., W. Jeong, S.Y .",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1128/ MCB.25.11.4541-4551.2005 Cho, K.J., J.M.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1007/s10059-011-1021-7 Domingo-Sananes, M.R., O. Kapuy, T. Hunt, and B. Novak.",Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"366:3584– 3594. http://dx.doi.org/10.1098/rstb.2011.0087 Fang, G., H. Yu, and M.W.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1016/ S1097-2765(00)80126-4 García-Higuera, I., E. Manchado, P. Dubus, M. Cañamero, J. Méndez, S.  Moreno, and M. Malumbres.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1093/embo-reports/kvd105 Han, Y .H., T. Kwon, S.U.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1128/MCB.00303-06 Ho, Y .S., Y .",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1038/ncb918 Jaspersen, S.L., J.F.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1016/ S0960-9822(99)80111-0 Kang, S.W., I.C.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1074/jbc.273.11.6303 Kang, S.W., H.Z.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1074/jbc.273.11.6297 Kim, T.S., J.E.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1091/mbc.11.5.1555Kwon, J., S.R.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1161/ CIRCRESAHA.111.243972 Leach, C., S. Shenolikar, and D.L.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"278:26015– 26020. http://dx.doi.org/10.1074/jbc.M300782200 Lee, K.W., D.J.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1074/jbc.M110.179416 Lindqvist, A., V .",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1083/jcb.200812045 Mocciaro, A., and E. Schiebel.",Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1242/jcs.074815 Mochida, S., S. Ikeo, J. Gannon, and T. Hunt.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.041408.115949 Peters, J.M.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1016/S0304-4165(03)00048-5 Poburko, D., J. Santo-Domingo, and N. Demaurex.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1083/jcb.200203035 Rhee, S.G. 2006.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1126/science.1130481 Rhee, S.G., H.A.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1074/jbc.R111.283432 Rusnak, F., and T. Reiter.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1016/ S0968-0004(00)01659-5 Schindler, K., and R.M.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1095/biolreprod.108.074906 Schmitz, M.H., M. Held, V .",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1038/ncb2092 Seo, M.S., S.W.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1074/jbc.M001943200 Song, M.S., A. Carracedo, L. Salmena, S.J.",Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"144:187– 199. http://dx.doi.org/10.1016/j.cell.2010.12.020 Tonks, N.K.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.org/10.1016/j.cell.2005.05.016,OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1002/jcp.1123 Whitaker, M. 2006.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1016/j.ceca.2006.08.018 Whitfield, M.L., G. Sherlock, A.J.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.org/10.1091/mbc.02-02-0030.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1113/ jphysiol.2009.178285 Wu, J., H.P.",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1083/jcb.200710127 Wu, J.Q., J.Y .",OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
"http://dx.doi.org/10.1038/ncb1871 Wurzenberger, C., and D.W. Gerlich.",Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
http://dx.doi.org/10.1038/sj.gt.3301164,Non-OADS,/arxiv_data1/oa_pdf/ae/fb/JCB_201412068.PMC4493999.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Andrew J. Holland: aholland@jhmi.edu Abbreviations used in this paper: AAV, adeno-associated virus; AID, auxin-in - ducible degron; IAA, indole -3-acetic acid; MTOC, microtubule-organizing cen - ter; PCM, pericentriolar material; Plk4, Polo-like kinase 4.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201502089/DC1.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.cub.2013.12.016 Arquint, C., K.F.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1242/jcs.099887 Basto, R., J. Lau, T. Vinogradova, A. Gardiol, C.G.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/ jcb.201107086 Coelho, P.A., L. Bury, B. Sharif, M.G.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.09.029 Cunha-Ferreira, I., A. Rodrigues-Martins, I. Bento, M. Riparbelli, W. Zhang,  E. Laue, G. Callaini, D.M.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1007/s00018-010-0323-9 Dzhindzhev, N.S., G. Tzolovsky, Z. Lipinszki, S. Schneider, R. Lattao, J. Fu, J.  Debski, M. Dadlez, and D.M.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"24:2526– 2532. http://dx.doi.org/10.1016/j.cub.2014.08.061 Eckerdt, F., T.M.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.cub.2011.01.072 Fry, D.W., P.J.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/nature08136 Ganem, N.J., H. Cornils, S.Y .",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/nrm3373 Graser, S., Y .D.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/ncb1320 Holland, A.J., and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.ccr.2014.07.017 Holland, A.J., W. Lan, S. Niessen, H. Hoover, and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1091/mbc.E11-12-1043 Holland, A.J., D. Fachinetti, Q. Zhu, M. Bauer, I.M.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"26:2684– 2689. http://dx.doi.org/10.1101/gad.207027.112 Hussein, D., and S.S. Taylor.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/nn.3831 Izquierdo, D., W.J.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.celrep.2014.07.022 Khodjakov, A., and C.L.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/jcb.153.1.237 Khodjakov, A., C.L.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/ jcb.200205102 Kitagawa, D., I. Vakonakis, N. Olieric, M. Hilbert, D. Keller, V .",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.cell.2011.01.008 Klebba, J.E., D.W. Buster, A.L.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/ ng1605 La Terra, S., C.N.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/jcb.200411126 Lecland, N., A. Debec, A. Delmas, S. Moutinho-Pereira, N. Malmanche, A.  Bouissou, C. Dupré, A. Jourdan, B. Raynaud-Messina, H. Maiato, and  A. Guichet.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1242/bio.20133327 Liu, L., C.Z.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00094-XMason, J.M., D.C. Lin, X. Wei, Y .",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.ccr.2014.05.006 Miki-Noumura, T. 1977.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.cell.2009.10.036 Nishimura, K., T. Fukagawa, H. Takisawa, T. Kakimoto, and M. Kanemaki.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/ nmeth.1401 Ohta, M., T. Ashikawa, Y .",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"5:5267. http://dx.doi.org/10.1038/ncomms6267 Palazzo, R.E., E. Vaisberg, R.W.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1126/science.1566068 Peel, N., N.R.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1126/ science.1142950 Rogers, G.C., N.M. Rusan, D.M.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/jcb.200808049 Silkworth, W.T., I.K.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/ng.971 Sir, J.H., M. Pütz, O. Daly, C.G.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.07.004 Suh, M.R., J.W.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1002/ cm.10033 Szollosi, D., P. Calarco, and R.P.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1016/0248-4900(91)90079-3 Tang, C.J., R.H. Fu, K.S.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/ncb1889 Tang, C.J.C., S.Y .",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1038/emboj.2011.378 Thompson, S.L., and D.A.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"188:369– 381. http://dx.doi.org/10.1083/jcb.200905057 Tiscornia, G., O.",Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"20:1666– 1671. http://dx.doi.org/10.1016/j.cub.2010.08.018 Uetake, Y ., and G. Sluder.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/jcb.200607073 van Breugel, M., M. Hirono, A. Andreeva, H.A.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1126/science.1199325van Breugel, M., R. Wilcken, S.H.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.7554/eLife.01812 Wang, W.J., R.K. Soni, K. Uryu, and M.F.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1083/jcb.201101109 Watson, P.A., H.H.",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1002/cyto.990120306 Wong, Y .L., J.V .",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
"http://dx.doi.org/10.1126/science.aaa5111 Yu, J., Y .",OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/JCB_201502089.PMC4494000.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*J.A.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"The Proteomics Platform at CIC bioGUNE lab is a member of Proteored, PRB2-ISCIII, and is supported by grant PT13/0001 of the PE I+D+i 2013-2016 (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?vgnextoid=83b192b9036c2210VgnVCM1000001d04140aRCRD), funded by ISCIII and FEDER.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.06.021 Barr, J., J. Caballería, I. Martínez-Arranz, A. Domínguez-Díez, C. Alonso, J.  Muntané, M. Pérez-Cormenzana, C. García-Monzón, R. Mayo, A. Martín-Duce, et al.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1021/pr201223p Bligh, E.G., and W.J.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.12.002 Chrast, R., G. Saher, K.A.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1038/cr.2013.168 Fernandez-Valle, C., R.P.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1007/BF01179817 Gillespie, C.S., D.L.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1093/brain/awu257 Hirata, K., and M. Kawabuchi.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1002/jemt.10108 Holtzman, E., and A.B.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1083/jcb.27.3.651 Hutton, E.J., L. Carty, M. Laurá, H. Houlden, M.P.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1111/j.1529-8027.2011.00360.x Inserra, M.M., D.A.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1002/ (SICI)1098-2752(1998)18:2<119::AID-MICR10>3.0.CO;2-0 Jang, S.Y ., Y .K.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1371/journal.pone.0116624 Jessen, K.R., R. Mirsky, and A.C. Lloyd.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1101/cshperspect.a020487 Jiménez, C.R., F.J. Stam, K.W.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.5115/ acb.2011.44.1.41 Jung, J., W. Cai, H.K.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.4537-10.2011 Kiel, J.A.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1098/rstb.2009.0237 Klionsky, D.J., F.C.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1083/jcb.200412022 Kroemer, G., G. Mariño, and B. Levine.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1038/nature09782 Mirsky, R., A. Woodhoo, D.B.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1111/j.1529-8027.2008.00168.x Mizushima, N., A. Yamamoto, M. Matsui, T. Yoshimori, and Y .",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1091/mbc.E03-09-0704 Niemi, J.P., A. DeFrancesco-Lisowitz, L. Roldán-Hernández, J.A.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3319-12.2013 Parkinson, D.B., A. Bhaskaran, P. Arthur-Farraj, L.A.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"181:625– 637. http://dx.doi.org/10.1083/jcb.200803013 Parrilla-Reverter, G., M. Agudo, F. Nadal-Nicolás, L. Alarcón-Martínez, M.  Jiménez-López, M. Salinas-Navarro, P. Sobrado-Calvo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1016/j.visres.2009.08.020 Pattingre, S., C. Bauvy, T. Levade, B. Levine, and P. Codogno.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.4161/auto.5.4.8390 Perry, V .H., J.W.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1111/j.1460-9568.1995.tb01063.x Ramaglia, V ., R. Wolterman, M. de Kok, M.A.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.2353/ajpath.2008.070660 Rangaraju, S., J.D.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"30:11388– 11397. http://dx.doi.org/10.1523/JNEUROSCI.1356-10.2010 Ravikumar, B., S. Sarkar, J.E.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1152/physrev.00030.2009 Rubinsztein, D.C., T. Shpilka, and Z. Elazar.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1016/j.cub.2011.11.034 Ruiz, J.I., and B. Ochoa.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1038/nature07976 Truett, G.E., P. Heeger, R.L.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1016/j.neuron.2014.01.037 Vargas, M.E., J. Watanabe, S.J.",OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"http://dx.doi.org/10.1097/NEN.0b013e318217eba0 Woodhoo, A., M.B.",Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/44/JCB_201503019.PMC4494002.pdf
"Our data reveal that Cnn  and PLP directly interact at two defined sites to coordinate the cell cycle–dependent rearrangement and scaffolding ac - tivity of the centrosome to permit normal centrosome organization, cell division, and embryonic viability.Interphase centrosome organization by the PLP-Cnn  scaffold is required for centrosome function Dorothy A. Lerit,1 Holly A. Jordan,1 John S. Poulton,2 Carey J. Fagerstrom,1 Brian J. Galletta,1 Mark Peifer,2   and Nasser M. Rusan1 1Cell Biology and Physiology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 2Biology Department, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1101/gad.486808 Balczon, R., L. Bao, and W.E. Zimmer.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.124.5.783 Basto, R., K.  Brunk, T.  Vinadogrova, N.  Peel, A.  Franz, A.  Khodjakov, and  J.W. Raff.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.cell.2008.05.039 Bond, J., E.  Roberts, K.  Springell, S.B.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"37:555) http://dx.doi.org/10.1038/ng1539 Brownlee, C.W., J.E.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/ jcb.201107086 Buchman, J.J., H.C. Tseng, Y .",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.cub.2010.11.011 Conduit, P.T., Z. Feng, J.H.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.7554/eLife.03399 Dammermann, A., and A. Merdes.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.200204023 de-Thé, G.  1964.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.23.2.265 Dictenberg, J.B., W. Zimmerman, C.A.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.org/10.1083/ jcb.141.1.163,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"17:1759– 1764. http://dx.doi.org/10.1016/j.cub.2007.08.065 Dobbelaere, J., F. Josué, S. Suijkerbuijk, B. Baum, N. Tapon, and J. Raff.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90504-5 Doxsey, S., D. McCollum, and W. Theurkauf.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1146/ annurev.cellbio.21.122303.120418 Foe, V .E., and B.M. Alberts.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1091/mbc.E13-10-0617 Gergely, F., D. Kidd, K. Jeffers, J.G.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1038/ nmeth.1318 Gillingham, A.K., and S. Munro.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1093/embo-reports/kvd105 Gomez-Ferreria, M.A., U.  Rath, D.W.  Buster, S.K.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.cub.2007.10.019 Gopalakrishnan, J., V .",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"2:359. http://dx.doi.org/10.1038/ncomms1367 Gould, R.R., and G.G. Borisy.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"73:601– 615. http://dx.doi.org/10.1083/jcb.73.3.601 Haren, L., T. Stearns, and J. Lüders.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.02.011 Hayashi, M.T., and J. Karlseder.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1038/ onc.2012.615 Kao, L.R., and T.L. Megraw.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.cub.2009.04.037 Kawaguchi, S., and Y .",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1091/mbc.E03-03-0191 Khodjakov, A., and C.L. Rieder.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.146.3.585 Kim, K., and K. Rhee.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1242/jcs.078329Kim, S., and K. Rhee.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"147:969– 980. http://dx.doi.org/10.1083/jcb.147.5.969 Lawo, S., M. Hasegan, G.D. Gupta, and L. Pelletier.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"21:439– 448. http://dx.doi.org/10.1016/j.cub.2011.01.073 Lerit, D.A., and N.M. Rusan.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1038/ncb1694 Lucas, E.P., and J.W. Raff.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.200704081 Lüders, J. 2012.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1038/ncb2617 Mahjoub, M.R., and M.F. Tsou.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1371/journal.pgen.1004070 Martinez-Campos, M., R. Basto, J. Baker, M. Kernan, and J.W. Raff.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.200402130 Megraw, T.L., K. Li, L.R.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1242/jcs.00134 Meijering, E., O. Dzyubachyk, and I. Smal.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.tcb.2013.10.001 Mogensen, M.M., J.B. Mackie, S.J.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1091/mbc.E08-11-1115 Moutinho-Santos, T., P. Sampaio, I. Amorim, M. Costa, and C.E. Sunkel.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1111/j.1768- 322X.1999.tb01104.x Nigg, E.A., and J.W. Raff.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/j.cell.2009.10.036 Pagan, J.K., A.  Marzio, M.J.  Jones, A.  Saraf, P.V .",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1242/jcs.01663 Poulton, J.S., F.W.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1242/ dev.094425 Rattner, J.B.  1992.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/B978-0-12-394770-3.50007-3 Rauch, A., C.T.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1126/science.1151174 Rebollo, E., S. Llamazares, J. Reina, and C. Gonzalez.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1371/journal.pbio.0020008 Robinson, J.T., E.J.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1242/bio.20122337Spradling, A.C., D.  Stern, A.  Beaton, E.J.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00202-2 Terada, Y ., Y .",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/ jcb.200305048 Theurkauf, W.E. 1994.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1083/jcb.200810159 Vaizel-Ohayon, D., and E.D.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1016/ S0960-9822(99)80393-5 Venken, K.J., J. Kasprowicz, S. Kuenen, J. Yan, B.A.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1093/nar/gkn486 Wang, Z., T. Wu, L. Shi, L. Zhang, W. Zheng, J.Y .",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.1074/jbc.M110.105965 Wang, Y ., T.J. Dantas, P. Lalor, P. Dockery, and C.G. Morrison.",Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
"http://dx.doi.org/10.4161/cc.23516 Zhang, J., and T.L.",OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
http://dx.doi.org/10.1091/mbc.E03-11-0796,Non-OADS,/arxiv_data1/oa_pdf/f4/30/JCB_201503117.PMC4494003.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Isabelle Sagot: isabelle.sagot@ibgc.cnrs.fr Abbreviations used in this paper: CHX, cycloheximide; MAP, MT-associated  protein; MBC, benzimidazol-2-yl-carbamate; MPA, mycophenolic acid; MT,  microtubule; MTOC, MT organizing center; SPB, spindle pole body; TBZ, thia - bendazole; WT, wild type.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201502025/DC1.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/ mbc.E12-03-0205 Allison, A.C., and E.M. Eugui.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/ S0162-3109(00)00188-0 Alushin, G.M., G.C.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cell.2014.03.053 Beinhauer, J.D., I.M.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1083/jcb.139.3.717 Bolte, S., and F.P.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1111/j.1365-2818.2006.01706.x Bostock, C.J.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.10.015 Braun, M., D.R.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1038/ncb2323 Browning, H., J. Hayles, J. Mata, L. Aveline, P. Nurse, and J.R. McIntosh.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1083/jcb.151.1.15 Brunner, D., and P. Nurse.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)00091-X Busch, K.E., and D. Brunner.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"3:95. http://dx.doi.org/10.1038/msb4100136 Carazo-Salas, R.E., C. Antony, and P. Nurse.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1126/science.1113465 Carlier, M.F., and D. Pantaloni.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1021/bi00510a030 Chang, F., and S.G. Martin.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1101/ cshperspect.a001347 Coller, H.A.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
334:1074– 1075. http://dx.doi.org/10.1126/science.1216242,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1007/BF00378203 Daga, R.R., and F. Chang.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1038/ncb1480 Daignan-Fornier, B., and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"6:20. http://dx.doi.org/10.1186/1747-1028-6-20 Daignan-Fornier, B., and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"6:10. http://dx.doi.org/10.1186/1747-  1028-6-10 Ding, R., K.L.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1371/journal.pone.0030738 Escobar-Henriques, M., A. Balguerie, C. Monribot, H. Boucherie, and B.  Daignan-Fornier.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1074/jbc.M103416200 Hachet, O., F.O.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.01.020 Höög, J.L., S.M.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1371/ journal.pone.0061698 Horio, T., and T. Murata.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"5:511. http://dx.doi.org/10.3389/fpls.2014.00511 Hürlimann, H.C., B. Laloo, B. Simon-Kayser, C. Saint-Marc, F. Coulpier, S.  Lemoine, B. Daignan-Fornier, and B. Pinson.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1083/ jcb.200410119 Janson, M.E., R. Loughlin, I. Loïodice, C. Fu, D. Brunner, F.J. Nédélec, and  P.T.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cell.2006.12.030 Jimenez, L., D. Laporte, S. Duvezin-Caubet, F. Courtout, and I. Sagot.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1242/jcs.137141 Kollman, J.M., A. Merdes, L. Mourey, and D.A.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1038/nrm3209 Kueh, H.Y ., and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1126/ science.1168823 Laporte, D., and I. Sagot.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.4161/nucl.28538 Laporte, D., B. Salin, B. Daignan-Fornier, and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1083/jcb.200711154Laporte, D., A. Lebaudy, A. Sahin, B. Pinson, J. Ceschin, B. Daignan-Fornier,  and I. Sagot.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1083/ jcb.201306075 Liu, I.-C., S.-W. Chiu, H.-Y .",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cub.2014.03.006 Marguerat, S., A. Schmidt, S. Codlin, W. Chen, R. Aebersold, and J. Bähler.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80279-2 Mitchison, T.J. 2014.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cell.2014.05.001 Mitchison, T., and M. Kirschner.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1038/312237a0 Narayanaswamy, R., M. Levy, M. Tsechansky, G.M.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.ceb.2006.02.009 Noree, C., B.K.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cub.2009.08.012 Qiu, Y ., L.D.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1097/00007890-200003150-00038 Sagot, I., B. Pinson, B. Salin, and B. Daignan-Fornier.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E06-04-0282 Sajiki, K., M. Hatanaka, T. Nakamura, K. Takeda, M. Shimanuki, T. Yoshida, Y .",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.3390/metabo3041118 Samejima, I., P.C.C.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E04-11-1003 Samejima, I., V .J.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cub.2010.10.006 Sawin, K.E., and P. Nurse.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.org/10.1083/jcb.142.2.457,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"117:689– 700. http://dx.doi.org/10.1242/jcs.00925 Sawin, K.E., and P.T.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1002/yea.1404 Sawin, K.E., P.C.C.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.cub.2004.03.042 Shah, K.H., R. Nostramo, B. Zhang, S.N.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1038/nature01672 Su, S.S., Y .",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.10.011 Tapia, H., and K.A.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E09-05-0376 Tischer, C., D. Brunner, and M. Dogterom.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"5:250. http://dx.doi.org/10.1038/msb.2009.5 Tran, P.T., L. Marsh, V .",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1083/jcb.153.2.397 Unsworth, A., H. Masuda, S. Dhut, and T. Toda.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E08-02-0224 Valiron, O., I. Arnal, N. Caudron, and D. Job.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1074/jbc.M109.099515van der Vaart, B., A. Akhmanova, and A. Straube.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1042/BST0371007 Vavylonis, D., J.-Q.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1126/science.1151086 Venkatram, S., J.J. Tasto, A. Feoktistova, J.L.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E03-10-0728 Venkatram, S., J.L.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E04-12-1043 Wade, R.H. 2009.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1007/s12033-009-9193-5 Wei, W., P. Nurse, and D. Broek.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
"http://dx.doi.org/10.1091/mbc.E04-10-0859 Zheng, L., C. Schwartz, L. Wee, and S. Oliferenko.",OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
http://dx.doi.org/10.1091/mbc.E04-08-0676,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JCB_201502025.PMC4494004.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*C.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201408060/DC1.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1093/emboj/16.13.3797 Arts, H.H., D. Doherty, S.E.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"39:882– 888. http://dx.doi.org/10.1038/ng2069 Besse, L., M. Neti, I. Anselme, C. Gerhardt, U. Rüther, C. Laclef, and S.  Schneider-Maunoury.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1242/dev.059808 Borgal, L., S. Habbig, J. Hatzold, M.C.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1074/jbc.M112.385658 Breusing, N., J. Arndt, P. V oss, N. Bresgen, I. Wiswedel, A. Gardemann, W.  Siems, and T. Grune.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/j.mad.2009.09.004 Brooks, P., G. Fuertes, R.Z.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1042/0264-6021:3460155 Corbit, K.C., A.E.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/ncb1670 Coux, O., K. Tanaka, and A.L.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1242/dmm.006262 Czarnecki, P.G., and J.V .",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.07.004 Dowdle, W.E., J.F.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1074/jbc.275.1.409 Farré, J.C., R. Manjithaya, R.D.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.12.011 Garcia-Gonzalo, F.R., K.C.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1242/jcs.089375 Gerdes, J.M., Y .",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1371/journal.pone.0057545 Guo, C.W., G. Liu, S. Xiong, F. Ge, T. Fuse, Y .F.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/j.febslet.2011.04.015 Gustafsson, M.G., L. Shao, P.M. Carlton, C.J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1529/ biophysj.107.120345 Hart, M., J.P. Concordet, I. Lassot, I. Albert, R. del los Santos, H. Durand, C.  Perret, B. Rubinfeld, F. Margottin, R. Benarous, and P. Polakis.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1371/journal.pgen.0010053 Ishikawa, H., and W.F.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/nrm3085 Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y .",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1006/bbrc.1997.6943 Kasahara, K., Y .",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"5:5081. http://dx.doi.org/10.1038/ncomms6081 Kitagawa, M., S. Hatakeyama, M. Shirane, M. Matsumoto, N. Ishida, K.  Hattori, I. Nakamichi, A. Kikuchi, K. Nakayama, and K. Nakayama.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1093/ emboj/18.9.2401 Kraft, C., A. Deplazes, M. Sohrmann, and M. Peter.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/ncb1723 Kwak, M.K., N. Wakabayashi, J.L.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1128/MCB.23.23.8786-8794.2003 Kwak, M.K., J.M.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/sj.onc.1202653 Li, Y ., J.D.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1172/JCI71898 Mahuzier, A., H.M. Gaudé, V .",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1002/ mc.20632 Moon, H., J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/nature12639 Pugacheva, E.N., S.A. Jablonski, T.R.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/j.cell.2007.04.035 Puram, S.V ., A.H. Kim, H.Y .",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/j.jnutbio.2008.02.002 Reinheckel, T., N. Sitte, O. Ullrich, U. Kuckelkorn, K.J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/ S0092-8674(94)90462-6 Rott, R., R. Szargel, J. Haskin, R. Bandopadhyay, A.J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/ nature05291 Rushmore, T.H., M.R.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1126/science.1156947 Söderberg, O., M. Gullberg, M. Jarvius, K. Ridderstråle, K.J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/nmeth947 Tammachote, R., C.J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1093/hmg/ddp272 Tang, Z., M.G.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/nature12606 Thurston, T.L., M.P.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/nature10744 Vierkotten, J., R. Dildrop, T. Peters, B. Wang, and U. Rüther.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1242/dev.003715 Wang, K., and D.J.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.4161/auto.7.3.14502 Wang, X., and J. Robbins.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1016/ S0092-8674(00)80678-9 Weatherbee, S.D., L.A. Niswander, and K.V .",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1128/MCB.01089-09 Wigley, W.C., R.P.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1083/jcb.201012116 Winston, J.T., P. Strack, P. Beer-Romero, C.Y .",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1101/gad.13.3.270 Wolf, M.T., S. Saunier, J.F.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/ sj.ki.5002630 Zaghloul, N.A., and N. Katsanis.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1038/nprot.2012.120 Zhang, Y ., P. Talalay, C.G.",Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1093/emboj/cdg158 Zheng, X., J.L.",OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
http://dx.doi.org/10.1128/MCB.02236-05,Non-OADS,/arxiv_data1/oa_pdf/af/56/JCB_201408060.PMC4494006.pdf
"http://dx.doi.org/10.1083/jcb.201503019 ) find  that clearance of the damaged myelin within Schwann  cells occurs not by phagocytosis but rather via selective  autophagy, in a process they term “myelinophagy.”Myelinophagy: Schwann cells dine in Michael Thumm1 and Mikael Simons2,3 1University Medicine, Institute of Cellular Biochemistry, and 2Department of Neurology, University of Göttingen, D-37073 Goettingen, Germany 3Cellular Neuroscience, Max Planck Institute of Experimental Medicine, 37075 Göttingen, Germany © 2015 Thumm and Simons This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.06.021 Bunge, R.P., M.B.",OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1056/NEJMra1205406 Conforti, L., J. Gilley, and M.P.",OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1038/nrn3680 Feng, Y ., D. He, Z. Yao, and D.J.",OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1038/cr.2013.168 Gomez-Sanchez, J.A., L. Carty, M. Iruarrizaga-Lejarreta, M. Palomo-Irigoyen,  M. Varela-Rey, M. Griffith, J. Hantke, N. Macias-Camara, M. Azkargorta, I. Aurrekoetxea, et al.",Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1038/sj.emboj.7600309 Jung, J., W. Cai, H.K.",OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.4537-10.2011 Napoli, I., L.A.",Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.11.031 Okamoto, K. 2014.",OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"http://dx.doi.org/10.1083/jcb.201404154 Snaidero, N., W. Möbius, T. Czopka, L.H.",Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
http://dx.doi.org/10.1146/ annurev.neuro.30.051606.094354 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/09/0d/JCB_201506039.PMC4494007.pdf
"Chan School of Public Health, Boston, MA 02115 2Harvard Medical School, Boston, MA 02115 3Dana-Farber Cancer Institute, Boston, MA 02115 © 2015 Garrett This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
"http://dx.doi.org/10.1126/science.282.5394.1717 Chen, L.M., S. Hobbie, and J.E.",OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
"http://dx.doi.org/10.1126/science.274.5295.2115 Fu, Y ., and J.E.",OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
"http://dx.doi.org/10.1038/45829 Garrett, W.S., L.M.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
"http://dx.doi.org/10.1016/ S0092-8674(00)00038-6 Hardt, W.D., L.M.",OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
http://dx.doi.org/10.1016/S0092-8674(00)81442-7Figure 1.,OADS,/arxiv_data1/oa_pdf/fd/30/JCB_201506019.PMC4494008.pdf
"http://dx.doi.org/10.1002/prot.21165 Buchan, D.W., F. Minneci, T.C.",Non-OADS,/arxiv_data1/oa_pdf/77/36/JCB_20140811106112015c.PMC4494009.pdf
"http://dx.doi.org/10.1093/nar/gkt381 Lee, W., J.L.",OADS,/arxiv_data1/oa_pdf/77/36/JCB_20140811106112015c.PMC4494009.pdf
"http://dx.doi.org/10.1007/s10858-014-9855-x Lee, W., M. Tonelli, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/77/36/JCB_20140811106112015c.PMC4494009.pdf
"http://dx.doi.org/10.1093/bioinformatics/btu830  Schwieters, C.D., J.J. Kuszewski, N. Tjandra, and G.M.",OADS,/arxiv_data1/oa_pdf/77/36/JCB_20140811106112015c.PMC4494009.pdf
"http://dx.doi.org/10.1016/S1090-7807(02)00014-9 Shen, Y ., and A. Bax.",OADS,/arxiv_data1/oa_pdf/77/36/JCB_20140811106112015c.PMC4494009.pdf
http://dx.doi.org/10.1007/s10858-013-9741-y,Non-OADS,/arxiv_data1/oa_pdf/77/36/JCB_20140811106112015c.PMC4494009.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*K.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201412028/DC1.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
Additional data are available in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201412028.dv.,OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/ncb2033 Basilico, F., S. Maffini, J.R. Weir, D. Prumbaum, A.M. Rojas, T. Zimniak, A.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.7554/eLife.02978 Bock, L.J., C. Pagliuca, N. Kobayashi, R.A. Grove, Y .",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/ncb2495 Carroll, C.W., M.C.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/jcb.201001013 Cheerambathur, D.K., and A. Desai.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/j.ceb.2013.12.005 Cheeseman, I.M.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1101/cshperspect.a015826 Cheeseman, I.M., J.S.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"3:101– 110. http://dx.doi.org/10.4161/nucl.18955 DeLuca, J.G., W.E.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1126/science.1221886 Earnshaw, W.C., and N. Rothfield.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1007/BF00328227 Fachinetti, D., H.D.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/ ncb1397 Fukagawa, T., and W.C. Earnshaw.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1107/ S0907444913022397 Guse, A., C.W.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/nature10379 Herzog, F., A. Kahraman, D. Boehringer, R. Mak, A. Bracher, T. Walzthoeni,  A. Leitner, M. Beck, F.U.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1126/ science.1221483 Hinshaw, S.M., and S.C. Harrison.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.08.036 Hori, T., M. Amano, A. Suzuki, C.B.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/ jcb.201210106 Hornung, P., P. Troc, F. Malvezzi, M. Maier, Z. Demianova, T. Zimniak, G. Litos,  F. Lampert, A. Schleiffer, M. Brunner, et al.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/jcb.201403081 Izuta, H., M. Ikeno, N. Suzuki, T. Tomonaga, N. Nozaki, C. Obuse, Y .",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"11:673– 684. http://dx.doi.org/10.1111/j.1365-2443.2006.00969.x Kato, H., J. Jiang, B.R.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1126/science.1235532 Kim, S., and H. Yu.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/jcb.201407074 Krizaic, I., S.J.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1080/19491034.2014.1003509 Liu, S.T., J.B. Rattner, S.A. Jablonski, and T.J.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/ jcb.200606020 Logsdon, G.A., E.J.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/ jcb.201412011 Maiolica, A., D. Cittaro, D. Borsotti, L. Sennels, C. Ciferri, C. Tarricone, A.  Musacchio, and J. Rappsilber.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/emboj.2012.356 Matson, D.R., P.B.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1101/gad.184184.111 McAinsh, A.D., and P. Meraldi.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/j.semcdb.2011.09.016 McCleland, M.L., M.J. Kallio, G.A.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/j.cub.2003.12.058 McClelland, S.E., S. Borusu, A.C. Amaro, J.R. Winter, M. Belwal, A.D.  McAinsh, and P. Meraldi.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601927 Milks, K.J., B. Moree, and A.F.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1091/mbc.E09-05-0378 Moree, B., C.B.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/jcb.201106079 Nishino, T., K. Takeuchi, K.E.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.061 Nishino, T., F. Rago, T. Hori, K. Tomii, I.M.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/emboj.2012.348 Obuse, C., H. Yang, N. Nozaki, S. Goto, T. Okazaki, and K. Yoda.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/ncb1396 Okada, M., K. Okawa, T. Isobe, and T. Fukagawa.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1091/mbc.E09-01-0065 Petrovic, A., S. Pasqualato, P. Dube, V .",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1083/jcb.201002070 Petrovic, A., S. Mosalaganti, J. Keller, M. Mattiuzzo, K. Overlack, V .",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/j.cub.2011.02.005 Rago, F., K.E.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1016/0092-8674(92)90538-N Santaguida, S., and A. Musacchio.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/emboj.2009.173 Schittenhelm, R.B., S. Heeger, F. Althoff, A. Walter, S. Heidmann, K. Mechtler,  and C.F.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1007/s00412-007-0103-y Schleiffer, A., M. Maier, G. Litos, F. Lampert, P. Hornung, K. Mechtler, and S.  Westermann.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1038/ncb2493 Screpanti, E., A.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1023/A:1018422325569,Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"30:717– 730. http://dx.doi.org/10.1016/j.devcel.2014.08.003 Tachiwana, H., S. Müller, J. Blümer, K. Klare, A. Musacchio, and G. Almouzni.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1093/nar/ gkt1124 Tanaka, K., H.L.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1242/jcs.01556 Trazzi, S., G. Perini, R. Bernardoni, M. Zoli, J.C. Reese, A. Musacchio, and G.  Della Valle.",Non-OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"http://dx.doi.org/10.1371/journal.pone.0005832 Unhavaithaya, Y ., and T.L.",OADS,/arxiv_data1/oa_pdf/73/72/JCB_201412028.PMC4494010.pdf
"Our results indicate that a major function of  Mio in mitosis is to regulate the activation/deactivation of Plk1 and Aurora A, possibly by linking them to mTOR signal - ing in a pathway to promote faithful mitotic progression.Mio depletion links mTOR regulation to Aurora A  and Plk1 activation at mitotic centrosomes Melpomeni Platani,1 Laura Trinkle -Mulcahy,2,3 Michael Porter,4 A. Arockia Jeyaprakash,1 and William C. Earnshaw1 1Wellcome Trust Centre for Cell Biology, Institute of Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, Scotland, UK 2Department of Cellular and Molecular Medicine, and 3Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Ontario K1H8M5, Canada 4Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK © 2015 by The Rockefeller University Press This article is distributed under the terms of  an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Melpomeni Platani: m.platani@ed.ac.uk; or William C.  Earnshaw: Bill.Earnshaw@ed.ac.uk Abbreviations used in this paper: mTOR, mammalian target of rapamycin;  NEBD, nuclear envelope breakdown; NPC, nuclear pore complex; PTEN, phos - phatase and tensin homologue.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201410001/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
Additional data are available in the JCB Dat- aViewer at http://dx.doi.org/10.1083/jcb.201410001.dv.,OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nmeth.1896 Andrews, P.D., Y .",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/ S1534-5807(04)00025-5 Astrinidis, A., W. Senapedis, and E.P.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1093/hmg/ddi444 Bar-Peled, L., L. Chantranupong, A.D. Cherniack, W.W. Chen, K.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1126/science.1232044 Barr, A.R., and F. Gergely.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/ jcs.013136 Barros, T.P., K. Kinoshita, A.A. Hyman, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.200101081 Bertran, M.T., S. Sdelci, L. Regué, J. Avruch, C. Caelles, and J. Roig.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.200802005 Boehmer, T., J. Enninga, S. Dales, G. Blobel, and H. Zhong.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.tibs.2012.09.005 Bruinsma, W., L. Macurek, R. Freire, A. Lindqvist, and R.H. Medema.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/jcs.137216 Carmena, M. 2012.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"2:120095. http://dx.doi.org/10.1098/rsob.120095 Carmena, M., S. Ruchaud, and W.C. Earnshaw.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/ S1534-5807(03)00193-X Caudron, M., G. Bunt, P. Bastiaens, and E. Karsenti.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1126/science.1115964 Davis, F.M., T.Y .",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1146/annurev.biochem.78.101807.093809 Dokudovskaya, S., F. Waharte, A. Schlessinger, U. Pieper, D.P.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1074/mcp.M110.006478 Elowe, S., S. Hümmer, A. Uldschmid, X. Li, and E.A.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.4161/cc.2.4.444 Eyers, P.A., and J.L.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1074/jbc.274.21.15005 Giet, R., D. McLean, S. Descamps, M.J. Lee, J.W.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.200108135 Giubettini, M., I.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/ jcs.075457 González-Aguilera, C., and P. Askjaer.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.4161/nucl.21135 Guertin, D.A., and D.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.ccr.2007.05.008 Guertin, D.A., and D.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1126/scisignal.267pe24 Hálová, L., and J. Petersen.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/jcs.083683 Harel, A., A.V .",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/S1097-2765(03)00116-3 Harris, T.E., and J.C. Lawrence Jr. 2003.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00642-1 Hochegger, H., N. Hégarat, and J.B. Pereira-Leal.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"3:120185. http://dx.doi.org/10.1098/rsob.120185 Iida, T., and M.A.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nrm1018 Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M.A.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/jcs.005959Kaláb, P., A. Pralle, E.Y .",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nature04589 Kapitein, L.C., E.J.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/ nature03503 Kapoor, T.M., T.U.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1128/MCB.01663-08 Kiyomitsu, T., and I.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/ncb2440 Klebig, C., D. Korinth, and P. Meraldi.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.200902128 Kline-Smith, S.L., A. Khodjakov, P. Hergert, and C.E.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1091/mbc.E03-08-0581 Knowlton, A.L., W. Lan, and P.T.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.cub.2006.07.057 Koffa, M.D., C.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.cub.2006.03.056 Kogasaka, Y ., Y .",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1002/mrd.22166 Kufer, T.A., H.H.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.200204155 Lan, W., X. Zhang, S.L.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.cub.2004.01.055 Lane, H.A., and E.A.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.135.6.1701 Laplante, M., and D.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/jcs.051011 Lee, K., and K. Rhee.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/jcb.201106093 Lens, S.M., E.E.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nrc2964 Littlepage, L.E., H. Wu, T. Andresson, J.K. Deanehan, L.T.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1128/ MCB.00516-12 Loewith, R., E. Jacinto, S. Wullschleger, A. Lorberg, J.L.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.org/10.1016/S1097-2765(02)00636-6,OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nature07185 Maehama, T., and J.E.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1083/ jcb.201108006 Ong, S.E., and M. Mann.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1126/ scisignal.2004112 Panchaud, N., M.P.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.4161/ cc.26000 Petersen, J., and P. Nurse.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/ncb1646 Peterson, R.T., P.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1074/jbc.275.10.7416 Petronczki, M., P. Lénárt, and J.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.04.014 Platani, M., R. Santarella-Mellwig, M. Posch, R. Walczak, J.R. Swedlow, and  I.W.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1074/mcp.M112.023291 Renner, A.G., L. Créancier, C. Dos Santos, C. Fialin, C. Recher, C. Bailly, A.  Kruczynski, B. Payrastre, and S. Manenti.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.4161/cc.9.9.11295 Rieder, C.L.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nrc1974 Sancak, Y ., T.R.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1126/ science.1157425 Senger, S., J. Csokmay, T. Akbar, T.I.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1242/dev.057372 Silljé, H.H., S. Nagel, R. Körner, and E.A.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.cub.2006.02.070 Smith, T.F., C. Gaitatzes, K. Saxena, and E.J.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/S0968-0004(99)01384-5 Smith, E., N. Hégarat, C. Vesely, I. Roseboom, C. Larch, H. Streicher, K.  Straatman, H. Flynn, M. Skehel, T. Hirota, et al.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/emboj.2011.120 Soliman, G.A., H.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1074/jbc.M109.096222 Swedlow, J.R., J.W.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.4161/bioa.1.2.15807 Toyoshima, F., and E. Nishida.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601599 Tsai, M.Y ., C. Wiese, K. Cao, O. Martin, P. Donovan, J. Ruderman, C. Prigent,  and Y .",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00235-6 Wang, X., and C.G.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1093/jmcb/mjq038 Wong, J., R. Lerrigo, C.Y .",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1016/j.cell.2006.01.016 Yu, C.T., J.M.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"25:5789– 5800. http://dx.doi.org/10.1128/MCB.25.14.5789-5800.2005 Zeng, K., R.N.",OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1091/mbc.E08-02-0198 Zitouni, S., C. Nabais, S.C. Jana, A. Guerrero, and M. Bettencourt-Dias.",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.1038/nrm3819 Zorba, A., V .",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"http://dx.doi.org/10.7554/ eLife.02667 Zuccolo, M., A. Alves, V .",Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
http://dx.doi.org/10.1038/sj.emboj.7601642,Non-OADS,/arxiv_data1/oa_pdf/b5/6c/JCB_201410001.PMC4494011.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/62/bhu010.PMC4494022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/56/bhu023.PMC4494028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/ef/evv101.PMC4494045.pdf
"The paired-end reads were de novo assem-bled with SOAPdenovo v. 1.03 software (BGI) ( http://soap.ge- nomics.org.cn/soapdenovo.html ,l a s ta c c e s s e dJ u n e9 ,2 0 1 5 ) , and the reads were assembled into eight large scaffolds.",OADS,/arxiv_data1/oa_pdf/a3/ef/evv101.PMC4494045.pdf
"Gaps between contigs were closed by custom primer walks or bylong-distance PCR ampliﬁcation followed by DNA sequencing.Genome annotation was performed using the RAST Server(http://rast.nmpdr.org , last accessed June 9, 2015).",OADS,/arxiv_data1/oa_pdf/a3/ef/evv101.PMC4494045.pdf
The me- tabolite synthesis operon was predicted by using the antiSMASH server ( http://antismash.secondarymetabolites.,Non-OADS,/arxiv_data1/oa_pdf/a3/ef/evv101.PMC4494045.pdf
"(available at https://github.com/ﬂauro/3tck_comparative ,l a s t accessed June 9, 2015; Lauro et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/ef/evv101.PMC4494045.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/e2/evv088.PMC4494046.pdf
"To ﬁt PCTs, we used system CLUS version2.12 (freely available at http://dtai.cs.kuleuven.be/clus/ ,l a s t accessed May 21, 2015) in a Random Forests setting, where an ensemble of trees is used to increase predictive perfor- mance ( Breiman 2001 ).",Non-OADS,/arxiv_data1/oa_pdf/63/e2/evv088.PMC4494046.pdf
Supplementary Material Supplementary table S1 andﬁgures S1–S12 are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/63/e2/evv088.PMC4494046.pdf
Available from: http://www.csie.ntu.edu.tw/~cjlin/ papers/guide/guide.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/e2/evv088.PMC4494046.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/08/evv093.PMC4494048.pdf
Available from: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/be/08/evv093.PMC4494048.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/60/evv086.PMC4494052.pdf
Mitochondr ial scaffolds were identiﬁed against a reference database ( ftp://ftp.ncbi.nlm.nih.gov/ge- nomes/MITOCHONDRIA/ ; 4 September 2014).,OADS,/arxiv_data1/oa_pdf/59/60/evv086.PMC4494052.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/5f/evv089.PMC4494055.pdf
"Using this se- quence, we searched the Thousand Plants (1KP) project (https://sites.google.com/a/ualberta.ca/onekp/ , last accessed May 29, 2015) assembly database for S. dubia.",OADS,/arxiv_data1/oa_pdf/09/5f/evv089.PMC4494055.pdf
Supplementary Material Supplementary tables S1–S6 andﬁgures S1–S4 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/09/5f/evv089.PMC4494055.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/6f/evv105.PMC4494057.pdf
"Disordered regions were predicted usingDISOPRED v3 ( Jones and Cozzetto 2015 ) with default settings using the UniRef90 database ( http://www.uniprot.org/help/ , last accessed May 14, 2010; UniProt Consortium 2014 )t h a t had been ﬁltered for repetitive regions, although we also per-formed the analysis using DISOPRED v2 ( Ward et al 2004 )a n d found similar results.",OADS,/arxiv_data1/oa_pdf/20/6f/evv105.PMC4494057.pdf
"Pfam domains were predicted by running HMMer 3.0(http://hmmer.janelia.org/ , last accessed May 14, 2010; Finn et al.",OADS,/arxiv_data1/oa_pdf/20/6f/evv105.PMC4494057.pdf
2 4( ftp://ftp.ebi.,OADS,/arxiv_data1/oa_pdf/20/6f/evv105.PMC4494057.pdf
"PaxDB ( http://pax-db.org/# !species/4932, last accessed April 14, 2010).",OADS,/arxiv_data1/oa_pdf/20/6f/evv105.PMC4494057.pdf
The assorted data can be downloaded from http://www.moseslab.csb.utoronto.ca/alan/snps_diso_ pfam.txt .,OADS,/arxiv_data1/oa_pdf/20/6f/evv105.PMC4494057.pdf
"Estimating Gene Expression and Codon-Specific Translational Efficiencies, Mutation Biases, and Selection Coefficients fromGenomic Data Alone z Michael A. Gilchrist1,2,*W e i - C h e nC h e n1,5,P r e m a lS h a h3,C e d r i cL .L a n d e r e r1, and Russell Zaretzki2,4 1Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville 2National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee 3Department of Biology, University of Pennsylvania 4Department of Business Analytics and Statistics, University of Tennessee, Knoxville 5Center for Biologics Evaluation and Research, Foo d and Drug Administration, Silver Spring, Maryland zCopy of manuscript and supporting materials archived at bioR /C31iv with doi: http://dx.doi.org/10.1101/009670 *Corresponding author: E-mail: mikeg@utk.edu.",Non-OADS,/arxiv_data1/oa_pdf/3c/51/evv087.PMC4494061.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/51/evv087.PMC4494061.pdf
"2014 ) which is freely available for down- load at http://cran.r-project.org/package=cubﬁts (last accessed April 4, 2015).",Non-OADS,/arxiv_data1/oa_pdf/3c/51/evv087.PMC4494061.pdf
"Details of the model ﬁtting can befound in Kubatko LS, Shah P, Herbei R, Gilchrist M (unpub-lished data) (available at bioRxiv doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/3c/51/evv087.PMC4494061.pdf
Available from: http://cran.r-project.org/package=cubﬁts Clarke B.,Non-OADS,/arxiv_data1/oa_pdf/3c/51/evv087.PMC4494061.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/4a/evv104.PMC4494067.pdf
"Raw read quality assessment was per- formed with FastQC to determine the need for base trimming and adapter removal ( http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ , last accessed June 10, 2015).",OADS,/arxiv_data1/oa_pdf/87/4a/evv104.PMC4494067.pdf
"Seqtk was used to trim bases from the reads using a default Mott algorithm based on phred score ( https://github.com/lh3/seqtk , last accessed June 10, 2015) while Trimmomatic ( http://www.",OADS,/arxiv_data1/oa_pdf/87/4a/evv104.PMC4494067.pdf
"For this assem- bly, assignment of gene ontology (GO) terms was performed in two parts: phase one of annotation followed a bioinformat-ics pipeline (SFG) made freely available online by the Palumbi lab (http://sfg.stanford.edu/guide.html ;De Wit et al.",OADS,/arxiv_data1/oa_pdf/87/4a/evv104.PMC4494067.pdf
Supplementary Material Supplementary ﬁgure S1 andtables S1–S3 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/87/4a/evv104.PMC4494067.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/b7/evv082.PMC4494068.pdf
Exonic se-quences and genomic annotation from all genes were down-loaded from the Pan troglodytes genes (CHIMP2.1.4) dataset at Ensembl v66 ( http://feb2012.archive.ensembl.org/index.,OADS,/arxiv_data1/oa_pdf/b7/b7/evv082.PMC4494068.pdf
"html, last accessed May 22, 2015) and mapped to the chim- panzee genome (PanTro3 assembly) using the liftOver tool atthe Galaxy website ( http://main.g2.bx.psu.edu/ , last accessed May 22, 2015).",OADS,/arxiv_data1/oa_pdf/b7/b7/evv082.PMC4494068.pdf
CNC hg19 coordinates were then mapped tothe chimpanzee genome (PanTro3) using the liftOver tool atthe Galaxy website ( http://main.g2.bx.psu.edu/ ).,OADS,/arxiv_data1/oa_pdf/b7/b7/evv082.PMC4494068.pdf
(http://main.g2.bx.psu.edu/ ) using the following strategy.,Non-OADS,/arxiv_data1/oa_pdf/b7/b7/evv082.PMC4494068.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/64/evv076.PMC4494069.pdf
"Tree ﬁgures were preparedwith FigTree ( http://tree.bio.ed.ac.uk/software/ﬁgtree/ ,M a r c h 2015).",OADS,/arxiv_data1/oa_pdf/cd/64/evv076.PMC4494069.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/b5/evv080.PMC4494070.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/33/evv109.PMC4494072.pdf
"MrBayes was run on the Cipres Science Gateway (https://www.phylo.org/portal2/ , last accessed June 15, 2015) ( Miller et al.",OADS,/arxiv_data1/oa_pdf/3c/33/evv109.PMC4494072.pdf
Supplementary Material Supplementary ﬁgures S1–S3 andtables S1–S8 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/3c/33/evv109.PMC4494072.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/43/evv100.PMC4494074.pdf
The phylogenetictrees were drawn with the aid of FigTree 1.3.1 ( http://tree.bio.,OADS,/arxiv_data1/oa_pdf/2f/43/evv100.PMC4494074.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:47-58 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.47 Original Article Toward angiogenesis of implanted bio-artificial liver using scaffolds with type I collagen and adipose tissue-derived stem cells Jae Geun Lee1, Seon Young Bak2, Ji Hae Nahm3, Sang Woo Lee1,2,  Seon Ok Min1,2, and Kyung Sik Kim1,2,4 1Department of Surgery, Yonsei University College of Medicine, 2Graduate Program of Nano Science and  Technology, Graduate School of Yonsei University, 3Department of Pathology, Y onsei University College of  Medicine, 4Cell Therapy Center, Severance Hospital, Seoul, Korea Backgrounds/Aims:  Stem cell therapies for liver disease are being st udied by many researchers worldwide, but scientific  evidence to demonstrate the endocrinologic effects of implant ed cells is insufficient, an d it is unknown whether im- planted cells can function as liver cells.",Non-OADS,/arxiv_data1/oa_pdf/e8/66/kjhbps-19-47.PMC4494077.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:59-65 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.59 Original Article Prognostic effect of preoperative s equential transcatheter arterial  chemoembolization and portal vein embolization for right  hepatectomy in patients with solitary hepatocellular carcinoma Jeong-Heon Choi1, Shin Hwang1, Young-Joo Lee1, Ki-Hun Kim1, Gi-Young Ko2, Dong Il Gwon2,  Chul-Soo Ahn1, Deok-Bog Moon1, Tae-Yong Ha1, Gi-Won Song1, Dong-Hwan Jung1, and Sung-Gyu Lee1 Departments of 1Surgery and 2Diagnostic Imaging, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  Both preoperative transcatheter arterial chemoemb olization (TACE) alone and portal vein emboliza- tion (PVE) alone have a detrimental prognostic effect on the post-resection outcomes in patients with hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/d4/3f/kjhbps-19-59.PMC4494078.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:66-70 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.66 Case Report Balloon dilation of jejunal afferent loop func tional stenosis following left hepatectomy and hepaticojejunostomy long time after  pylorus-preserving pancreaticoduodenectomy: a case report Young-In Yoon1, Shin Hwang1, Gi-Young Ko2, Jae-Jun Lee1, Chul-Min Kang1,  Ji-Hyun Seo1, Yong-Jae Kwon1, and Sung-Jin Cheon1 Departments of 1Surgery and 2Diagnostic Imaging, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea We present a rare case of functional stenosis of the je junal loop following left hepatectomy and hepaticojejunostomy  long after pylorus-preserving pancreaticoduodenectomy (PPPD), which was successfully managed by balloon dilation.",Non-OADS,/arxiv_data1/oa_pdf/3b/df/kjhbps-19-66.PMC4494079.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:71-74 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.71 Case Report Long-term outcome of ischemic type bili ary stricture after  interventional treatment in liver liv ing donors: a report of two cases Dong-Hwan Jung, Shin Hwang, Tae-Yong Ha, Gi -Won Song, Ki-Hun Kim, Chul-Soo Ahn,  Deok-Bog Moon, Gil-Chun Park, Bo-Hyun J ung, Sung-Hwa Kwang, and Sung-Gyu Lee Division of Hepatobiliary Surgery and Liver Transplanta tion, Department of Surgery, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea The wall of normal proximal bile duct is occasionally thin  with close approximation to the right hepatic artery.",Non-OADS,/arxiv_data1/oa_pdf/7b/b5/kjhbps-19-71.PMC4494080.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:75-77 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.75 Case Report Bilateral ovarian metastasis from distal common bile duct  carcinoma developing after choledochal cyst excision Seung Eun Lee1, Yoo Shin Choi1, Mi Kyung Kim2, Hyoung-Chul Oh3, and Jae Hyuk Do3 1Department of Surgery, 2Department of Pathology and 3Devision of Gastroenterology,  Chung-Ang University College of Medicine, Seoul, Korea Ovarian metastases represent about 3-5% of all ovarian malig nancies.",Non-OADS,/arxiv_data1/oa_pdf/dc/7f/kjhbps-19-75.PMC4494081.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:78-81 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.78 Case Report Gallstone ileus indu cing obstructive jaundice at the afferent loop o f Roux-en-Y hepaticojejunostomy after bile duct cancer surgery:  a case report Hyun Gu Lee, Shin Hwang, Yo-Han Joo, Yu-Jeong Cho, and Kyunghak Choi Department of Surgery, Asan Medical Center, Univer sity of Ulsan College of Medicine, Seoul, Korea The diagnosis of gallstone ileus is occasionally challenging du e to the variability of its pr esentation.",Non-OADS,/arxiv_data1/oa_pdf/ca/69/kjhbps-19-78.PMC4494082.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:82-85 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.82 Case Report A rare case of gallbladder torsion along the axis of body:  a case report Hyung Jun Kwon, and Sang Geol Kim Department of Surgery, Kyungpook National University Medical Center, Daegu, Korea Abnormal attachment of the gallbladder to the liver is the main cause for gallbladder torsion.",Non-OADS,/arxiv_data1/oa_pdf/c3/2c/kjhbps-19-82.PMC4494083.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:86-88 http://dx.doi.org/10.147 01/kjhbps.2015.19.2.86 Editorial Gallbladder neck cancer and perihilar cholangiocarcinoma -  siblings, cousins or look alikes ?",Non-OADS,/arxiv_data1/oa_pdf/00/a6/kjhbps-19-86.PMC4494084.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:1-5 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.1 Original Article An interim safety analysis of hepatocellular carcinoma patients  administrating oral vitamin K with or without sorafenib Dong-Hwan Jung1, Shin Hwang1, Gi-Won Song1, Baek-Yeol Ryoo2,  Nayoung Kim3, Eunyoung Tak3, and Hea-Nam Hong4 Departments of 1Surgery and 2Oncology, Asan Medical Center, Univer sity of Ulsan College of Medicine, 3Asan Institute for Life Sciences, Asan Medical Center, 4Department of Anatomy and Cell Biology,  University of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  Vitamin K may plays a role in controlling hepatoce llular carcinoma (HCC) cell growth.",Non-OADS,/arxiv_data1/oa_pdf/a8/eb/kjhbps-19-1.PMC4494089.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:11-16 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.11 Original Article Survival analysis following resection of AJCC stage III gallbladde r  carcinoma based on different combinations of T and N stages Kyoung-Yeon Hwang*, Young-In Yoon*, Shin  Hwang, Tae-Yong Ha, Chul-Soo Ahn,  Ki-Hun Kim, Deok-Bog Moon, Gi-Won Song, Dong-Hwan Jung , Young-Joo Lee,  Kwang-Min Park, and Sung-Gyu Lee Department of Surgery, Asan Medical Center, Univer sity of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  According to 7th AJCC TNM staging system, ga llbladder carcinoma (GBC) with lymph node (LN)  metastasis is classified as N1 or N2; thus making the stage  IIIB (N1) or IVB (N2).",Non-OADS,/arxiv_data1/oa_pdf/5e/a0/kjhbps-19-11.PMC4494090.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:17-24 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.17 Original Article Therapeutic effect of trans-drain  administration of antibiotics  in patients showing intractabl e pancreatic leak-associated  pus drainage after pancreaticoduodenectomy Young-In Yoon, Shin Hwang, Yu-Jeong Cho, Ta e-Yong Ha, Gi-Won Song, and Dong-Hwan Jung Department of Surgery, Asan Medical Center, Univer sity of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  To cope with intractable pus drainage from persistent pancreatic leak after pancreaticoduodenectomy  (PD), we have empirically performed loca l administration of high-concentration antibiotics cocktail solution into abdomi- nal drains.",Non-OADS,/arxiv_data1/oa_pdf/09/0a/kjhbps-19-17.PMC4494091.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:25-29 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.25 Original Article Pneumatosis intestinalis after adult living donor liver  transplantation: report of three cases  and collective literature review Cheon-Soo Park1, Shin Hwang2, Dong-Hwan Jung2, Gi-Won Song2, Deok-Bog Moon2,  Chul-Soo Ahn2, Gil-Chun Park2, Ki-Hun Kim2, Tae-Yong Ha2, and Sung-Gyu Lee2 1Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung,  2Department of Surgery, Asan Medi cal Center, University of Ulsan College of Medicine, Seoul, Korea Backgrounds/Aims:  Pneumatosis intestinalis (PI) is  a condition in which multiple ga s-filled mural cysts develop in the  gastrointestinal tract.",Non-OADS,/arxiv_data1/oa_pdf/2f/fb/kjhbps-19-25.PMC4494092.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:30-34 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.30 Case Report Customized left-sided hepatectomy and bile duct resection  for perihilar cholangiocarcinoma in a patient with left-sided  gallbladder and multiple combined anomalies Helayel Almodhaiberi1,2, Shin Hwang1, Yoo-Jeong Cho1,  Yongjae Kwon1, Bo-Hyun Jung1, and Myeong-Hwan Kim3 Departments of 1Surgery and 3Gastroenterology, Asan Medical Center, Un iversity of Ulsan College of Medicine,  Seoul, Korea, 2Department of Hepatobiliary and Liver Tr ansplant Unit, General Surgery Department,  Prince Sultan Military Medical City, Riyadh, Saudi Arabia Left-sided gallbladder (LSGB) is a rare anomaly, but it is  often associated with multiple combined variations of the  liver anatomy.",Non-OADS,/arxiv_data1/oa_pdf/5f/9d/kjhbps-19-30.PMC4494093.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:35-39 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.35 Case Report Endovascular stenting of the inferior vena cava in a patient  with Budd-Chiari syndrome and main hepatic vein thrombosis:  a case report Young-In Yoon1, Shin Hwang1, Gi-Young Ko2, Tae-Yong Ha1, Gi-Won Song1,  Dong-Hwan Jung1, Young-Sang Lee3, and Sung-Gyu Lee1 Departments of 1Surgery, 2Diagnostic Imaging, and 3Gastroenterology,  Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Endovascular stenting is accepted as an effective treatment  for patients with Budd-Chiar i syndrome (BCS).",Non-OADS,/arxiv_data1/oa_pdf/ed/e8/kjhbps-19-35.PMC4494094.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:40-46 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.40 Case Report Fenestration of liver cysts in  polycystic liver disease to  improve quality of life: a case report and literature review Dong-Hwan Jung, Shin Hwang, Chul-Soo Ahn, Deok-Bog Moon, Gi-Won Song,  Ki-Hun Kim, Tae-Yong Ha, Gil-Chun Park, and Sung-Gyu Lee Division of Hepatobiliary Surgery and Liver Transplantation, Depa rtments of Surgery,  Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Polycystic liver disease (PCLD) is characterized by a large number of liver cysts scattered throughout the liver  parenchyma.",Non-OADS,/arxiv_data1/oa_pdf/ff/8f/kjhbps-19-40.PMC4494095.pdf
"Korean J Hepatobiliary Pancreat Surg 2015;19:6-10 http://dx.doi.org/10.147 01/kjhbps.2015.19.1.6 Original Article Gallbladder perforation: a single center experience of 32 cases Gopalakrishnan Gunasekaran, Debasis Na ik, Ashwani Gupta, Vimal Bhandari,  Manigandan Kuppusamy, Gaind Kumar, and Niuto S Chishi Department of Surgery, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India Backgrounds/Aims:  Gallbladder perforation is a rare but potentially fatal disease.",Non-OADS,/arxiv_data1/oa_pdf/5d/c2/kjhbps-19-6.PMC4494096.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/58/ijwh-7-663.PMC4494101.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 663–672International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  663RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6682 4endometriosis and ovarian cancer: links, risks,  and challenges faced Mary ellen Pavone1 Brianna M Lyttle2 1Division of Reproductive  endocrinology and Infertility,   Department of Obstetrics and  Gynecology, Northwestern University  Feinberg School of Medicine, Chicago,   IL, USA; 2Department of Obstetrics  and Gynecology, University of  Massachusetts Medical School,   Worcester, MA, USAAbstract:  Endometriosis is a benign gynecological condition characterized by specific histological,  molecular, and clinical findings.",Non-OADS,/arxiv_data1/oa_pdf/1a/58/ijwh-7-663.PMC4494101.pdf
"Recent advances in technology have allowed for further characterization of  endometriosis associated ovarian cancers (EAOCs), leading to the identification of Correspondence: Mary ellen Pavone Division of Reproductive endocrinology  and Infertility, Department of Obstetrics  and Gynecology, Northwestern  University Feinberg School of Medicine,  675 North St Clair, Suite 14-200,  Chicago, IL 60611, USA Tel +1 312 695 7269 email m-pavone@northwestern.ed u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Pavone and Lyttle Running head recto: Endometriosis and ovarian cancer DOI: http://dx.doi.org/10.2147/IJWH.S66824",Non-OADS,/arxiv_data1/oa_pdf/1a/58/ijwh-7-663.PMC4494101.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1a/58/ijwh-7-663.PMC4494101.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/58/ijwh-7-663.PMC4494101.pdf
Available from: https://www.sgo.org/clinical- practice/guidelines/sgo-clinical-practice-statement-salpingectomy-for- ovarian-cancer-prevention/.,Non-OADS,/arxiv_data1/oa_pdf/1a/58/ijwh-7-663.PMC4494101.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/1f/dddt-9-3455.PMC4494175.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3455–3458Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3455Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8643 8Siltuximab (CNTO 328): a promising option  for human malignancies Runzhe Chen Baoan Chen Department of Hematology and  Oncology, Zhongda Hospital, Medical  School, Southeast University, Nanjing,   Jiangsu Province, People’s Republic  of ChinaAbstract:  Siltuximab (CNTO 328) is a promising antibody-drug conjugate targeting cytokine  interleukin-6 (IL-6).",Non-OADS,/arxiv_data1/oa_pdf/a4/1f/dddt-9-3455.PMC4494175.pdf
"Mechanisms The main mechanism of siltuximab is verified highly binding to cytokine IL-6 and  thus neutralizing IL-6 bioactivity.10 IL-6 has various functions, including its critical  role in B cell development, neuronal cell differentiation, myeloid lineage maturation,  immune response, hepatic function, and bone resorption,10 and it also plays a pivotal  role in the progression, differentiation, survival, and angiogenesis of malignant cells.11  Growing evidence suggests that blocking IL-6 may be an effective strategy in diseases  with IL-6 dysregulation.6,10,12 IL-6 plays an important role in Janus kinase/signal transducer and activator of  transcription (JAK-STAT) pathway according to the research.13 The STAT family  of transcription factors are potential targets for the treatment and prevention of can - cers.14 Siltuximab could inhibit STAT3 tyrosine phosphorylation in a cell-dependent  manner and thus inhibiting tumor growth.8,15 Siltuximab can also decrease p44/p42  mitogen-activated protein kinases (MAPK) and phosphoinositide 3-kinase (PI3K)/ Akt pathway in cancer cells.16–18 IL-6 can promote the angiogenesis within the tumor  microenvironment by co-regulating tumor necrosis factor- α (TNF-α), interleukin-1 Correspondence: Baoan Chen Department of Hematology and  Oncology, Zhongda Hospital, Medical  School, Southeast University, Dingjiaqiao  87, Gulou District, Nanjing 210009,  Jiangsu Province, People’s Republic  of China Tel +86 25 8327 2006 Fax +86 25 8327 2011 email cba8888@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Chen and Chen Running head recto: Siltuximab (CNTO 328) DOI: http://dx.doi.org/10.2147/DDDT.S86438",Non-OADS,/arxiv_data1/oa_pdf/a4/1f/dddt-9-3455.PMC4494175.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a4/1f/dddt-9-3455.PMC4494175.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/1f/dddt-9-3455.PMC4494175.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/5b/cia-10-1085.PMC4494176.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1085–1090Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1085OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7443 9Depressive symptoms in caregivers of patients  with dementia: demographic variables and burden Pasquale De Fazio1 Paola Ciambrone1 gregorio Cerminara1 elvira Barbuto1 Antonella Bruni1 Patrizia gentile1 Amalia Talarico2 roberto lacava2 Pietro gareri2 Cristina segura-garcía1 1Psychiatric Unit, Department of  health sciences, University Magna  graecia, Catanzaro, Italy; 2Unit for  the elderly, AsP Catanzaro, Catanzaro,   ItalyObjective:  Individuals suffering from dementia are affected by a progressive and significant  global deterioration and, consequently, might require longer assistance in the advanced stage  of the illness.",Non-OADS,/arxiv_data1/oa_pdf/26/5b/cia-10-1085.PMC4494176.pdf
"Therefore, it  is expected to reach 65.7 million in 2030 and 115.4 million by 2050.1 Individuals suffering from dementia are affected by a progressive and significant  global deterioration and, consequently, might require longer assistance in the advanced  stage of the illness.2,3 The person who takes care of a patient with dementia is known  as a caregiver; in most cases, the caregiver is a family member.4 Assisting a person affected by cognitive disorders can drain the emotional resources  of any individual so much that the caregiver is often defined as “the hidden patient” Correspondence: Pasquale De Fazio Psychiatric Unit, Department of health  sciences, University Magna graecia,   Viale europa, Catanzaro 88100, Italy Tel +39 0961 712 408 Fax +39 0961 712 393 email defazio@unicz.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: De Fazio et al Running head recto: Burden of dementia on caregivers DOI: http://dx.doi.org/10.2147/CIA.S74439",Non-OADS,/arxiv_data1/oa_pdf/26/5b/cia-10-1085.PMC4494176.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/26/5b/cia-10-1085.PMC4494176.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/26/5b/cia-10-1085.PMC4494176.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dddt-9-3413.PMC4494177.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3413–3421Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3413Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8792 0Anti-veGF treatment for myopic choroid  neovascularization: from molecular  characterization to update on clinical application Yan Zhang1 Qian Han2 Yusha Ru1 Qiyu Bo1 Rui Hua wei1 1Tianjin Medical University eye  Hospital, Tianjin Medical University  eye institute, College of Optometry  and Ophthalmology, Tianjin Medical  University, Tianjin, 2Tangshan eye  Hospital, Tangshan, Hebei Province,   People’s Republic of ChinaAbstract:  Choroidal neovascularization (CNV) secondary to pathologic myopia has a very  high incidence in global, especially in Asian, populations.",Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dddt-9-3413.PMC4494177.pdf
"It severely deteriorates quality of life and  generates huge socioeconomic burdens as it mainly affects the population aged 40  and above.4 Traditional therapeutic modalities for myopic CNV include laser photo - coagulation for extrafoveal and juxtafoveal CNV,5,6 and verteporfin photodynamic  therapy (PDT) for subfoveal CNV.7,8 Nonetheless, the patients with myopic CNV  show variable responses to these modalities9–16 and have a poor natural history.17   On the other hand, pilot studies have recently demonstrated the safety and promising  efficacy of anti-VEGF therapy in treating CNV secondary to pathologic myopia, and  the anti-VEGF agents have been proposed as the first-line therapy for subfoveal and  juxtafoveal myopic CNV.18Correspondence: Rui Hua wei Tianjin Medical University eye  Hospital, College of Optometry  and Ophthalmology, Tianjin Medical  University, Fukang Road 251, Nankai  District, Tianjin 300384, People’s  Republic of China Tel +86 22 5828 0862 Fax +86 22 5828 6434 email rwei07@tmu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: Anti-VEGF for myopic CNV DOI: http://dx.doi.org/10.2147/DDDT.S87920",Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dddt-9-3413.PMC4494177.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dddt-9-3413.PMC4494177.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/d8/dddt-9-3413.PMC4494177.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/0d/copd-10-1265.PMC4494178.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1265–1273International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1265OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8337 8Prediction of short term re-exacerbation in  patients with acute exacerbation of chronic  obstructive pulmonary disease Dong liu1 shao-hua Peng2,3 Jing Zhang2 si-hong Bai2,4 hai-Xia liu1 Jie-Ming Qu1,5 1Department of Pulmonary Medicine,   huadong hospital, 2Department  of Pulmonary Medicine, Zhongshan  hospital, shanghai Medical College,   Fudan University, shanghai, 3shaowu  Municipal hospital, Fujian, 4The  People’s hospital of song County,   henan Province, 5ruijin hospital,   shanghai Jiaotong University,    school of Medicine, shanghai,    People’s republic of ChinaBackground:  The objective of the study is to develop a scoring system for predicting a  90-day re-exacerbation in hospitalized patients with acute exacerbations of chronic obstructive  pulmonary disease (AECOPD).",Non-OADS,/arxiv_data1/oa_pdf/57/0d/copd-10-1265.PMC4494178.pdf
"However, to our knowledge, few Correspondence: Jing Zhang Department of Pulmonary Disease,  Zhongshan hospital, shanghai Medical  College, Fudan University, no 180  of Fenglin road, shanghai 200032,  People’s republic of China email zhang.jing@zs-hospital.sh.c n  Jie-Ming Qu Department of Pulmonary Medicine,  huadong hospital, shanghai Medical  College, Fudan University, no 221  of Yan’an West road, shanghai,  People’s republic of China email jmqu0906@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Liu et al Running head recto: Re-exacerbation in patients with AECOPD DOI: http://dx.doi.org/10.2147/COPD.S83378",Non-OADS,/arxiv_data1/oa_pdf/57/0d/copd-10-1265.PMC4494178.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/57/0d/copd-10-1265.PMC4494178.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/0d/copd-10-1265.PMC4494178.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/57/0d/copd-10-1265.PMC4494178.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/d2/ijn-10-4225.PMC4494179.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4225–4237International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4225OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8455 5Nonspecifically enhanced therapeutic effects of  vincristine on multidrug-resistant cancers when  coencapsulated with quinine in liposomes Yuzhen Xu1 Liyan Qiu2 1College of Pharmaceutical Sciences,   2Ministry of Education Key Laboratory  of Synthesis and Functionalization,   Department of Polymer Science and  Engineering, Zhejiang University,   Hangzhou, People’s Republic of ChinaAbstract:  The use of vincristine (VCR) to treat cancer has been limited by its dose-dependent  toxicity and development of drug resistance after repeated administrations.",Non-OADS,/arxiv_data1/oa_pdf/03/d2/ijn-10-4225.PMC4494179.pdf
"Encapsulation of VCR into sphingomyelin and  cholesterol liposomes reduces toxicity and allows larger doses to be delivered with greater  specificity to target tissues.4 Accordingly, VCR sulfate liposome injections have been  approved by the US Food and Drug Administration for the treatment of relapsed and clini - cally advanced Philadelphia chromosome-negative acute lymphoblastic leukemia.4 Furthermore, resistance to VCR has been developed by a number of tumors, and  this has become one of the most significant impediments to successful chemotherapy of  cancer.5 It has been confirmed that cellular resistance to VCR is predominantly related  to overexpression of P-glycoprotein (P-gp) on cancer cell membranes.6 We have devel - oped a VCR and quinine hydrochloride (QN) codelivery liposome called VQL in order   to increase the chemotherapeutic efficacy of VCR by restoring drug sensitivity and  decreasing the systemic side effects.Correspondence: Liyan Qiu Ministry of Education Key Laboratory  of Synthesis and Functionalization,  Department of Polymer Science and  Engineering, Zhejiang University,  38 Zheda Road, Hangzhou 310027,  People’s Republic of China Tel +86 571 8795 2306 Fax +86 571 8795 2306 Email lyqiu@zju.edu.cn Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Xu and Qiu Running head recto: Vincristine and quinine coloaded liposome DOI: http://dx.doi.org/10.2147/IJN.S84555",Non-OADS,/arxiv_data1/oa_pdf/03/d2/ijn-10-4225.PMC4494179.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/03/d2/ijn-10-4225.PMC4494179.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/d2/ijn-10-4225.PMC4494179.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/c3/dddt-9-3423.PMC4494180.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3423–3434Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3423Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8519 3Pharmacokinetics, pharmacodynamics, and safety  of lesinurad, a selective uric acid reabsorption  inhibitor, in healthy adult males Zancong shen colin rowlings Brad Kerr Vijay hingorani Kimberly Manhard Barry Quart li-Tain Yeh chris storgard ardea Biosciences, inc. (a member  of the astraZeneca group), san Diego,   ca, UsaAbstract:  Lesinurad is a selective uric acid reabsorption inhibitor under investigation for  the treatment of gout.",Non-OADS,/arxiv_data1/oa_pdf/ce/c3/dddt-9-3423.PMC4494180.pdf
"URAT1 is responsible for the majority  of the reabsorption of filtered uric acid from the renal tubular lumen.4–6 By inhibiting correspondence: Zancong shen ardea Biosciences, inc., 9390 Towne  centre Drive, san Diego, ca 92121, Usa Tel +1 858 652 6623 email zshen@ardeabio.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Shen et al Running head recto: Pharmacokinetics, pharmacodynamics, and safety of lesinurad DOI: http://dx.doi.org/10.2147/DDDT.S85193",Non-OADS,/arxiv_data1/oa_pdf/ce/c3/dddt-9-3423.PMC4494180.pdf
Available from: http://decisionresources.com/Products- and-Services/Report?r =dbaspd181 0.,OADS,/arxiv_data1/oa_pdf/ce/c3/dddt-9-3423.PMC4494180.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ce/c3/dddt-9-3423.PMC4494180.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/c3/dddt-9-3423.PMC4494180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/79/ceg-8-175.PMC4494181.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 175–182Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  175OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S8021 2Partial hepatectomy induces delayed hepatocyte  proliferation and normal liver regeneration in  ovariectomized mice Makoto Umeda1 Masaki hiramoto1,2 Takeshi imai1 1Department of aging intervention,   national Center for Geriatrics  and Gerontology, Obu, aichi, Japan;   2Department of Biochemistry, Tokyo  Medical University, T okyo, Japan Correspondence: Takeshi imai   Department of aging intervention,  national Center for Geriatrics and  Gerontology, Obu, aichi  474-8511, Japan   Tel +81 562 46 2311  Fax +81 562 46 8397  Email dai.ncgg@gmail.co mAbstract:  Estrogens play central roles in sexual development, reproduction, and hepatocyte  proliferation.",Non-OADS,/arxiv_data1/oa_pdf/b6/79/ceg-8-175.PMC4494181.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/b6/79/ceg-8-175.PMC4494181.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/79/ceg-8-175.PMC4494181.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/6c/ijn-10-4203.PMC4494182.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4203–4223International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4203OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8395 3comparative assessment of the apoptotic  potential of silver nanoparticles synthesized  by Bacillus tequilensis  and Calocybe indica   in MD a-MB-231 human breast cancer cells:  targeting p53 for anticancer therapy sangiliyandi gurunathan Jung hyun Park Jae Woong han Jin-hoi Kim Department of animal Biotechnology,   Konkuk University, seoul, republic  of KoreaBackground:  Recently, the use of nanotechnology has been expanding very rapidly in diverse  areas of research, such as consumer products, energy, materials, and medicine.",Non-OADS,/arxiv_data1/oa_pdf/da/6c/ijn-10-4203.PMC4494182.pdf
"correspondence: sangiliyandi gurunathan Department of animal Biotechnology  Konkuk University, 120 gwangjin-gu,  seoul 143-701, republic of Korea email gsangiliyandi@yahoo.co m Jin-hoi Kim Department of animal Biotechnology,  Konkuk University, seoul 143-701,  republic of Korea Tel +82 2 450 3687 Fax +82 2 544 4645 email jhkim541@konkuk.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Gurunathan et al Running head recto: Targeting p53 for anticancer therapy DOI: http://dx.doi.org/10.2147/IJN.S83953",Non-OADS,/arxiv_data1/oa_pdf/da/6c/ijn-10-4203.PMC4494182.pdf
Available  from http://www.who.int/healthinfo/global_burden_disease/GBD_ report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/6c/ijn-10-4203.PMC4494182.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/da/6c/ijn-10-4203.PMC4494182.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/6c/ijn-10-4203.PMC4494182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2015:9 47–56Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  47Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5735 6emerging treatments and combinations in the  management of NSCLC: clinical potential of  nintedanib Martin Reck1 Anders Mellemgaard2 1Department of Thoracic Oncology,  Lung Clinic Grosshansdorf, and  member of the Airway Research  Center North, German Center  for Lung Research, Grosshansdorf,  Germany;  2Department of Oncology,  Herlev University Hospital,  Copenhagen, Denmark Correspondence: Martin Reck   Department of Thoracic Oncology,   Lung Clinic Grosshansdorf,  wohrendamm  80, 22927 Grosshansdorf,   Germany   Tel +49 4102 601 2101   Fax +49 4102 601 247   email dr.martin.reck@web.d eAbstract:  There remains an unmet need for effective, well-tolerated treatment options in  advanced non-small cell lung cancer (NSCLC) to alleviate the disease burden for a broad selec - tion of patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
"Nintedanib (Vargatef®;  Boehringer Ingelheim Ltd, Ingelheim, Germany) is a triple  angiokinase inhibitor ( https://youtu.be/0gDnGFumAX E)  that simultaneously inhibits signaling pathways activated by VEGF , fibroblast growth factor (FGF), and platelet-derived  growth factor (PDGF).",Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
Available from: http://globocan.iarc.fr/ Pages/fact_sheets_cancer.aspx #.,Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
"Available from: http://www.nccn.org/professionals/  physician_gls/pdf/nscl.pd f. Accessed February  19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
"Available from: http://ec.europa.eu/health/  documents/community-register/2014/20141121130020/anx_130020_ en.pd f. Accessed March  19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0223116 4.,Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
2014. http://clinicaltrials.gov/ct2/show/ NCT0102492 0.,Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
"Available from: http://www.fda.gov/ newsevents/newsroom/pressannouncements/ucm418994.ht m. Accessed  February  19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/6b/67/btt-9-047.PMC4494183.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 377–385ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  377ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7468 2impact of noncommunicable diseases in the state  of Qatar salma Khalaf al-Kaabi andrew atherton supreme Council of health,    Doha, Qatar Correspondence: salma Khalaf al-Kaabi   supreme Council of health, al Rumaila  West, PO Box 42, Doha, Qatar   Email skalkaabi@sch.gov.q aAbstract:  This study, commissioned by the Supreme Council of Health in the State of Qatar,  focuses on the main noncommunicable diseases (NCDs) globally and regionally, in order to gauge  their potential impact on Qatar.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"available from: http://www.who.int/mediacentre/factsheets/fs310/en/index2.htm l. accessed  October 20, 2014.4 Abbreviations:  HIV, human immunodeficiency virus; AIDS, acquired immune deficiency syndrome; COPD chronic obstructive pulmonary disease; LRTI, lower respiratory  tract infection.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"available from: http://www.who.int/mediacentre/factsheets/fs310/en/index2.htm l. accessed  October 20, 2014.4 Abbreviations:  COPD chronic obstructive pulmonary disease; LRTI, lower respiratory tract infection.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.who.int/chp/steps/Qatar_ Factsheet_2012.pd f. accessed December 24, 2014.11",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.booz.com/me/home/thought_leadership_strategy/reports_and_white_papers_me/display/the-68-billion-dollar- challenge?cm_mid=3108890&cm_crmid={95462fe6-3e45-475a-bb64-5f541513f176}&cm_medium=emai l. accessed March 24, 2014.10 0246(Millions)81012 9.9Visits and admissions, 2013–2022O utpatient visits by country, 2013 9.3 0.4 2013 2014 2015 2016 2017 2018 2019 2020 2021 Inpatient admissionsBahrain Kuwait Oman Qatar Saudi Arabia United Arab Emirates Outpatient visits20220.4 0.5 0.5 0.5 50%1% 5%8%4% 32%10.511.211.9 Figure 5 Visits and admissions for noncommunicable diseases in 2013–2022.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.booz.com/me/home/thought_leadership_strategy/reports_and_white_papers_me/display/the-68-billion-dollar- challenge?cm_mid=3108890&cm_crmid={95462fe6-3e45-475a-bb64-5f541513f176}&cm_medium=emai l. accessed March 24, 2014.10study to calculate the cost of illness.6 This model is based  on information that is more robust and readily available  (such as the prevalence rates of the main NCDs), so the  conclusions drawn can be regarded as more robust.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.instituteofhealthequity.org/Content/ FileManager/pdf/fairsocietyhealthylives.pd f. Accessed May 19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available  from: http://www.who.int/mediacentre/factsheets/fs310/en/index2.htm l.  Accessed October 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.who.int/chp/chronic_ disease_ report/full_report.pd f. Accessed April 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.hsph.harvard.edu/ program-on-the-global-demography-of-aging/WorkingPapers/2012/ PGDA_WP_87.pd f. Accessed December 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Avail - able from: http://www.ncdalliance.org/sites/default/files/resource_files/ Brief%20-%20%20Disability%20and%20NCD.pd f. Accessed May 19,  2014.",OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
Available from: http://www.who.int/healthinfo/global_ burden_ disease/en /.,Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.booz.com/me/ home/thought_leadership_strategy/reports_and_white_papers_me/ display/the-68-billion-dollar-challenge?cm_mid =3108890&cm_ crmid={95462fe6-3e45-475a-bb64-5f541513f176}&cm_ medium=emai l. Accessed March 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
Available from: http://www.who.int/chp/steps/Qatar_FactSheet_2012.,Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
Available from:  http://www.booz.com/me/home/press_media/management_ consulting_ press_releases/article/5320781 2.,Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: https://www2.deloitte.com/content/ dam/Deloitte/global/Documents/Life-Sciences-Health-Care/dttl-lshc- 2014-global-health-care-sector-report.pd f. Accessed May 19, 2014.",OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.sch.gov.qa/about-sc h. Accessed February  19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
"Available from: http://www.who.int/chp/steps/Part6_Section3B.pd f.  Accessed March 10, 2014.",OADS,/arxiv_data1/oa_pdf/5b/26/ceor-7-377.PMC4494184.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4239–4253International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4239OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8340 2compound antimalarial ethosomal cataplasm:  preparation, evaluation, and mechanism of   penetration enhancement shuo shen shu-Zhi liu Yu-shi Zhang Mao-Bo Du ai-hua liang li-hua song Zu-guang Ye Institute of chinese Materia Medica,   china academy of chinese Medical  sciences, Beijing, People’s republic  of chinaAbstract:  Malaria is still a serious public health problem in some parts of the world.",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
"The antimalarial action of artemisinin was quick and without cross-resistance,  and it could eliminate almost all asexual and sexual stages of Plasmodium spp..2,3  correspondence: shu-Zhi liu;   Zu-guang Ye Institute of chinese Materia Medica,  china academy of chinese Medical  sciences, Dongcheng District, Dongzhimen  Nanxiao road 16, Beijing 100700,  People’s republic of china Tel +86 10 8404 3227 Fax +86 10 8404 3227 email liushuzhi2004@sina.co m;  yezuguang@vip.sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Shen et al Running head recto: Compound antimalarial ethosomal cataplasm DOI: http://dx.doi.org/10.2147/IJN.S83402",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
Available from: http://www.who.int/malaria/publi - cations/world_malaria_report_2013/report/en /.,Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
Available from: http://www.cnki.net/kcms/detail/detail.aspx?,OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
"Available from: http://www.drugfuture.com/Pharmacopoeia/ CP2010-II/420–421.pd f. Accessed January 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
Avail - able from: http://www.zgyxzz.com.cn/CN/article/downloadArticleFile.,Non-OADS,/arxiv_data1/oa_pdf/d7/f0/ijn-10-4239.PMC4494185.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 387–395ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  387ORiginal RESEaRCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8104 5Relationship between patient dependence and  direct medical-, social-, indirect-, and informal-care  costs in Spain Josep Darbà1 lisette Kaskens2 1Department of Economics, University  of Barcelona, 2BCn Health Economics  and Outcomes Research Sl,   Barcelona, Spain Correspondence: Josep Darbà   Department of Economics,   University of Barcelona, Diagonal 690,  08034 Barcelona, Spain   Tel +34 93 4021 937   Fax +34 93 4039 082   Email darba@ub.ed uObjective:  The objectives of this analysis were to examine how patients’ dependence on others  relates to costs of care and explore the incremental effects of patient dependence measured by  the Dependence Scale on costs for patients with Alzheimer’ s disease (AD) in Spain.",Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
Available from: http://www.ine.es /.,Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
"213 Martes, 8 de noviembre de 2011  Available from: http://www.xunta.es/dog/Publicados/2011/20111108/ AnuncioC3K1-041111-8283_es.htm l. Accessed September 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
"Available from: http://www20.gencat.cat/portal/site/portaldog c.  Accessed September 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
1/87  Available from: https://sede.asturias.es/portal/site/Asturias/menuitem.,Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
"Available from: http://www.osakide - tza.euskadi.net/r85ekgnrl00/es/contenidos/informacion/libro_tarifas/ es_libro/adjuntos/tarifas2013.pd f. Accessed September 2, 2013.",Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
Available from: http://www.ine.es /prensa/np741.pdf.,Non-OADS,/arxiv_data1/oa_pdf/de/c1/ceor-7-387.PMC4494186.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/dddt-9-3445.PMC4494187.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3445–3454Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3445Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5607 1Animal models of ischemic stroke and their  application in clinical research Felix Fluri Michael K Schuhmann Christoph Kleinschnitz Department of Neurology, University  Clinic wuerzburg, wuerzburg,   GermanyAbstract:  This review outlines the most frequently used rodent stroke models and discusses  their strengths and shortcomings.",Non-OADS,/arxiv_data1/oa_pdf/d8/9b/dddt-9-3445.PMC4494187.pdf
"kleinschnitz@uni- wuerzburg.d eJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Fluri et al Running head recto: Animal models of ischemic stroke DOI: http://dx.doi.org/10.2147/DDDT.S56071",Non-OADS,/arxiv_data1/oa_pdf/d8/9b/dddt-9-3445.PMC4494187.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d8/9b/dddt-9-3445.PMC4494187.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/9b/dddt-9-3445.PMC4494187.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/d0/cia-10-1091.PMC4494188.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1091–1096Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1091CAse reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CIA.S8282 3Hyponatremia after initiation and rechallenge  with trimethoprim–sulfamethoxazole in an older  adult Ashley M Huntsberry1 sunny A Linnebur1 Maria Vejar2 1University of Colorado skaggs school  of pharmacy and pharmaceutical  sciences, Aurora, Co , UsA; 2Division  of Geriatrics, Department of Internal  Medicine, University of Colorado  school of Medicine, Aurora, Co , UsAPurpose:  The purpose of this study is to describe a case report of a patient experiencing  hyponatremia from trimethoprim–sulfamethoxazole (TMP–SMX) upon initial use and  subsequent rechallenge.",Non-OADS,/arxiv_data1/oa_pdf/9b/d0/cia-10-1091.PMC4494188.pdf
"Common  adverse reactions include nausea, vomiting, anorexia, and diarrhea, as well as urti - carial and allergic skin reactions.1 More serious side effects such as Stevens–Johnson  Syndrome, toxic epidermal necrolysis, aplastic anemia, agranulocytosis, and fulminant  hepatic necrosis are rare but have been reported.1 There have been several reports of  electrolyte abnormalities such as severe and symptomatic hyponatremia in patients  receiving TMP–SMX, however, it is usually accompanied by hyperkalemia.4Correspondence: sunny A Linnebur University of Colorado skaggs school  of pharmacy and pharmaceutical sciences,  room V20-2125, 12850 east Montview  Boulevard, Aurora, Co 80045, UsA email s unny.linnebur@ucdenver.ed u Journal name: Clinical Interventions in Aging Article Designation: Case report Y ear: 2015 Volume: 10 Running head verso: Huntsberry et al Running head recto: Hyponatremia after initiation and rechallenge with TMP–SMX in an older adult DOI: http://dx.doi.org/10.2147/CIA.S82823",Non-OADS,/arxiv_data1/oa_pdf/9b/d0/cia-10-1091.PMC4494188.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/9b/d0/cia-10-1091.PMC4494188.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9b/d0/cia-10-1091.PMC4494188.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
http://dx.doi.org/10.1016/j.prnil.2015.03.004 p2287-8882 e2287-903X/ ©2015 Published by Elsevier B.V. on behalf of Prostate International.Prostate International 3 (2015) 62 e64,Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
"Discussion There is increasing recognition that the nonmotor symptoms of PD are the most troublesome as the disease advances, and promi- nent among these are LUTS.10,11http://www.sciencedirect.com/ science/article/pii/S0022534709000718 LUTS have a great impact on quality of life, early institutionalization, and health economics.",Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
"http://www.sciencedirect.com/science/article/pii/ S0022534709000718 In patients with PD, the most prevalent LUTS is nocturia and the most common urodynamic ﬁnding is detrusor overactivity, usually with complete bladder emptying.",Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
"In PD, widespread degeneration of dopaminergic and nondopaminergic areas involved in lower urinary tract function is prominent, including locus coeruleus, cerebellar Purkinje cells, dorsal motor nucleus of the vagus, intermediolateral cell column (preganglionic neurons innervating the internal sphincter and the bladder), and Onuf's nucleus (neurons innervating the external sphincter).12 http://www.sciencedirect.com/science/article/pii/S0022534709000718 In PD, neurodegeneration in the nigrostriatal dopamine system removes the tonic inhibitory control over the pontine micturition center, resulting in decreased bladder capacity and detrusor overactivity.",Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
"http://www.sciencedirect.com/science/ article/pii/S0022534709000718 Neurogenic detrusor overactivity in PD is easily explained, because dopaminergic mechanisms are thought to play a central role in normal micturition control and dysfunction of these may lead to detrusor overactivity.",Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
"com/science/article/pii/S0022534709000718 Although impaired relaxation or bradykinesia of the urethral sphincter has been sug- gested to result in voiding dysfunction, http://www.sciencedirect.Table 1 Characteristics of PD patients.",Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
com/science/article/pii/S0022534709000718 urodynamic studies have shown that bladder outlet obstruction is not common in PD.14 http://www.sciencedirect.com/science/article/pii/S0022534709000718 .,Non-OADS,/arxiv_data1/oa_pdf/53/ea/main.PMC4494204.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org.,Non-OADS,/arxiv_data1/oa_pdf/97/d3/main.PMC4494213.pdf
http://dx.doi.org/10.1016/j.prnil.2015.03.002 p2287-8882 e2287-903X/ ©2015 Published by Elsevier B.V. on behalf of Prostate International.Prostate International 3 (2015) 51 e55,Non-OADS,/arxiv_data1/oa_pdf/97/d3/main.PMC4494213.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org http://dx.doi.org/10.1016/j.prnil.2015.02.003 p2287-8882 e2287-903X/ ©2015 Published by Elsevier B.V. on behalf of Prostate International.Prostate International 3 (2015) 6 e9,Non-OADS,/arxiv_data1/oa_pdf/41/5e/main.PMC4494537.pdf
Contents lists available at ScienceDirect Prostate International journal homepage: http://p-international.org http://dx.doi.org/10.1016/j.prnil.2015.02.007 p2287-8882 e2287-903X/ ©2015 Published by Elsevier B.V. on behalf of Prostate International.Prostate International 3 (2015) 31 e34,Non-OADS,/arxiv_data1/oa_pdf/2e/1a/main.PMC4494599.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/d1/opth-9-1159.PMC4494604.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1159–1163Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1159ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8072 4Plateau iris in Japanese patients with primary  angle closure and primary angle closure glaucoma Takanori Mizoguchi1 Mineo Ozaki2,3 Harumi Wakiyama1,4 Nobuchika Ogino1,5 1Mizoguchi Eye Clinic, Nagasaki, Japan;   2Ozaki Eye Clinic Miyazaki, Japan;   3Department of Ophthalmology,   Faculty of Medicine, University  of Miyazaki, Miyazaki, Japan; 4The  Japanese Red Cross Nagasaki  Genbaku Hospital, Nagasaki, Japan;   5Nishigaki Eye Clinic, Nagoya, JapanPurpose:  To determine the prevalence of plateau iris in Japanese patients with primary angle  closure (PAC) and primary angle closure glaucoma (PACG) and analyze the biometric parameters  in patients with plateau iris using ultrasound biomicroscopy (UBM).",Non-OADS,/arxiv_data1/oa_pdf/f5/d1/opth-9-1159.PMC4494604.pdf
"Recent evidence has shown  that non-pupil block mechanisms, such as plateau iris, may play a more important role  in the PACG than previously thought.7,8 Irido-angle contact with plateau iris after LPI  is thought to be one of the causes for progression of the angle closure disease.9–11 There  are some reports that 30% of PAC suspects (PACS) from Singapore8 and 60% of PACS  from the People’s Republic of China were found to have plateau iris configuration.12Correspondence: Takanori Mizoguchi Mizoguchi Eye Clinic, 6-13 Tawara-machi,  Sasebo, Japan 857-0016 Tel +81 956 22 5681 Fax +81 956 25 6040 Email t-mizo@siren.ocn.ne.j pJournal name: Clinical Ophthalmology Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 9 Running head verso: Mizoguchi et al Running head recto: Plateau iris in Japanese patients with PAC and PACG DOI: http://dx.doi.org/10.2147/OPTH.S80724",Non-OADS,/arxiv_data1/oa_pdf/f5/d1/opth-9-1159.PMC4494604.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f5/d1/opth-9-1159.PMC4494604.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/d1/opth-9-1159.PMC4494604.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1043–1045Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1043LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8809 1Which people should take aspirin for primary  prevention of cardiovascular disease?,Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
"In addition to this, it must add a greater use in general population of preventive  medications for different atherosclerotic risk factors, such as antihypertensive and  lipid-lowering drugs, and other preventive measures, which together result in fewer  events than expected.15 Correspondence: Roberto Lozano Pharmacy Department, Hospital Real de  Nuestra Señora de Gracia, C/Ramón y  Cajal 60, 50004 Zaragoza, Spain Tel +34 976 764 522 Fax +34 976 764 555 email rlozano@salud.aragon.e s Journal name: Therapeutics and Clinical Risk Management Article Designation: Letter Y ear: 2015 Volume: 11 Running head verso: Lozano and Franco Running head recto: Which people should take aspirin for primary prevention DOI: http://dx.doi.org/10.2147/TCRM.S8809 1",Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0013522 6.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0050105 9.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0103858 3.,Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/08/fd/tcrm-11-1043.PMC4494605.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/jpr-8-303.PMC4494606.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 303–309Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  303ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8280 6T emporal analysis of pain responders and  common adverse events: when do these first  appear following treatment with pregabalin Bruce Parsons Birol emir andrew clair Pfizer, new Y ork, nY, Usa correspondence: Bruce Parsons   Pfizer, 235 East 42nd Street, New York,  nY 10017, Usa   Tel +1 212 573 1649   email bruce.parsons@pfizer.co mBackground:  Pregabalin is an α2δ ligand indicated in the USA for treatment of a number of  chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, pain  associated with spinal cord injury, and fibromyalgia.",Non-OADS,/arxiv_data1/oa_pdf/c1/e2/jpr-8-303.PMC4494606.pdf
Available from: http://labeling.pfizer.com/ ShowLabeling .,Non-OADS,/arxiv_data1/oa_pdf/c1/e2/jpr-8-303.PMC4494606.pdf
